0001721868-21-000488.txt : 20210816 0001721868-21-000488.hdr.sgml : 20210816 20210816153858 ACCESSION NUMBER: 0001721868-21-000488 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210816 DATE AS OF CHANGE: 20210816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: American Cannabis Company, Inc. CENTRAL INDEX KEY: 0000945617 STANDARD INDUSTRIAL CLASSIFICATION: TELEVISION BROADCASTING STATIONS [4833] IRS NUMBER: 942901715 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-26108 FILM NUMBER: 211177446 BUSINESS ADDRESS: STREET 1: 2590 WALNUT STREET STREET 2: #6 CITY: DENVER STATE: CO ZIP: 80205 BUSINESS PHONE: 303-974-4770 MAIL ADDRESS: STREET 1: 2590 WALNUT STREET STREET 2: #6 CITY: DENVER STATE: CO ZIP: 80205 FORMER COMPANY: FORMER CONFORMED NAME: Brazil Interactive Media, Inc. DATE OF NAME CHANGE: 20130617 FORMER COMPANY: FORMER CONFORMED NAME: NATUREWELL INC DATE OF NAME CHANGE: 20000731 FORMER COMPANY: FORMER CONFORMED NAME: LA JOLLA DIAGNOSTICS INC DATE OF NAME CHANGE: 19950523 10-Q/A 1 f2sammj10q081221.htm
0000945617 true --12-31 Q2 2021 This amendment is being filed to include the ixbrl in the html file. 0000945617 2021-01-01 2021-06-30 0000945617 2021-08-13 0000945617 2021-06-30 0000945617 2020-12-31 0000945617 2021-04-01 2021-06-30 0000945617 2020-04-01 2020-06-30 0000945617 2020-01-01 2020-06-30 0000945617 2019-12-31 0000945617 2020-06-30 0000945617 us-gaap:CommonStockMember 2020-03-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000945617 us-gaap:RetainedEarningsMember 2020-03-31 0000945617 2020-03-31 0000945617 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0000945617 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0000945617 us-gaap:CommonStockMember 2020-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000945617 us-gaap:RetainedEarningsMember 2020-06-30 0000945617 us-gaap:CommonStockMember 2021-03-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000945617 us-gaap:RetainedEarningsMember 2021-03-31 0000945617 2021-03-31 0000945617 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000945617 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000945617 us-gaap:CommonStockMember 2021-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000945617 us-gaap:RetainedEarningsMember 2021-06-30 0000945617 us-gaap:CommonStockMember 2019-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000945617 us-gaap:RetainedEarningsMember 2019-12-31 0000945617 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0000945617 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0000945617 us-gaap:CommonStockMember 2020-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000945617 us-gaap:RetainedEarningsMember 2020-12-31 0000945617 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0000945617 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0000945617 us-gaap:AcquisitionRelatedCostsMember 2021-06-30 0000945617 us-gaap:OfficeEquipmentMember 2021-06-30 0000945617 us-gaap:SoftwareDevelopmentMember 2020-12-31 0000945617 us-gaap:SoftwareDevelopmentMember 2021-06-30 0000945617 us-gaap:OfficeEquipmentMember 2020-12-31 0000945617 us-gaap:FurnitureAndFixturesMember 2021-06-30 0000945617 us-gaap:FurnitureAndFixturesMember 2020-12-31 0000945617 us-gaap:MachineryAndEquipmentMember 2021-06-30 0000945617 us-gaap:MachineryAndEquipmentMember 2020-12-31 0000945617 us-gaap:LeaseholdImprovementsMember 2021-06-30 0000945617 us-gaap:LeaseholdImprovementsMember 2020-12-31 0000945617 2019-01-01 2019-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

  

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 10-Q/A

 

(Mark One)

 

  ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2021

 

  ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______ to ______.

  

Commission File Number 000-26108

  

 

AMERICAN CANNABIS COMPANY, INC.

 

(Exact name of registrant as specified in its charter)

 

Delaware   90-1116625
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
2590 Walnut #6    
Denver, Colorado   80205
(Address of principal executive offices)   (Zip Code)

 

(303) 974-4770

(Registrant's telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer  ☐
Non-accelerated filer ☒   Smaller reporting company  ☒
Emerging growth company ☐      

   

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐   No ☒

 

At June 30, 2021 and August 13, 2021, 79,902,938 and 80,152,938 shares of common stock were outstanding, respectively.

 

 

 

 
TABLE OF CONTENTS

 

    Page
PART I. FINANCIAL INFORMATION  
     
Item 1. FINANCIAL STATEMENTS:  
     
  CONDENSED CONSOLIDATED BALANCE SHEETS AS OF JUNE 30, 2021 (UNAUDITED) AND DECEMBER 31, 2020 3
     
  CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2021 AND 2020 (UNAUDITED). 4
     
  CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020 (UNAUDITED) 6
     
  CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020 (UNAUDITED). 5
     
  NOTES TO THE UNAUDITED CONDENSEND CONSOLIDATED FINANCIAL STATEMENTS.  7
     
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 24
     
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 28
     
Item 4. CONTROLS AND PROCEDURES 28
     

PART II. OTHER INFORMATION 

  
   
Item 1. LEGAL PROCEEDINGS 30
     
Item 1A. RISK FACTORS 30
     
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 30
     
Item 3. DEFAULTS UPON SENIOR SECURITIES 30
     
Item 4.   MINE SAFETY DISCLOSURES 30
     
Item 5. OTHER INFORMATION 30
     
Item 6. EXHIBITS 31
   
SIGNATURES 32

 

 2

 

 

PART I—FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

AMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

           
   June 30,   December 31, 
   2021   2020 
ASSETS          
Current Assets          
Cash and Equivalents  $1,131,833   $1,723,132 
Accounts Receivable, Net   23,331    24,955 
Deposits   2,895    2,895 
Inventory   331,494    62,402 
Prepaid Expenses and Other Current Assets   24,072    50,302 
Total Current Assets   1,513,625    1,863,686 
           
Property and Equipment - Net   468,216    24,655 
Other Assets          
Intangible Assets, net   1,115,182    - 
Goodwill   1,530,316    - 
Right of Use Assets - Operating Leases, net   163,416    - 
Long Term Deposits   6,001    - 
Total Other Assets   2,814,915    - 
TOTAL ASSETS  $4,796,756   $1,888,341 
LIABILITIES AND SHAREHOLDERS' EQUITY          
Current Liabilities          
Accounts Payable  $264,468   $13,153 
Advances from Clients   63,447    88,843 
Accrued and Other Current Liabilities   136,368    49,244 
Stock payable   28,690    - 
Right of Use Liabilities, current   147,131    - 
Note payables, current   1,230,186    109,914 
Total Current Liabilities   1,870,290    261,154 
Long Term Liabilities          
Right of Use Liabilities   16,286    - 
Total Long Term Liabilities   16,286    - 
TOTAL LIABILITIES   1,886,576    261,154 
Shareholders' Equity          
Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2021 and December 31, 2020   -    - 
Common stock, $0.00001 par value; 500,000,000 shares authorized; 79,902,938 and 70,727,938 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively   798    707 
Additional paid-in capital   11,408,199    9,634,748 
Accumulated deficit   (8,498,817)   (8,008,268)
Total Shareholders' Equity   2,910,180    1,627,187 
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY  $4,796,756   $1,888,341 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 3

 

  

AMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED) 

 

                     
   For The Three Months Ended   For the Six Months Ended 
   June 30,   June 30,   June 30,   June 30, 
   2021   2020   2021   2020 
Revenues                
Consulting Services  $39,501   $131,238   $201,393   $355,613 
Product & Equipment   273,401    418,675    437,489    634,682 
Cannabis Products   307,077    -    307,077    - 
Total Revenues   619,979    549,913    945,958    990,295 
                     
Cost of Revenues                    
Cost of Consulting Services   6,006    22,429    26,706    114,555 
Cost of Products and Equipment   209,148    287,368    330,257    423,609 
Cost of Cannabis Products   146,074    -    146,074    - 
Total Cost of Revenues   361,228    309,797    503,037    538,164 
Gross Profit   258,751    240,116    442,921    452,131 
                     
Operating Expenses                    
General and Administrative   535,641    240,187    870,569    560,773 
Selling and Marketing   61,006    92,621    127,743    163,028 
Stock Based Compensation Expense   13,027    19,659    28,690    24,162 
Total Operating Expenses   609,674    352,467    1,027,002    747,963 
Loss from Operations   (350,923)   (112,351)   (584,081)   (295,832)
                     
Other Income (Expense)                    
Interest (expense)   (18,629)   -    (18,810)   - 
Debt Forgiveness   -    -    110,543    - 
Other income   900    10,588    1,799    16,522 
Total Other (Expense) Income   (17,729)   10,588    93,532    16,522 
Net Loss   (368,654)   (101,763)   (490,549)   (279,310)
Income Tax Expense   -    -    -    - 
NET LOSS  $(368,652)  $(101,763)  $(490,549)  $(279,310)
Basic net loss per common share  $(0)  $(0)  $(0)  $(0.01)
Basic weighted average common shares outstanding   76,256,839    54,206,866    76,329,457    53,460,270 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

 

 4

 

 

AMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED) 

 

           
   For the Six Months Ended 
   June 30,   June 30, 
   2021   2020 
CASH FLOWS FROM OPERATING ACTIVITIES          
Net Loss  $(490,549)  $(279,310)
Adjustments to reconcile net loss to net cash used in operating activities:          
Gain on Sale of assets   -    (500)
Depreciation   8,979    7,095 
Stock-based compensation to employees   28,690    24,162 
Debt Forgiveness   (109,914)   - 
Changes in operating assets and liabilities:          
Accounts receivable   1,624    59,435 
Deposits   -    1,605 
Inventory   (119,092)   (45,473)
Prepaid expenses and other current assets   26,230    346 
Right to Use Lease Asset   (163,416)   25,497 
Accounts Payable   251,314    163,761 
Advances from Clients   (25,396)   (60,643)
Accrued and other current liabilities   87,124    10,501 
Operating Lease Liability   163,416    (25,947)
Net Cash used in Operating Activities  $(340,990)  $(119,471)
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   (360,015)   (2,269)
Proceeds from sales of property and equipment   -    2,500 
Acquisition of Assets   (1,100,000)   - 
Intangible assets   (4,022)   - 
Net Cash Provided by (Used in) Investing Activities  $(1,464,037)  $231 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from PPP loan   130,186    - 
Proceeds from sale of common stock   1,083,542    69,503 
Net Cash Provided by Financing Activities  $1,213,728   $69,503 
           
NET DECREASE IN CASH   (591,299)   (49,737)
           
CASH AT BEGINNING OF PERIOD   1,723,132    945,181 
           
CASH AT END OF PERIOD  $1,131,833   $895,444 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Cash paid for income taxes  $-   $- 
Cash paid for interest  $-   $- 
Stock issued for receivables  $-   $25,472 
Stock issued for acquisition of assets  $690,000   $- 
Note Payable issued for acquisition of assets  $1,100,000   $- 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 5

 

  

AMMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

(UNAUDITED)

FOR THE THREE MONTHS ENDED JUNE 30, 2021 AND 2020

 

                          
                     
           Additional       Total 
   Common Stock   Paid-In   Accumulated   Shareholders' 
   Shares   Amount   Capital   Deficit   Equity 
Balance, March 31, 2020   53,456,866   $534   $8,398,424   $(7,653,402)  $745,556 
Stock-based compensation to employees   -    -    -    -    - 
Shares issued cash and receivables   750,000    7    94,968    -    94,975 
Net Loss   -    -    -    (101,763)   (101,763)
Balance, June 30, 2020   54,206,866   $541   $8,493,392   $(7,755,165)  $738,768 

 

           Additional       Total 
   Common Stock   Paid-In   Accumulated   Shareholders' 
   Shares   Amount   Capital   Deficit   Equity 
Balance, March 31, 2021   76,377,938   $763   $10,632,985   $(8,130,165)  $2,503,583 
Stock issued for asset acquisition   3,000,000    30    689,970    -    690,000 
Stock issued for cashless exercise of warrants   25,000    -    -    -    - 
Stock issued for cash   500,000    5    85,244    -    85,249 
Net Loss   -    -    -    (368,652)   (368,652)
Balance, June 30, 2021   79,902,938   $798   $11,408,199   $(8,498,817)  $2,910,180 

 

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020 

                     
           Additional       Total 
   Common Stock   Paid-In   Accumulated   Shareholders' 
   Shares   Amount   Capital   Deficit   Equity 
Balance, December 31, 2020   52,978,605   $529   $8,354,920   $(7,475,855)  $879,594 
Stock-based compensation to employees   478,261    5    43,504    -    43,509 
Shares issued cash and receivables   750,000    7    94,968    -    94,975 
Net Loss   -    -    -    (279,310)   (279,310)
Balance, June 30, 2020   54,206,866   $541   $8,493,392   $(7,755,165)  $738,768 

 

           Additional       Total 
   Common Stock   Paid-In   Accumulated   Shareholders' 
   Shares   Amount   Capital   Deficit   Equity 
Balance, December 31, 2021   70,727,938   $707   $9,634,748   $(8,008,268)  $1,627,187 
Stock issued for asset acquisition   3,000,000    30    689,970    -    690,000 
Stock issued for cashless exercise of warrants   125,000    1    (1)   -    - 
Stock issued for cash   6,050,000    60    1,083,482    -    1,083,542 
Net Loss   -    -    -    (490,549)   (490,549)
Balance, June 30, 2021   79,902,938   $798   $11,408,199   $(8,498,817)  $2,910,180 

  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 6

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Note 1. Principles of Consolidation.

 

The unaudited condensed consolidated financial statements for the three months ended June 30, 2021 and 2020 include the accounts of American Cannabis Company, Inc. and its wholly owned subsidiary, Hollister & Blacksmith, Inc., doing business as American Cannabis Company, Inc. Intercompany accounts and transactions have been eliminated.

 

Note 2. Description of Business.

 

American Cannabis Company, Inc. and its wholly owned subsidiary Company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and sell both exclusive and non-exclusive customer products commonly used in the industry.

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

1.Three Medical Marijuana (MMC) Store Licenses;

 

2.One Marijuana Infused Product Licenses (MIPS); and,

 

3.One Option Premises Cultivation License (OPC); and,

 

4.Related real property assets, goodwill, and related business assets.

  

As a result, the Company has expanded its business model to include the cultivation and retail sale of cannabis in the medicinal cannabis industry.

 

Note 3. Summary of Significant Accounting Policies

 

Basis of Accounting

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.

 

 7

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Use of Estimates in Financial Reporting

 

The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.

 

Unaudited Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.

 

Segment Information

 

Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker, or decision-making group, in deciding how to allocate resources and assess performance. The Company reports results of operations in 3 distinct segments: Consulting Services, Soil Product and Equipment and Cannabis Products.

 

The Consulting Services segment provides services to the Cannabis industry as to the development and expansion of cultivation and retail facilities. These services include business plans, design advice and cultivation oversight. These services are offered throughout the United States.

 

The Soil Product and Equipment Segment handles the sale of our So-Hum Living Soils Product and the resale of Equipment in connection with our consulting services not only in the Cannabis industry but also to other agricultural industries. These products are offered for sale throughout the United States.

 

The Cannabis Product segment handles both the cultivation of and the retail sale of medicinal cannabis products in the State of Colorado.

 

 8

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of June 30, 2021 and December 31, 2021, the Company had cash balances in excess of FDIC insured limits of $250,000.

 

Accounts Receivable

 

Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of June 30, 2021, and December 31, 2020, the Company’s allowance for doubtful accounts was $60,354 and $57,512, respectively. The Company recorded bad debt expense during the six months ended June 30, 2021 and 2020 of $0 and $22,500, respectively.

 

Deposits

 

Deposits is comprised of advance payments made to third parties, for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale.

 

Inventory

 

Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in first-out and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of June 30, 2021 and December 31, 2021, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third party vendors for retail sales at dispensaries is determined using the first in first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production related depreciation and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At June 30, 2021, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary.

 

 9

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

 

Significant Clients and Customers

 

During the six months ended June 30, 2021, three customers accounted for 42.5% of the Company’s total revenues for the period.

 

During the six months ended June 30, 2020, three customers accounted for 35.4% of the Company’s total revenues.

 

Property and Equipment, net

 

Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in progress construction are capitalized as incurred and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of June 30, 2021 and December 31, 2020.

 

Goodwill

 

Goodwill represents the excess of fair value over identifiable tangible and intangible net assets acquired in business combinations. Goodwill is not amortized, instead goodwill is reviewed for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value.

 

Accounting for the Impairment of Long-Lived Assets

 

The Company evaluates long lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long lived assets as of June 30, 2021 and December 31, 2020.

 

 10

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Fair Value Measurements

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.

 

Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.  

 

Revenue Recognition

 

We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “Revenue from Contracts with Customers (Topic 606). Due to the nature of our contracts with customers, adopting the new accounting principles did not have a significant impact on our prior period results of operations, cash flows or financial position.

 

Our service and product revenues arise from contracts with customers.  Service revenue includes Operations Divisions consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, (c) Cannabis sales division.  The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.

 

We may also enter into contracts with customers that identify a single, or few, distinct performance obligations, but that also have non-distinct, underlying performance obligations.  These contracts are typically fulfilled within one to six months.  Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods and, accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.

 

We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues:

 

(1)Identify the contract with the Customer. Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.

  

(2)Identify the performance obligations in the contract. We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.

  

(3)Determination of the transaction price. Prices are typically fixed, and no price protections or variables are offered.

  

(4)Allocation of the transaction price to the performance obligations in the contract. Transaction prices are typically allocated to the performance obligations outlined in the contract.

 

 11

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 
(5)Recognize Revenue when (or as) the entity satisfies a performance obligation. We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.

  

Advances from Clients deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received.  Where possible, we obtain retainers to lessen our risk of non-payment by our customers.  Advances from Clients deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.

 

Product and Equipment Sales

 

Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, title has transferred, and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606. During the six months ended June 30, 2021 and 2020, sales returns were $0.

 

Consulting Services

 

We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services.

 

For hourly based fixed fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients” account, and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer based significant financing, that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.

 

Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the three months ended March 31, 2021 and 2020, we incurred no losses from fixed fee engagements that terminate prior to completion. We believe if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.

 

 12

 

  

We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.

 

Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price.

 

While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.

 

Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.

 

Cannabis Sales

 

Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the three months ended June 30, 2021.

 

Loyalty Reward Program

 

The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based upon the total amount of a purchase, at the time of purchase. Management has determined that as there is no separate performance obligation to the reward program, i.e. the accumulation and redemption of points, and as such the Company recognizes the revenue at the time of purchase.

 

Costs of Revenues

 

The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

 

Advertising and Promotion Costs

 

Advertising and Promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the six months ended June 30, 2021 and 2020 these expenses were $33,238 and $8,489, respectively.

 

Shipping and Handling Costs

 

For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.

 

 13

 

  

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

  

Stock-Based Compensation

 

Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. During the six months ended June 30, 2021 and 2020, stock-based compensation expense for restricted shares for Company employees was $28,690 and $4,503, respectively and $13,027 and $19,659 for the three months ended June 30, 2021. Compensation expense for warrants are based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model and are expensed over the expected term of the awards. During the six months ended June 30, 2021, no warrants were issued as stock compensation.

         

Research and Development

 

As a component of our equipment and supplies offerings, from time-to-time we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include, but are not limited to: The Satchel™, Cultivation Cube™, So-Hum Living Soils™ and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the six months ended June 30, 2021 and 2020, our research and development costs were de minimis.

 

Income Taxes

 

The Company’s corporate status changed from an S Corporation, which it had been since inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2010, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of June 30, 2021 and December 31, 2020, we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.

 

Net Loss Per Common Share

 

The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities since that would have an anti-dilutive effect on earnings.

 

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

 

Related Party Transactions

 

The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

 14

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

Impact of COVID-19 Pandemic

 

On March 11, 2020, the World Health Organization declared the current coronavirus (“COVID-19”) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact upon many sectors of the economy, including retail commerce.

 

In response to state and local measures and for protection of both employees, the Company made required changes to operations, which did not have a material impact upon operations or the financial condition of the Company.

 

While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-19 cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these unaudited condensed consolidated financial statements.

 

Recent Accounting Pronouncements

 

Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.

 

In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes”.  The pronouncement simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740, “Income Taxes”.  The pronouncement also improves consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance.  This standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted.  The Company is still evaluating the impact this guidance will have on its consolidated financial statements.

 

In January 2020, the FASB issued ASU No. 2020-01, "Investments — Equity Securities: Clarifying the Interactions between Topic 321, Topic 323, and Topic 815" ("ASU No. 2020-01"). ASU No. 2020-01 clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with ASC 321, "Investments — Equity Securities" immediately before applying or upon discontinuing the equity method of accounting in ASC 323, "Investments—Equity Method and Joint Ventures." The provisions of ASU No. 2020-01 are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years with early adoption permitted, including early adoption in an interim period for public business entities for periods for which financial statements have not yet been issued. The Company is still evaluating the impact this guidance will have on its consolidated financial statements.

 

 15

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Note 4. Naturaleaf Asset Acquisition

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

5.Three Medical Marijuana (MMC) Store Licenses;

6.One Marijuana Infused Product Licenses (MIPS); and,

7.One Option Premises Cultivation License (OPC); and,

8.Related real property assets, goodwill, and related business assets.

  

The aggregate consideration paid for the Assets was $2,890,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000.

 

The asset acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations. As the acquirer for accounting purposes, the Company has estimated the fair value of Medihemp LLC and Medical Cannabis Caregivers, Inc.’s (hereafter “Naturaleaf’s”) assets acquired and conformed the accounting policies of Naturaleaf to its own accounting policies. The Company expensed certain legal, auditing and licensing costs with the acquisition of $83,095.

  

As part of the acquisition, the owners of Naturaleaf retained the outstanding cash balance on the date of the acquisition and had agreed to the payment of all outstanding accounts payables and related party advances.

 

The Company has performed a preliminary valuation analysis of the fair market value of Naturaleaf’s assets. The following table summarizes the allocation of the preliminary purchase price as of the acquisition date:

 

     
Cash  $ -- 
Inventory   150,000 
Property, plant and equipment   92,523 
Long Term Deposits   6,000 
Identifiable intangible assets   1,111,161 
Goodwill   1,530,316 
Accounts payable   -- 
Total consideration  $2,890,000 

 

Preliminary goodwill from the acquisition primarily relates to the future economic benefits arising from the assets acquired and is consistent with the Company's stated intentions and strategy. Other assets include inventory and fixed assets.

 

The preliminary fair value of Naturaleaf’s identifiable intangible assets was $1,111,161 million at April 30, 2021, consisting of $694,476 in licenses and $416,875 in brand names. Due to the indefinite life of the identifiable intangible assets at this time, the Company did not recognize an amortization expense during the six months ended June 30, 2021.

 

 

 16

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

The estimated fair values assigned to identifiable assets acquired assumed are provisional and are based on the information that was available as of the acquisition date to estimate the fair value of assets acquired and liabilities assumed. The Company believes that information provides a reasonable basis for estimating the fair values of assets acquired and liabilities assumed, but the Company is waiting for additional information necessary to finalize those fair values. Therefore, the provisional measurements of fair value reflected are subject to change and such changes could be significant. The Company expects to finalize the valuation and complete the purchase price allocation as soon as practicable, but no later than one year from the acquisition date.

 

The results of operations of Naturaleaf for the period from April 30, 2021 through June 30, 2021 are included in the Company's unaudited condensed consolidated financial statements as of June 30, 2021.

 

Unaudited Pro Forma Financial Information

 

The following unaudited pro forma information presents a summary of the Company’s combined operating results for the three and six months ended June 30, 2021 and 2020, as if the acquisition had occurred on January 1, 2020. The following pro forma financial information is not necessarily indicative of the Company’s operating results as they would have been had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including, but not limited to, differences between the assumptions used to prepare the pro forma information, basic shares outstanding and dilutive equivalents, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses.

 

Pro Forma Financial Information             
   Three Months Ended  Six Months Ended
   June 30,  June 30,
   2021  2020  2021  2020
             
Total Revenues  $808,243   $1,162,406   $1,712,496   $2,468,724 
Loss from Operations  $(351,728)  $(8,908)  $(383,864)  $(88,189)
                     
Basic and diluted loss per share  $—     $—     $—     $—   

 

 

Note 5. Accounts Receivable and Advance from Clients    

         

Accounts receivable was comprised of the following:

 

          
   June 30, 2021   December 31, 2020 
Accounts Receivable – Trade  $168,101   $82,467 
Less:  Allowance for Doubtful Accounts   (144,770)   (57,512)
Accounts Receivable, net  $23,331   $24,955 

 

The Company had bad debt expense during the six months ended June 30, 2021 and 2020 of $0, respectively.

 

Our Advances from Clients had the following activity:

 

   Amount 
December 31, 2020  $88,843 
    Additional deposits received   199,892 
    Less:  Deposits recognized as revenue   (225,288)
June 30, 2021  $63,447 

 

Note 6. Inventory

 

Inventory consisted of the following:

 

          
   June 30, 2021   December 31, 2020 
Raw Materials  $92,132   $39,746 
Work In Process   66,287    - 
Finished Goods   173,075    22,656 
Total Inventory  $331,494   $62,402 

  

 17

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Note 7. Property and Equipment, net

 

Property and equipment, net, was comprised of the following:

 

          
   June 30, 2021   December 31, 2020 
Office equipment  $38,481   $34,071 
Software   13,204    13,204 
Furniture and Fixtures   2,328    - 
Machinery and Equipment   329,992    - 
Leasehold Improvements   115,808    - 
Property and equipment, gross  $499,813   $47,275 
Less: Accumulated Depreciation   (31,597)   (22,621)
Property and equipment, net  $468,216   $24,654 

 

As part of the Naturaleaf Asset Acquistion, the Company acquired $92,535 in fixed assets consisting of machinery and equipment and leasehold improvements. During the six months ended June 30, 2021, the Company purchased office equipment in the amount of $1,576 and has made purchases of machinery and equipment of $308,438 in order to upgrade operations at the new cultivation facilities and has spent $50,000 in leasehold improvements at the cultivation facilities.

 

Note 8. Accrued and Other Current Liabilities

 

Accrued and other current liabilities consisted of the following:

 

          
   June 30, 2021   December 31, 2020 
Accrued Interest  $18,629   $449 
Accrued Payroll   33,112    - 
Sales Tax Payable   17,633    - 
Other Accrued Expenses & Payables   66,994    48,795 
Accrued and other current liabilities  $136,368   $49,244 

 

Note 9. Stock Payable

 

The following summarizes the changes in common stock payable:

 

     
   Amount 
December 31, 2020  $- 
    Additional Expenses Incurred   28,690 
    Payments Upon Issuance of Shares   - 
June 30, 2021  $28,690 

  

 18

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Note 10. Operating Lease Right-of-Use Asset/Operating Lease Liability

 

The Company leases property under operating leases. Property leases include retail and cultivation space with fixed rent payments and lease terms ranging from one to two years. The Company is obligated to pay the lessor for maintenance, real estate taxes, insurance and other operating expenses on certain property leases. These expenses are variable and are not included in the measurement of the lease asset or lease liability. These expenses are recognized as variable rent expense when incurred.

 

The Company’s lease portfolio consists of the following.

 

Schedule of lease              
Lease Name  Asset Type  Start Date  Expiration Date  Monthly Rent
Durango Lease  Real Property  5/1/2021  5/31/2022  $10,200 
Lehman Lease  Real Property  5/1/2021  12/31/2022  $2,732 
Palmer Lease  Real Property  5/1/2021  6/30/2022  $1,069 
Greenspace Membership  Real Property  4/15/2021  12/31/2021  $1,000 
Tejon Lease  Real Property  5/1/2021  4/30/2022  $3,700 

 

On June 1, 2020, the Company entered into a new lease membership agreement for a one-year term for an amount of $2,895 per month, the lease expired on May 31, 2021. At that time the Company entered into an 8 ½ month lease for less space for an amount of $1,000 per month. We determined under ASC 842, due to the short-term nature of the lease that the lease membership agreement met the criteria of ASC 842-20-25-2 and as such it was not necessary to capitalize the lease and rent will be recognized on a monthly straight-line basis.

 

On May 1, 2020, as part of the Naturaleaf Acquisition, leases for grow facilities and dispensaries were assigned to the Company. These leases were determined to be operating leases under ASC 842 and such leases was capitalized. It was determined that the Tejon lease, due to the short-term nature of the lease met the criteria of ASC 842-20-25-2 and as such it was not necessary to capitalize the lease and rent would be recognized on a straight-line basis.

 

The Company records the lease asset and lease liability at the present value of lease payments over the lease term. The leases typically do not provide an implicit rate; therefore, the Company uses its estimated incremental borrowing rate at the time of lease commencement to discount the present value of lease payments. The Company’s discount rate for operating leases at June 30, 2021 was 12.5%. Leases often include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. Lease expense is recognized on a straight-line basis over the lease term to the extent that collection is considered probable. As a result, the Company been recognizing rents as they become payable.

 

As of June 30, 2021, the maturities of operating leases liabilities are as follows:

 

       
    Operating
Leases		  
2021   $ 84,474  
2022     91,158  
Total     175,632  
Less: amount representing interest     (12,216 )
Present value of future minimum lease payments     163,416  
Less: current obligations under leases     147,131  
Long-term lease obligations   $ 16,286  

  

As of June 30, 2021, the aggregate remaining minimal annual lease payments under these operating leases, including those accounted for under practicable expedient were as follows: 

 

2021  $112,213 
2022   103,844 
Total  $216,057 

 

 19

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Note 11. Loans Payable

 

PPP Loans

 

On March 27, 2020, the CARES Act was enacted to provide financial aid to family and businesses impacted by the COVID-19 pandemic.  The Company participated in the CARES Act, and on August 6, 2020, the Company entered into a note payable with a bank under the Small Business Administration (“SBA”) Paycheck Protection Program (“PPP loan”) in the amount of $109,914. This loan payable matures on August 6, 2022 with a fixed interest rate of 1% per annum with interest deferred for six months. The PPP loan has an initial term of two years, is unsecured and guaranteed by the SBA. Under the terms of the PPP loan, the Company may apply for forgiveness of the amount due on the PPP loan. The Company used the proceeds from the PPP loan for qualifying expenses as defined in the PPP. The Company intends to apply for forgiveness of the PPP loan in accordance with the terms of the CARES Act. However, the Company cannot assure at this time that the PPP loan will be forgiven partially or in full. If the loan is not forgiven based on the PPP guidelines to be issued by the SBA, as defined, then, the monthly payment amount will be $6,186 beginning on March 6, 2021 through August 6, 2022. On March 3, 2021, the SBA forgave the principal of $109,914 and any accrued interest at that time.

 

On April 23, 2021, the Company entered into a second note payable with a bank under the SBA PPP Loan in the amount of $130,186. The PPP Loan is subject to the same terms of forgiveness as above. The monthly payment amount will be $3,056 beginning on September 22, 2022.

 

Naturaleaf Seller Note

 

As part of the Naturaleaf Acquisition, the Company issued a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”). The note has a term of 1 year with a due date of April 1, 2022 and does not require any payments prior to the due date. The note has an annual interest rate of 10%. At June 30, 2021, interest of $18,383 had been accrued.

 

Note 12. Related Party Transactions

 

The Company has a related party entity, Tabular Investments, LLC (“Tabular”) which was set to assign the Company’s interest in various equity partnership. The sole member of Tabular is Tad Mailander, the Company’s outside legal counsel and Director. The Company has valued all of its equity partnership investments at $0. Neither our direct equity ownership in, nor our assignments of equity to Tabular Investments, LLC are, or are reasonably likely to allow for, substantive terms, transactions, and arrangements, whether contractual or not contractual, that will have a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources. We have no direct or indirect majority influence or control over any entity in which we have a direct equity interest or equity interests assigned to Tabular. We do not have any direct or indirect interest in, and do not control Tabular. We have not absorbed losses from either our direct equity interests or assignments to Tabular, and we have provided no subordinated financial support to any project

 

Note 13. Stock Based Compensation

 

During the six months ended June 30, 2021, the Company issued stock-based compensation for employees and service providers pursuant to its 2015 Equity Incentive Plan.

 

 20

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Restricted Shares

 

From time to time, the Company grants certain employees restricted shares of its common stock to provide further compensation in-lieu of wages and to align the employee’s interests with the interests of its stockholders. Because vesting is based on continued employment, these equity-based incentives are also intended to attract, retain and motivate personnel upon whose judgment, initiative and effort the Company’s success is largely dependent.

 

During the six months ended June 30, 2021, the Company granted 135,616 restricted shares and recognized $28,690 in associated employee stock-based compensation expense , which is included as part of the outstanding stock payable June 30, 2021. The fair value of restricted stock unit is determined based on the quoted closing price of the Company’s common stock on the date grant.

 

During the six months ended June 30, 2020, the Company granted 225,000 restricted shares and recognized $19,347 in associated employee stock-based compensation expense, which is included as part of the outstanding stock payable June 30, 2020, that was issued in December 2020. The fair value of the restricted stock is determined based on the quoted closing price of the Company’s common stock on the date of grant.

 

During the six months ended June 30, 2020, the Company issued 478,261 shares of restricted shares granted during the fiscal year ended December 31, 2019.

 

Net Loss Per Share

 

Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the reporting period. Diluted net loss per share is computed similarly to basic loss per share, except that it includes the potential dilution that could occur if dilutive securities are exercised.

 

Outstanding stock options and common stock warrants are considered anti-dilutive because we are in a net loss position.  Accordingly, the number of weighted average shares outstanding for basic and fully diluted net loss per share are the same.

 

The following summarizes equity instruments that may, in the future, have a dilutive effect on earnings per share:

 

          
   June 30, 2021   December 31, 2020 
Warrants   10,000    397,500 
Stock Payable   135,616    - 
Total   145,616    397,500 

 

Warrants

 

During the six months ended June 30, 2021, warrants with a cashless exercise provision were exercised for 125,000 restricted shares . Of which, a warrant for 100,000 shares was exercised by an officer/director of the Company.

 

During the six months ended June 30, 2021, the Company did not issue or approve any warrants. Warrants exercisable for 287,500 shares expired.

  

 21

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Note 14. Shareholders’ Equity

 

Preferred Stock

 

American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $0.01 par value. No shares of preferred stock were issued and outstanding at June 30, 2021 and December 31, 2020, respectively.

 

Common Stock

 

During the six months ended June 30, 2021, the Company issued 6,050,000 registered shares of common stock in exchange for net proceeds of $1,083,541 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019 with White Lion Capital LLC.

 

During the six months ended June 30, 2021, the Company issued 3,000,000 shares of its restricted common stock to the sellers of Naturaleaf, as part of the acquisition of assets of Naturaleaf. The shares had a value of $690,000 based on a closing market price on April 23, 2021 of $0.23 per share.

 

During the six months ended June 30, 2021, warrants with a cashless exercise provision were exercised for 125,000 restricted shares . Of which, a warrant for 100,000 shares was exercised by an officer/director of the Company.

 

During the six months ended June 30, 2020, the Company issued 478,261 shares of restricted shares granted during the fiscal year ended December 31, 2019.

 

Note 15.   Commitments and Contingencies

 

Legal

 

In the ordinary course of its business, the Company becomes involved in various legal proceedings involving a variety of matters. The Company does not believe there are any pending legal proceedings that will have a material adverse effect on the Company’s business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. The Companies expenses legal fees in the period in which they are incurred.

 

Turoff Matter

 

On November 15, 2019, Erin Turoff filed suit against the Company and Mr. Terry Buffalo, our chief executive officer and director, and Mr. Ellis Smith our chief development officer and director, in Denver County District Court. The complaint seeks a declaratory judgement and damages related to Ms. Turoff’s allegation that she was misclassified as an independent contractor while working for the Company. Ms. Turoff alleges she is owed unpaid overtime, liquidated damages, wages, and other compensatory damages for her misclassification and alleged wrongful terminations. Ms. Turoff’s suit against Mr. Buffalo and Mr. Smith alleges that each are the alter ego of the Company and are therefore jointly and severally liable. All parties have appeared in the case and the case is currently in the discovery. At this time, there is no reasonable basis from which a determination or estimate may be made concerning any contingent liability related to this lawsuit. 

 

 22

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020

(UNAUDITED)

 

Note 16. Subsequent Events

 

In accordance with ASC 855-10, the Company has analyzed its operations after Unaudited consolidated financial statements were available to be issued and has determined that there were no other significant subsequent events or transactions that would require recognition or disclosure in the unaudited condensed consolidated financial statements for the six months ended June 30, 2021, other than as follows.

 

In August 2021, the Company issued 250,000 registered shares of common stock in exchange for net proceeds of $26,935 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019 with White Lion Capital LLC.

 

 

 23

 

  

  ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

  

The statements contained in this report that are not statements of historical fact, including without limitation, statements containing the words “believes,” “expects,” “anticipates” and similar words, constitute forward looking statements that are subject to a number of risks and uncertainties. From time to time we may make other forward-looking statements. Investors are cautioned that such forward looking statements are subject to an inherent risk that actual results may materially differ as a result of many factors, including the risks discussed from time to time in this report, including the risks described under “Risk Factors” in any filings we have made with the SEC.

 

Government Regulation

 

Currently, there are thirty-six states plus the District of Columbia that have laws and/or regulation that recognize in one form or another legitimate medical uses for cannabis and consumer use of cannabis in connection with medical treatment. There are currently sixteen states and the District of Columbia that allow recreational use of cannabis. As of June 30, 2021, the policy and regulations of the Federal Government and its agencies is that cannabis has no medical benefit and a range of activities including cultivation and use of cannabis for personal use is prohibited on the basis of federal law and may or may not be permitted on the basis of state law. Active enforcement of the current federal regulatory position on cannabis on a regional or national basis may directly and adversely affect the willingness of customers of the Company’s medicinal cannabis products to invest in or buy products. Active enforcement of the current federal regulatory position on cannabis may thus indirectly and adversely affect revenues and profits of the Company.

 

Our discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these unaudited condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis, we evaluate these estimates, including those related to useful lives of real estate assets, bad debts, impairment, net lease intangibles, contingencies, and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. There can be no assurance that actual results will not differ from those estimates.

 

BACKGROUND

 

American Cannabis Company, Inc. and subsidiary company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”, “we”, “us”, or “our”) are based in Denver, Colorado and operate a fully integrated business model that features end to end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been decriminalized for medical use and/or legalized for recreational use. The Company provides advisory and consulting services specific to this industry, manufactures proprietary industry solutions including; the Satchel™, SoHum Living Soils™, Cultivation Cube™ and the High Density Cultivation System.™ The Company also sells 3rd party industry specific products and manages a strategic group partnership that offers both exclusive and nonexclusive customer products commonly used in the industry. American Cannabis Company, Inc. is a publicly listed company quoted on the OTCQB Tier under the symbol “AMMJ”.

 

Naturaleaf Acquisition

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.

 

Medihemp and SLAM, respectively own fixed assets and operate two retail Medical Marijuana Centers located in Colorado Springs, Colorado. Medical Cannabis owns fixed assets and operates a retail Medical Marijuana Center located in Colorado Springs, Colorado. Medical Cannabis also owns and operates a Medical Marijuana Optional Premises Cultivation license, and a Medical Marijuana-Infused Product Manufacturer license.

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

1.Three Medical Marijuana (MMC) Store Licenses;

2.One Marijuana Infused Product Licenses (MIPS); and,

3.One Option Premises Cultivation License (OPC); and,

4.Related real property assets, goodwill, and related business assets.

  

As a result, the Company has expanded its business model to include the cultivation and retail sale of cannabis in the medicinal cannabis industry.

 

The aggregate consideration paid for the Assets was $2,890,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000.

 

The asset acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations. As the acquirer for accounting purposes, the Company has estimated the fair value of Medihemp LLC and Medical Cannabis Caregivers, Inc.’s (hereafter “Naturaleaf’s”) assets acquired and conformed the accounting policies of Naturaleaf to its own accounting policies.

 

 24

 

 

As part of the acquisition, the owners of Naturaleaf retained the outstanding cash balance on the date of the acquisition and had agreed to the payment of all outstanding accounts payables and related party advances.

 

The Company has performed a preliminary valuation analysis of the fair market value of Naturaleaf’s assets. The following table summarizes the allocation of the preliminary purchase price as of the acquisition date:

  

Cash  $ -- 
Inventory   150,000 
Property, plant and equipment   92,523 
Long Term Deposits   6,000 
Identifiable intangible assets   1,111,161 
Goodwill   1,530,316 
Accounts payable   -- 
Total consideration  $2,890,000 

  

Preliminary goodwill from the acquisition primarily relates to the future economic benefits arising from the assets acquired and is consistent with the Company's stated intentions and strategy. Other assets include inventory and fixed assets.

 

The preliminary fair value of Naturaleaf’s identifiable intangible assets was $1,111,161 million at April 30, 2021, consisting of $$694,476 in licenses and $416,875 in brand names.

 

The estimated fair values assigned to identifiable assets acquired assumed are provisional and are based on the information that was available as of the acquisition date to estimate the fair value of assets acquired and liabilities assumed. The Company believes that information provides a reasonable basis for estimating the fair values of assets acquired and liabilities assumed, but the Company is waiting for additional information necessary to finalize those fair values. Therefore, the provisional measurements of fair value reflected are subject to change and such changes could be significant. The Company expects to finalize the valuation and complete the purchase price allocation as soon as practicable, but no later than one year from the acquisition date.

 

RESULTS OF OPERATIONS

 

Revenues

 

Total revenues were $945,958 for the six months ended June 30, 2021 as compared to $990,295 for the six months ended June 30, 2020. Total revenues were $619,978 for the three months ended June 30, 2021 as compared to $549,913 for the three months ended June 30, 2021. The decreases in total revenue of $44,337, represents a decrease of $154,221 in consulting revenue combined with a $197,193 decrease in product and equipment revenue offset by the revenue stream from the sale of cannabis products.

 

Costs of Revenues

 

Costs of revenues primarily consists of labor, travel, cost of equipment and soil sold, and other costs directly attributable to providing services or soil products. Costs of revenues related to our cannabis products include cultivation costs, including labor, utilities, supplies and cultivation facility rent. During the six months ended June 30, 2021, our total costs of revenues were $503,037 compared to $538,168 for the six months ended June 30, 2020. Decreases in costs of consulting services and products and equipment were offset by $146,074 in costs associated with the Company’s cannabis products.

 

 25

 

 

Consulting Services

 

Consulting service revenues during the six months ended June 30, 2021 were $201,393 versus $335,613 for the six months ended June 30, 2020. Decreases in consulting services is a direct result of the effects of COVID-19 on clients plans. Management had started to see an op tick in services as a result of several states legalizing cannabis for medicinal and/or recreational use in late 2020, but during the last six months the use of such services has been effected by delays in finalization of rules for implementation in those states that in 2020 legalized cannabis for either medicinal or recreational purposes.

 

Costs of Services were $26,706 compared to $114,555 for the six months ended June 30, 2021 and 2020. Costs associated with consulting services decreased $87,849 as the Company has focused on the use of internal staff, rather than consultants for a majority of this work.

 

 

Soil Product and Equipment Revenues

Our product and equipment revenues for the six months ended June 30, 2021 were $437,489 revenues versus $634,682 for the six months ended June 30, 2020. As a result of changes in warehousing and production practices, soil sales are seeing a decrease in the sales recognized during the period due to the timing of sales requiring prepayment at the end of the quarter not being ready for shipment in the last days of the quarter and therefor not recognizable as revenue at the prior to the end of the period.

 

Costs of Products and Equipment were $330,257 and $423,609, during the six months ended June 30, 2021 and 2020. Costs associated with products and equipment decreased $93,352, from as a result of the change in the products being offered offset by an increase in cost per bag for one product.

 

Cannabis Product Revenues

 

Cannabis product revenues during the six and three months ended June 30, 2020 were $307,077, respectively. The Company acquired the assets of Naturaleaf on April 30, 2021 and only began recognizing revenues from these operations on May 1, 2021.

 

Costs associated with cannabis products consists of those costs incurred in the cultivation of the plants and the retail sale of the products. During the six months ended June 30, 2021 such costs were $146,074.

 

Gross Profit

 

Total gross profit was $442,921 for the six months ended June 30, 2021, compromised of consulting services gross profit of $174,687, products and equipment gross profit of $107,232 and a gross profit of $161,003 for cannabis products. This compares to total gross profit of $452,131 for the six months ended June 30, 2020, compromised of consulting services gross profit of $241,058 and products and equipment gross profit of $211,073. The relative decreases are a result of the actions described above.

 

The decrease in our consulting services gross profits reflects the effects of COVID-19 which has been compounded by delays in finalization of rules for implementation in states that in 2020 legalized cannabis for either medicinal or recreational purposes The decrease in gross profits for products and equipment was due to the Company expanding its product line in large quantity container (“Tote”) selling at lower margins as a promotion to clients during the period.

  

Operating Expenses

 

Total operating expenses were $1,027,002, for the six months ended June 30, 2021, and $747,963 for the six months ended June 30, 2020. The increase in operating expenses is attributed to increases legal, accounting and other third party consultant costs associated with the closing of the Naturaleaf asset acquisition. The Company has seen additional increases in sales and marketing expenses and web site design during the period.

 

Other Income (Expense)

 

Other income (expense) for the six months ended June 30, 2021 was $93,532 as compared with $16,522 for the six months ended June 30, 2020. The increase is a direct result of the forgiveness of the Company’s then outstanding PPP loan by the Small Business Administration offset by increases in interest expenses resulting from the $1,100,000 promissory note issued in connection with the asset acquisition from Naturaleaf.

 

Net Loss

 

Net loss for the six months ended June 30, 2021 was ($490,549) as compared to a net loss of ($279,310) for the six months ended June 30, 2020.

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of June 30, 2021, our primary internal sources of liquidity were our working capital, which included cash and cash equivalents of $1,131,833 and accounts receivable of $23,331. We have seen an increase is liquidity as a result of the asset acquisition of Naturaleaf due to the immediacy the receipt of funds as a result of retail revenue. Additionally, considering that our fixed overhead costs are low, we have the ability to issue stock to compensate employees and management. In prospective, due to the delay in additional states enacting legalization for cannabis products management has initiated raising additional capital as needed to offset general and administrative expenses for at least the next 12 months. Management believes this strategy will adequately provide the necessary liquidity and capital resources to fund our operational and general and administrative expenses for at least the next 12 months.

 

During the six months ended June 30, 2021, the Company issued 6,050,000 registered shares of common stock in exchange for net proceeds of $1,083,542 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019 with White Lion Capital LLC. The Company has registered 34,000,000 million shares of its common stock to sell to White Lion Capital, LLC on as needed basis for funds to support operational activities.

 

 26

 

 

Operating Activities

 

Net cash used by operating activities for the six months ended June 30, 2021 was a use of ($340,990), compared to net cash used by operating activities of ($119,471), for the six months ended June 30, 2020. Increases in cash used were a result of the increases in inventory, prepaid expenses, and prepaid acquisition costs offset by decreases in advances from clients.

 

Investing Activities

 

For the six months ended June 30, 2021 and 2020, investing activities were a use of cash of ($1,464,036) and ($231) respectively. The increases were result of the cash payment in the acquisition of the assets of Naturaleaf of $1,100,000, expenditures of equipment and leasehold improvements for the cultivation and dispensary facilities of $360,015.

 

Financing Activities

 

During the six months ended June, 2021 proceeds received from financing activities was $1,213,541 and $69,503 for the six months ended June 30, 2020. Funds received during the six months ended June 30, 2021 were from the sale of shares of the Company’s registered common stock and a receipt of funds from the Company’s second SBA PPP Loan.

 

Off Balance Sheet Arrangements

 

As of June 30, 2021, and December 31, 2020, we did not have any off balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

  

Non-GAAP Financial Measures

 

We use Adjusted EBITDA, a Non-GAAP metric, to monitor our overall business performance. We define Adjusted EBITDA as net income (loss) before interest expense, net, provision for (benefit from) income taxes, stock-based compensation, and certain nonrecurring expenses, which to date have been limited to costs associated with the Reverse Merger. We believe that such adjustments to arrive at Adjusted EBITDA provides us with a more comparable measure for managing our business. We also believe that it is a useful measure for securities analysts, investors, and other interested parties in the evaluation of our Company.

 

 27

 

 

A reconciliation of net income(loss) to Adjusted EBITDA is provided below:

 

   Six Months   Six Months 
   Ended June 30,   Ended June 30, 
   2021   2020 
         
Adjusted EBITDA reconciliation:          
Net income (loss)  $(490,549)  $(279,310)
Bad Debt Expense   —    -- 
Depreciation   8,979    7,095 
Interest Expense   —    — 
Stock-based compensation to employees   28,690    24,162 
Adjusted EBITDA  $(452,880)  $(248,053)

  

ITEM 3. QUANTITATIVE & QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting Company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer/Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

 

We carried out an evaluation under the supervision and with the participation of management, including our Chief Executive Officer/Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2021, the end of the period covered by this Report.  Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level due to the material weaknesses discussed below.

 

Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, our principal executive officer and principal financial officer and effected by the Board, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes those policies and procedures that:

 

● pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets,

● provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures of are being made only in accordance with authorizations of our management and directors; and

● provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

 

Because of our inherent limitations, our internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

 28

 

  

Management identified the following material weaknesses:

 

●      we do not have an Audit Committee – While not being legally obligated to have an Audit Committee, it is the management’s view that such a committee, including a financial expert board member, is an utmost important entity level control of the Company’s financial statements. Currently the Board of Directors acts in the capacity of the Audit Committee and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.

 

  ● we have not performed a risk assessment and mapped our processes to control objectives.

 

  ● we have not implemented comprehensive entity-level internal controls.

 

  ● we have not implemented adequate system and manual controls; and

 

  ● we do not have sufficient segregation of duties.

 

Our management assessed the effectiveness of internal control over financial reporting as of June 30, 2021.  In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organization of the Treadway Commission (“COSO”) in Internal Control – Integrated Framework (2013).  Based on management’s assessment, management concluded that the above material weaknesses have not been remediated and, accordingly, our internal control over financial reporting is not effective as of June 30, 2021.

 

Remediation of Material Weaknesses

 

We have designed and plan to implement, or in some cases have already implemented, the specific remediation initiatives described below:

 

● We intend to allocate resources to perform a risk assessment and map processes to control objectives and, where necessary, implement and document internal controls in accordance with COSO.

● Our entity-level controls are, generally, informal and we intend to evaluate current processes, supplement where necessary, and document requirements.

● While we have implemented procedures to identify, evaluate and record significant transactions, we need to formally document these procedures and evidence the performance of the related controls.

● We plan to evaluate system and manual controls, identify specific weaknesses, and implement a comprehensive system of internal controls.

  

 29

 

 

PART II—OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

On November 15, 2019, Erin Turoff filed suit against the Company and Mr. Terry Buffalo, our principal executive officer and director, and Mr. Ellis Smith our chief development officer and director, in Denver County District Court, case number 19-cv34380. The complaint seeks a declaratory judgement and damages relating to Ms. Turoff’s allegations that while working for the Company, she was misclassified as an independent contractor when she was allegedly an employee of the Company. Ms. Turoff alleges she is owed unpaid overtime, liquidated damages, wages, and other compensatory damages for her misclassification and alleged wrongful terminations. Ms. Turoff’s suit against Mr. Buffalo and Mr. Smith alleges that each are the alter ego of the Company and are therefore jointly and severally liable. All parties have appeared in the case and the case is currently in the discovery. At this time, there is no reasonable basis from which a determination or estimate may be made concerning any contingent liability related to this lawsuit. 

  

ITEM 1A. RISK FACTORS

 

We are a smaller reporting Company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On April 23, 2021, the Company issued 3,000,000 shares of its restricted common stock as part of the acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc. (“Naturaleaf”). The shares were issued to its common owner.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

No senior securities were issued and outstanding during the six months ended June 30, 2021 and 2020.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

 30

 

  

ITEM 6. EXHIBITS

 

This list is intended to constitute the exhibit index.

 

31.1 Certification of Principal Executive & Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 Certification of Principal Executive & Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes0Oxley Act of 2002.
101.INS XBRL Instance Document*
101.SCH XBRL Taxonomy Extension Schema Document*
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB XBRL Taxonomy Extension Label Linkbase Document*
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document*

 

*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities and Exchange Act of 1934, and otherwise are not subject to liability under those sections.

 

 31

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

AMERICAN CANNABIS COMPANY, INC.

 

Date: August 13, 2021

  

By: /s/ Terrry Buffalo  

 

Terry Buffalo,

Chief Executive Officer & Chief Financial Officer

 

 32

 EX-31.1 2 f2sammj10q081221ex31_1.htm CERTIFICATION OF CHIEF EXECUTIVE CHIEF FINANCIAL OFFICER

 

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE & CHIEF FINANCIAL OFFICER

 

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, I, Terry Buffalo, certify that:

 

  1. I have reviewed this report on Form 10-Q of American Cannabis Company, Inc., for the fiscal quarter ended June 30, 2021;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonable likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

  

Date: August 13, 2021

 

/s/ Terry Buffalo  

 

Terry Buffalo

 

Chief Executive Officer

& Chief Financial Officer

 

 

 EX-32.1 3 f2sammj10q081221ex32_1.htm CERTIFICATION PURSUANT TO

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

 

18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of American Cannabis Company, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Terry Buffalo, Chief Executive Officer & Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002, that, to the best of my knowledge and belief:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

  

Date: August 13, 2021

 

/s/ Terry Buffalo  

 

Terry Buffalo

 

Chief Executive Officer &

Chief Financial Officer

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 GRAPHIC 4 img001.jpg GRAPHIC begin 644 img001.jpg M_]C_X 02D9)1@ ! @ 9 !D #_[ 11'5C:WD 0 $ 9 _^X #D%D M;V)E &3 ?_; (0 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$" M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# M P,# P,# P,#_\ $0@ + %S P$1 (1 0,1 ?_$ :( & @,! M <(!@4$"0,* @$ "P$ 8# 0$! !@4$ P<"" $) H+ M$ " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7 M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8 MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R'EZ>W MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FINDMM^ED\.HS MM[M3>W9#^?\ JIT$%%VKB)>ZVK-;;CS;[?SS!;6#; M:SST2DD_3(+8>P[]6-OW%O&QJX?GC^7^?HN&_P!O>7'[NMCH*TX^?V5\_L]. MAT%E %_K[/5,4*Z:Y;H\R>NK:>?Z^V@!;-XAX'JW'IOH!>@I_P#J'!_W@^_6 M!J:^I_RGIJX7Q@?F.I/I7Z#VNN"=->M06JQY\^I?O?5^O>_=>Z][]U[KWOW7 MNO>_=>Z][]U[K@ /ZW]VSU[Q%/#KG[KUKCU[W[K?7O?NO=>]^Z]U[W[KW6*[ M?ZD?[;W>@]>F \U:4Z[!;^H_V_O6.K 2GK)[KT[U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO==7'OW6JCKU_?NO$CK@1<6_Q/^]^[5H>M1G3QZ]ILMO?JYKUZ4ZA0 M=9/=>K=>]^Z]UP-OQ;_8_P#&_=OMZTWB>76,M+?Z<>[ )TD9[@' QUG]M]+. MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZBQR M!Q8_7F]O?N'2:-ED7B.BU?(3HB/NG:0HL=N[=W66_L&TF0V/V7L6J%#NG:V6 M97TJ':H/\?/T/VGCZ]8J0^]NZ^U^^_N3G MR.9K1Y#W:3@$X-1AL&O'(\P,]#W\J>^]E[@D^+/S@Z$W-1;XV7MS<&4V?N7, M;=D\GEQ.XHQ"V*RF,>\N%>$I6ZRZZD9EN-+*2$N?-PEV^.&\@.H*ZC]C5H0. M%<^>:'Y]"7GWF]=[M+/F'V_EC(,J:@&%0-0-&%< BM,YH?0TLXE[&_O#VSLK M9&WJF.2CAVRF_=RUT=B,A0LB0X'#WT@EB^:7) 7/"CZ>T%[SCKWJ&UC:H(7% M16E/,?9UE78,TMK"&_I8$'_;>Y@O7$FV"6,ZJ@<,]*,*1J M-#U@Q_\ P I_^H8?[U[]MU0JU_U<>JJ:+4?ZN/0+]U=]]2_'S;-!O3M_>>$V M!MG)[DVWLRDRV88HAW-GI2N#PY95UK2M13KUQ:]Q M;^M^/>J'K>I:5J*=>!!^A!_UC[]0]>!#"JY'7=P?H??NO @\.NB0 ;^]CK3$ M 5/0#T_=^S9.]J_X\0G,#L"BZHQGN=Q];C_ M &_NM.MZA2M13KOW[KU1UU^MQ?W[KP(KTD\SF,7MW&5V M7S>3H,=B,=2FMK'1!9?YIGP=%7 P[RC.WJG-?P1.P#L3LG_1'_$=?Z3VU_=;_ $8^#3_R M\OXL<3Q?R>]#1YD_LZ!EUSQ;Q3"-5:A-*Z?GPZL(QN2Q^9H:+*4%=2U^.R5+ M]W255'5?Q#'UM P4AT?]+763\7YXYY'NE.A@DT;H'U"C"O'I_O[]T[\NNKC^ MHX^O/T]^H>M:ER*BHZ]O5!S44Z]D9F \QT"O4O=NQNZ%W\^S*FNJ?]&?:6Z^I-R+64?\ M#].^=CNB9V)+@%XU>51<@?BX]Z%#PX]5%PM?B%>E_NSL]_P"" M[9Z^V/V5M=:[^[N_]I;(*MY]";<'Z$?[?WKI:"#P/41[N0!BOG_J]0?V]!.#G:%Y#&ZM@D5H?7\Q3[#T=W9^\MJ= MD;6P&\=D;EQ&Z=I;GQ2Y?;N?P&43*8S,XN4*(LGB_=;ZZN/ZCW[AQZ\"#PZ]_=5U+PJ*CKN_OW5NO>]5'7NJ]_DS\Z:GXWP MY P?$WY9=R/C4U-E.I^JX]R;<*FP+',C<*@ 7L3I]LR7#4J :>O0(W?FFTVR M(S16LC4\\T_P=4<]L?\ "E_+[)S,^ P_PBW=AJJE%FI^WM^2[$RAY^JX-NO) M9%^O^J/LO:YH^.'^KY=0]O/OE?6$ABMK"0C@*U-#_O(Z)]W'_P * L)\CMJK ML/OSX$]:;^V=/6&M- >XLICMR81;,%R^%SC]::]O[A0FX*D-?ZDCCV3;[(L\ MZHBJ*^E>/4:[<6Z[>VT\^[0MY82B@(72RU^8%:]%,V)\J\1UF^>R72_5/ M?>-Z;[8H7H-\]:]G42[CV1G%)S)LAD.S7$J_P"+%V-*MBM34D%C0D5\ MAUMU?!!L[V9UIM?LJKRU/AZK>FSMBG+4Q3_?Y18_ X0X5,/+ZE. !D7^S=@? MZ?7WBYR:LG,_O!,;*?P;%& ,9.31:&@/73;VVOFN-G6Y:AK&I .:5&/R'_%= M6@>"-(P0=-J?GZGZ <\GZ$>\\-HVZSM+-H;(:)< L:G\\XIT>7]N;FS%0 N>-.GK2WAM;;23@<>JJ>Z-@;<^:?RUSW36[J: MGSO2?QBZBR";\Q0*?993O;Y&8.3"[>B&L*'DZOZ8%=D0."'W)1GW9 9#0\ / M\.*_EQ^P=1GNS6]S?L%:JK4_X!7\N/Y4Z&_X']E;JW=T(-@=BY,9#M_X\;@W M3\2W9_7K87="C@ 9:P M[WCP]7F,?X1_,?X">E MW*N_:MP,':*BGV@?R/KT37XV]B?S"_FM\8^O>[]F]Q==?'N6OVSE MZ3#TU9U'@.Q:WM/=NW\MFMO9?=>]4FW5$-@;$J=P8@Z,9B1_%U4-J=/2&K5R M/F1_E^6?\_IT4[3=W&X;"TJDU+2&OG0.<^N*?[!Z?NANVOG'\\?C_LSN'K3L M38'Q(A.)S>'EH:OK?#]RU_8_9FQ\YN+9&\\A_N=W+_ORNHO[_P"W:Q<*H!SA MAC+R$ H'3VUVSDL,#_">%?D*U_P=*>7]TEW?EV%P2&I(..202*_+(/V' ^2@ MP7SW[#RGP_\ CIO3%[)VS4?*+Y$]AY3H';>ULC5YJGZ\PG;NQLUOO"]J[KS& M:2&2J7KW:"]?YO)Z8P97 3'!FD)(]=W9)#4RQ^P?,\:9_9QX =);+F[]R\NV MPES++)(M3C)>A-3\R,UH,\ .I_:6]/EC\5MB9+O[C*??C8MH(K1:G[!QXTI3^?Y]! MAUED/G[\MMA87Y#;1[QV#\8-G;\HEWKTMTS5=,8;M*NK^O\ .LVC3Y3(_*S,]!;*KF_CWVV8_)VUF96S'8^QMK8BG&5_C&6 MV7+4U6T#/+,\=*RG+,D>+B+!PUM1>5N[B ?\%?L'_%&G2C>9WM]HMRK:6#$$ M_G3R!^SY&G0 =?\ >W:'7GR2Z>ZHW-W[L?Y1=3_(*FW[0[1[ V[BME;=WCU] MV1L; +OYL-G$Z^+;8W!MO=.WC7%6M%.DD7^H)#U+*1I!K7_#_J_+I//OPCWB MWCK52I_;I_U>H_/I-[![D^9/R/[.^6'577NZMC]/[3Z-^0&XNO*;NS*[#7>F M8R>(_N=L;<>"V1L79$FYSMQ]P;3_ (_(V9W)EG:ZUU(%Q?U]I84=I-(QDC]G M^;U\N/3<&_27EI>*O$.H!^=?E_,^5:GRZ&WX4=P]P[DW/\C^A/D#FL'O3MCX MR]C[8VW6]C;6V[_=/%=A[%[ V+M_?VR,[+@HZF5-O[@BAS#19A(6:(24EP"# M?VJ4]FD\1T;;->,VY7:MY!/\'^JIX_LZ1_SOPR=R=K?#3XK[@J9Z?JKN[M#? MFY^W,72^M=][4Z,V9)OV'K'-K&X\FV=V;E>B.8 -RM#8$7]M"IHOX2?]7^S^ MWHMWY7DO8XVJ$+9_U?92OV5ZL*J=I[3JMJG8]3M[#5.TJG%#;D^U:G$8JLP# M;<:$808B7",$B?!^,VT:2JH+$:?2/,:&@X="BVL+=[,!E6FFG '_ %>O\^BR M9WI[.=,=$;4ZG^+FX]B=&;4V7404']Y>QJ7/]B8O8VQD;-3YV3 XW.[GB-1G M89&72V5R@Q*6;TG5I]V2H( ( ]3^8\_7_4>B?>=LM[/:H&ADHP M'^#HNNP^]NU^M?D3TUUWG>_]B_*[J'OR3>VR\1O7 8K9.W]X=>=G[$V0^_VQ M&63KWS;@ %,\?V_ZOV^?13<\PWEIO5M$G=&R MD']@XUQ_,@9\^FC;/;GS%[_[N^5_2W6F>V1T_M'HKNF#:LG>N:V9%O7;ZP&T=D[';O5(-UEF MOMR121I*4R<5S0>GY#CTE]L?*CY#["Z-_F1[-[4W1M?>7?'P@VEEMU;=[1PN MU/[O[=WOM[/=*R=L]79//[)2HGBP6X82&7.)&[Q+INEP ??F++@X(_V#_L^O M3:;T\5EN*N3K3PZ'AQI_G\\^1X==9C=7\Q7L[X^_[-#L;M#K3I6>FZOB[8V/ M\=:[J_$]C+N_&# 3[C7 =J=I)N8M@MP;H1 K':P5,0& U.UQ[V;IM-33AZ?. MG^K\^'5XYYU02,WX:C\^.?FO9FQ?DAL7I+=W=VQODUUSWE MM/M//=;]H;;P^R\%O+;6[.JY]O-F=G[SCV!.-L9W"R[>S9\.2CQD+>2C <7( M'MI2S.$-"#Z?ZN'J2"*9Z*;J^?;W"%@VKS''\\/BIM_Y/]BY[ MYH[/ZDWYM_H786'^=/?DU3VY4;&Q':F^]T[EER^WVEPNW]G9YH-N;3_ (Q(Q L %8K0.ZDA32A_XKUX?ZJ]4L4FW:KQ-I"M7]G#UP*?EZGHPW5W MR5[[VI5_)WX\]\S[6S/>'1_3?^G'KCM/;VW9MM;<[DZTS6)W##B=Y9;8]V.V M]Q;6W_@9,7F<:C^)K*R75]3*=)!TGB!7'I_Q?RKQKPZ>MN8[I/KH9$KX86F! MPI_G_/C7AT@=Q?+_ +8R/4?\N_%U'9.R>C]U_+CK_';GWUW]N;"8>NVMM;,8 MOK';F]I-H;,PNY)(]K-OSL\9]GPT>58H,/CJYQ&\RI:AP*$TJ*_9_P 7_J-. MJ77,]R/H4II#ZJ_\5\QP_P (!))YNE-J]_[0S&\-L=Z=*Q,BLP_58^[VX-3D$8_U8Z$&V3-% M=:G:H]?+/ECA_+UZ+W_,US^;DZ@Z>Z/Q67R6W:'Y4_)KI_XY;ZW%@:S^&Y3' M;"WR<_GM]+AI/59MT;:V76XGDW(R!^ONEU4^M*CIGG;<66!%CKI+@5^TX'SZ M/ULO8&RNOMEX+86R-M8;;6R]LX=-O;;VOB:04.+QF*1++BX8F+JL5A_3FYO? MWX$J2!PZ$,-G!>6ZL%%-&<9X9K_EZ(OW!N'9?P"Z:Q6WOCKUAAJC>WH8,DF*V=7=Q=VYR?-5$K:E:+;O7FWR:[@?<_='1.*ZAHNN%QFPJ-SFMY9#I/>\6[)=QON3:NW#*\4>Z/,F5CC+.8W*J M=&IR<@NU?D]WYO+Y*=2=*? M&Q-HU.V>[_C!)W%0;\W+ASD:7K1(]\[<2/LC-XE623/Q56WLNE#A<:SHG\7( M,A$8;W9DHP"^:@U_U?LIG/SZ\.;+O<&6.)>*@U^WC^PU%,FM?/H-_P#2S\\> MHODQ2_$>OWAUY\@,WW'UP.R^K^[\OUP.NZ'IS&;&R)P?:"=I;&V/NI5WMB9% MJ<=_!'Q;80G+Y'1)Z;%=FJCPS0U%0?2G'\L''YCYE,&[;C'S-X+"J$5'RI6O MVC!QZY&>(P=1[Z^474WR_H_C;W]VCM_OO:/9?3VZ>V^KNQ\9UOB.IMR[?W-L M3=VV\!OG9V=PNW-P383/X7[?>]#D5< 2@\$-8>ZD!1I)%"./I_J/Y>?1V-\N MX]_,1%04-/D:'_*.'#@1T&O1N]OG;\M]N;WR^)[CV!\=MK;&[U[WZVP.[\5U M9A.Q=W]AQ[([.W!MS @X3<6Y%VQL? ;8,;8O2HDS.6_A^IS&K*6K9N".X@#^ M9/\ D _U5Z+]FWGF_?X9 X"(K, :"ISY^E/7]E>AZ^-G>_?>Z,O\A_CKV_0; M$I/D[T-0;9R>(W+A8,UCNJNS=F[_ ,/FINK.R!AXY9L_@XFW'@,ACT^IEJ0P/V>8X?+_ %9'2'<-TDM=KAF+U;6:T/$: MJ'T_E]HX=#!\AODKW_AODMT+T?\ '[![8W)'WCT3VIO"FR6\J:23;6P\MLS/ M]>31]D[U3;\B[CSFW5P&?J\;'C<<;9'+Y&C]:QZF]Z[C11P.?\/^S]O3UWS$ MS;Q;0H>UE/\ @.?\.//'25V]O;Y3]&?*OJ;H3NOO+;/>NT?D[L3MJLZ]W;#U M#B.M]T=>]D]/XC YO,+48G!YVIP6Y-B[@V]GS(@.F45"!2X!8FT2NQ"5QFGR M/[>!_93RZ+MRGN-IOT742MZ33Y:?3/ ^?E3-.C%?#GOK<_9G2VX#W3-CL9W# MT1OK?/37>HIH#CL1_>G8$K-%NZ#S.8XL%O/K^HQ^Y$Y"A,@ M@H'M;'( H5O M7_9Z%,6[)>VI*FDUJ*'[6X$_9Z?+JO+_ (<@[4_N=_?3^*4/W&K_ &/SK^7#_5_GZ!7T M_N-Q\=?CU<%^#A3A^=?SX]7V^17XT*W_ 9P?^AA?VN:!?F.I5=;AOCA4C[1 MTAMU;'V1NZ@EH=Y[*VKNK'D'[FCW#M_$96A8 7),.8CEB-A^>?:62R6A(/E7 MR_P]$=U9;6 7N[2'&23I_P )IUK8_,'YG=,[%[.'17\O/XX=+[K[P_BQPF6[ M4V1TMM'(5V!W-_SJ=E18';:'/;D=1?\ B3 X9+D$G\ V\D83A H)!XT_D#_J MK_AQ"]V?=L;5O2\N^W>U)?[G(VEB%&#PPQ!%/F#GR^879?XI=M=+[(A^1'S' MSV0[0^2_:F6;:_4NQ=R9M=S8WK>;.V&:W;E(XW;;7]XH^3B,;C-.$P9KPJAR M6,8-YSW,PVRP+4RR$ ?,TSC]@'VDB@! N\^W7,.W6=OS?S"G^[J=T(M<:5! M:A)\N' 9XDB@#7B])]7CK#?N/ZMK()<=1Y/KO;>Y=J9:F(;(T.Y-OX;";>S M_J'I%[!N;BW'YO[A#8?;E]F]WGW*^9HIRJLH4&A)0'B,?+[?V=9\K"89";B86%K"HXY'UOQ] ?>7D=];7*V;:#Y?R\J?Y^JLOC#_ "]N MLMY]91]P?+GI[$9GY*=[[EW'W'VX,MEMG6/I6DWZ<74YC(8WK;O?J021X+<&6.UZ_9>]]L;;W'C=R;5SU,*')X&5MX[A=8W1;A1XG5N;75P? MI;W[N&.!%>K^WVV4Y>=+@,K:Y10@@U+'_5\NNOY8'7F^.KOA#U/L7LO:V:V5 MOG$YKN%LCMS/TD=!E<=!G>Z.P<_@VDB<$WGV[EJ2N%KFS7_!]I[6U*BG#_5_ MJ/3G*>RG;>7XT(HU93]E2W_%]$-J?AAV1O+X1]#_ ,=ZBHMU]C?'KY9]Q=WI MT'V=!BJ?']J;%W%W3V]'F=I-_'8*F&'.[HZ[WS_%L))*/$F:%&6](/O=S9G4 M!QH>'K_EZ"UWRLU_L%J^DZXY'8J?DU>&#FGED^6>A"BZ_P#C)V#4;5VQT[_* MJHFW1G%$+Q-55"Y!' <> _+_+7HT>S>K=W8/^9A MV3V1#L[(T'4T_P (.G>L]O[NBITBVU_>G =R]BYZIVCAM(\=XMNYVC=@ +& MUO=Q:DL36@I_Q0_P=&D-E!8.Q5>( P*^E!TFMZ_'_/=D_P PCM*MW%M7,MTE MV)_+CCZ/RV^*1!'C1N3,]T[];/;+CR]BR9_^[6=_B !Y4&YO^?5HQKP((_U? MX>DUWR_]G=?Q.ZFVG\;.Z/B_P#(7L/?'2>U\3L+ M9>_^@.N6WIUMW)M;;P;;NQ\WA\]_><_Z/\Y_=N*A.8QNZ6B\?\ JK\_+AUZUF?8(_!TL3P% ZW^W[D.P]];BF,73_9>6P24RP=Q0[-V])50Y7'".3^#Y M>O3)XSR&ANR?4X8%P:>?G_L_:*CSX=%>^--<;5;%D8C620 21FIKY_,BH\^' MDWY_;^:[$^6OPW[LZR^(.X]B]<;&[#[ VUOWLG-]>XCK[L6O3>G6.X-M;=GE MV2E/3[FI^O-O9T1M+D+DT8"B@\?/\ U#/\J]-3[=+/N]LZ MJ0@'&GJM?Y9H?LJ>'1IOAAU]OC9V\?F_+N_:.8VO0;W^8>]=[[-J,E"J1;JV MUE=E]>X.'=>';EC33' ,M[6LI]VC8B8OFE3_ #KG[>CC:-A*V]ZS5[I!Y?,U M(^=.H?QKZXW[MKYK_P Q7>VX-JYK"[/[#WE\;ZO8>Y:RG!QV[\;MWH' 8#/) MB'-^=L[EB*,?K_P#H3?5#VKTKD\]-E4VOD-RKB _/H*(?G+W=_#!MJ?\ E]_* MR#NS3_#3M/[?9YZA_O/=61W?R_P"* M_/I V]W,-N(M#"0CT-./[:?.M.@>[RV!\DJG$?#7?GR@ZWI?DIMCKO<6^LU\ ME>HNDMN'<.UL3NC?;%NJ=XX3J[< \O;VW?C\Y.,U -FB'_BJXTMJ"^7#:F%0 M./R_XK]GD>D&ZP[B-KMGGU.H8D@#AGT^7IP\CCIBW=@\OV1\K?A;W!U9\,MV M[-Z[V-VSNBDW_P!J9_KG$==]G&AWIU9OK;N&_P!^=4&'?\/7FVL^\1S.0RT< M*:C2-BPP+$:TDY48!_U?/R/KTM\6 ;Q;ZHVX<:'S&.%3BASGHX/Q)Z^WKM+M MCYVY+=6ULE@L5OKY3#=6SLGDZ+V(_I[TI( M-?+_ %?SZ?VS9R=PW)V!HYCICY5QT3SL_HWMW,9C^=[48_KK=&0I.]NBM@[: MZ?%-3#5V7EL/\7MQ;&S>%VE<\R-N:08PCZF4@^]FK$^I'^JGR_R=$6Y;5(D. MY! (K3Y C[!U85M?:&Y:3X;;8V55X6IIMY4WQIP^V*S;Q4??CA7)M_AVB@#_0Q]O#_.:]5:4_4_8N MQ-D_RV]R]W]#[\[EZ+ZG^+6'V!V-TGA-L?Z1MQ=6=\OL?KJ+;_9N[^KUEG?> MD.V,!@LYAB N4?"25[.JDL';0LR &-"H_P!G]O\ J!Z"=Q!-&ZL 2H;R'^JM M./I04.,="A-L_-;[^;GQ+[XZU^(FXNN.KL W>^Q]V]@Y'8V'ZZWSD,MOCKD5 M& SV]]DZ8=RX3KR%\!_#DR&6\66_C5/$CTZZZ(W]W1\4-P_)E.S/C=V]NCJWLWY?]\=@]?; MIZ/S^?K7U(KD=*38W7O<_>>Z_E+\K>Q>K]R]82;P^--= M\=?C[TSNQ,4.Q_[CN=Q;BS>\M[8C#-,,!N3=^YLNJ##^21XXZ%!<70E22Q.H M^E /E]G^K-?GTHM(XV^MD9"-06@I]M:#\R3BA-?GTH-GUF3ZN^(WQ)ZF[E^( MV_NXMB1_'WK#;?:%%C-C[2[9R'76^L#LG;]-48/>?2HFEW'GH4G2J#Y#$1Y< MI*EV7]Q6.@2$92.TCT_,']E?/@?EUZYB@5+,>&2I#5[:T/$']EM),;\J]W;U^/W4?:_Q[^*-1U))A]V;'[$QF\.N=M[P[LEW=BN:R:P8L9B;)(/&XC,GO=IQ:E=/\ A.?]7^JG2JS\3ZL! VC% M<'C_ )/V^O"O1U_EW\?Y_D?U!EMB8?-C9V_\)FMN=D]1=@I0?Q%]@=O;"S4& MX-D;A5?7(8X(8#/$7'SZ07VVR[ZZW#BC*P8? MEG'[,9IQ\^N/=GR%[P^374V:^.W2/Q2^0_6_9G;^!R6P=V[\[UV"FSNL.FMK MYDKMS>^[LYO%MP2C?6=?.O0G;(Z+S?7/S=Z.FP&VV96 M*FM/3_5PX=+3>&P-[U/\R#I7L>AVQF*GKO#_ !=[AV9F-YTL/^XNBW/G>Q^O M<]AL'E2+$EJ?;KN@')/)MS;Q!H/2G^4_Y^G3#;KS(KB,Z=/&F//Y>1Z=^PME M;JR?ST^.W8&/V[D:K8^V?C]\D=MYC<]##')C<+N;<.\NA9=O8C*Z7 _RN# U MTB@'@T)_H?>F#$ _+C_G^SIN^1[;'S/5G:7?FR>LNL>C.F,QNU=I]DX_HOJG)39W/ M8;=V], 2=@]@=_G<&;CLI!''_#^1P!3IN78> M<=ZN7GU^&AX#' $'-:<1G\C@ CIL^0VW=J]W_"WL?HSXY_R[]\;=WP>K !-.CE8/8V_63RM-Z=H[HW#GNA<]A-EYW@E=PO_ &O+#_54!^OO>2RU!P*<.EM MOL;W.]6DK@Z5CIP]%_U?RZ=OD/USOGT?AT;-2/]C_B^CO=-I_>=VK$ M$?1UI\]8(_/Y_+HHOS;VIV+L+Y(ML'J/_)J#^:+MW&= [\JZ&J)KMC[DZLQ+ MG>'IQY@?S!XVQE88* MUOV Q7&BE20. K^5>K4/]EPZ=O_ ,>OC]'^A'_9=-%E_P"90Z+?W(_5_P ! MO/\ N?ZK_>_:S0OH>%./^K/GZ=#[Z3_AK4^G_P!0^VOGT8EK#FP_'X]N#..A M*IU#HK'R%Z/W/WMMR'8Y.M]D90M2[XJ=C!\;O;=&,,8!PN(SWDE?9F*D M*-JD4-(U[?F[>)++I/#^9_V/EP\^@/S+R_-N*LL;,%:H-":Y\O2@]*T\^L7Q MZ^)?07Q@PT6(Z;ZPVSLTU0"UF4HZ):_<>1( );-[OSSU.YLVK?CR3.;_ -/: M".R3)C%!Z\3^W'\@/SZ1\D>W6V M7S$ZG@R-&T^P^C=HR]@95ZA+X^NW;N#,B#;F&L;@LO\ 5R7/%\?;W'_ #!L M+75VC%055EK]@-?\_2'F3E:WYCW6,MF.-U)'E0'4>CQY#:6*S69VSG*F$-D= MJU&3J,/4@CT)F,1)@\LM@/U-%+S_ *P]B:/:P2)' ,OK3/#UZDZ-=$:H, ? MX!TN MA[.%MV5*>5.KU%>F_%_P# *B_ZAEO_ +9?=;+A^9_PGK1X=.) M]![ M62DA:^?6E '#KNP_H/;G6J"M?/KP 'T '^L />ZD]>4!110 /EUW8>]=> % M!PZZL+6L+?TMQ[]4]>TK2E!3KH*H^BJ/]8#WNI]>JB-!P4#\NN[#^@_VWO53 MU8JIX@==^_=>H.NBJGZ@'_7 ][J>M%$/$ _EUUI7_4K_ +8>]=>T(<$"GV== MZ5_U(_VP]^H.O:5K6@KUZP_H/]M[]UN@&!UW8?T]^Z]0]=;H!PZZL#]0.?KQ]??JGKQ53Q SUW[]UN@ZZTC^ M@_VP][J>JZ%]!U[2/Z#_ &P]ZZ]I7T'7M*_ZD?[8>_5/7BB'B!^SKVE?Z#_; M#WNIZ]H3T'[.O:5_H/\ ;#WZIZ]H3T'[.O6']!_MA[UU[2OH.N[#^GOW'CU; MCQZZTK_J1_MA[W4]5*(>('[.O6 ^@'O76P . '7M*_ZD?[8>]U/6M">@_9UZ MP_H/]M[U4];TKZ#KUA>]A?\ K;GWNIZUI6M:"O714$'@7((^@]^!/Y=:9%(. M!6G19?C5T51_'G86:V11;AJ=P#*=I=I=EBNJJ5*%HW[6[*W#OU\2 "P_9ESI M0_DM_A:_J*!0<>B/9ML%F['YGR_U?;T98G2+GG^E^;?X^]Z0QX#H\FE\,8X] M9=*GZ@'_ %P/=>'#K956&0#UZP_H/?NMT -:9ZXZ>"/Z^[5SUJ10P('GT1[ M?&+,57RMS/R<[ [3K.P&P>U7#PM*^\]] M[HFV[2QME7,13%1%-!U"^A2M2!7[.B&XV07$@D< E3BH!IGYXKT>'2/\/TZ? M?J_X>CSPQ_QFG7FM8?T]['3R?+KB+?C_ (GWL_/JQ^?4:/\LM_G-/C.B]_P :?I;VQ@MLVCZUZUUUS_L?GTK?=^A5UQ-_;#^+3'6\=-V+_P" 5%_U#+_O2^TUEP_, M_P"$]>\NG(_3VKF^#\^O#CUW[=ZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7#_7^G^^_I[M]G5A3\/73V_/O:UZ2S:?/CUD J]TZ4#KWOW7NN)_0;_P!/?NM)6@IQZX>[].]<_P#HWW7_ #]5_P _7__9 end EX-101.SCH 5 ammj-20210630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Principles of Consolidation. link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Description of Business. link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Naturaleaf Asset Acquisition link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Accounts Receivable and Advance from Clients link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Property and Equipment, net link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Accrued and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Stock Payable link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Loans Payable link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Stock Based Compensation link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Shareholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Naturaleaf Asset Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Accounts Receivable and Advance from Clients (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Property and Equipment, net (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Accrued and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Stock Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Stock Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Naturaleaf Asset Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Naturaleaf Asset Acquisition (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Accounts Receivable and Advances from Clients - Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Property and Equipment, net - Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Property and Equipment, net (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Accrued and Other Current Liabilities - Accrued and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Stock Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Stock-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Stock Based Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 ammj-20210630_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 ammj-20210630_def.xml XBRL DEFINITION FILE EX-101.LAB 8 ammj-20210630_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Nonrecurring Adjustment [Axis] Acquisition-related Costs [Member] Long-Lived Tangible Asset [Axis] Office Equipment [Member] Software Development [Member] Furniture and Fixtures [Member] Machinery and Equipment [Member] Leasehold Improvements [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current Assets Cash and Equivalents Accounts Receivable, Net Deposits Inventory Prepaid Expenses and Other Current Assets Total Current Assets Property and Equipment - Net Other Assets Intangible Assets, net Goodwill Right of Use Assets - Operating Leases, net Long Term Deposits Total Other Assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities Accounts Payable Advances from Clients Accrued and Other Current Liabilities Stock payable Right of Use Liabilities, current Note payables, current Total Current Liabilities Long Term Liabilities Right of Use Liabilities Total Long Term Liabilities TOTAL LIABILITIES Shareholders' Equity Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2021 and December 31, 2020 Common stock, $0.00001 par value; 500,000,000 shares authorized; 79,902,938 and 70,727,938 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively Additional paid-in capital Accumulated deficit Total Shareholders' Equity TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY Preferred stock Par Value Preferred Stock Shares Authorized Preferred Stock Shares Issued Preferred Stock Shares Outstanding Common stock Par Value Common Stock Shares Authorized Common Stock Shares Issued Common Stock Shares Outstanding Income Statement [Abstract] Revenues Consulting Services Product & Equipment Cannabis Products Total Revenues Cost of Revenues Cost of Consulting Services Cost of Products and Equipment Cost of Cannabis Products Total Cost of Revenues Gross Profit Operating Expenses General and Administrative Selling and Marketing Stock Based Compensation Expense Total Operating Expenses Loss from Operations Other Income (Expense) Interest (expense) Debt Forgiveness Other income Total Other (Expense) Income Net Loss Income Tax Expense NET LOSS Basic net loss per common share Basic weighted average common shares outstanding Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net Loss Adjustments to reconcile net loss to net cash used in operating activities: Gain on Sale of assets Depreciation Stock-based compensation to employees Debt Forgiveness Changes in operating assets and liabilities: Accounts receivable Deposits Inventory Prepaid expenses and other current assets Right to Use Lease Asset Accounts Payable Advances from Clients Accrued and other current liabilities Operating Lease Liability Net Cash used in Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property and equipment Proceeds from sales of property and equipment Acquisition of Assets Intangible assets Net Cash Provided by (Used in) Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from PPP loan Proceeds from sale of common stock Net Cash Provided by Financing Activities NET DECREASE IN CASH CASH AT BEGINNING OF PERIOD CASH AT END OF PERIOD SUPPLEMENTAL CASH FLOW INFORMATION: Cash paid for income taxes Cash paid for interest Stock issued for receivables Stock issued for acquisition of assets Note Payable issued for acquisition of assets Statement [Table] Statement [Line Items] Balance, December 31, 2021 Beginning Balance, Shares Stock issued for asset acquisition Stock issued for asset acquisition, Shares Stock issued for cashless exercise of warrants Stock issued for cashless exercise, Shares Stock-based compensation to employees Stock-based compensation to employees, Shares Stock issued for cash Shares issued for cash, Shares Net Loss Balance, June 30, 2021 Ending Balance, Shares Accounting Policies [Abstract] Principles of Consolidation. Description of Business. Summary of Significant Accounting Policies Business Combination and Asset Acquisition [Abstract] Naturaleaf Asset Acquisition Receivables [Abstract] Accounts Receivable and Advance from Clients Inventory Disclosure [Abstract] Inventory Property, Plant and Equipment [Abstract] Property and Equipment, net Payables and Accruals [Abstract] Accrued and Other Current Liabilities Stock Payable Stock Payable Operating Lease Right-of-use Assetoperating Lease Liability Operating Lease Right-of-Use Asset/Operating Lease Liability Debt Disclosure [Abstract] Loans Payable Related Party Transactions [Abstract] Related Party Transactions Equity [Abstract] Stock Based Compensation Shareholders’ Equity Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Basis of Accounting Use of Estimates in Financial Reporting Unaudited Interim Financial Statements Segment Information Cash and Cash Equivalents Accounts Receivable Deposits Inventory Prepaid Expenses and Other Current Assets Significant Clients and Customers Property and Equipment, net Goodwill Accounting for the Impairment of Long-Lived Assets Fair Value Measurements Revenue Recognition Product and Equipment Sales Consulting Services Cannabis Sales Loyalty Reward Program Costs of Revenues Advertising and Promotion Costs Shipping and Handling Costs Stock-Based Compensation Research and Development Income Taxes Net Loss Per Common Share Related Party Transactions Impact of COVID-19 Pandemic Recent Accounting Pronouncements Purchase price as of the acquisition Pro Forma Financial Information Accounts Receivable and Advance from Clients Inventory Property and Equipment, Net Accrued and Other Current Liabilities Schedule of stock payable Schedule of lease Operating leases liabilities Schedule of stock based compensation Cash, FDIC Insured Amount Allowance for doubtful accounts Bad debt expense Selling and marketing expense stock based compensation expense Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Cash Inventory Property, plant and equipment Long Term Deposits Identifiable intangible assets Accounts payable Total consideration Total Revenues Loss from Operations Basic and diluted loss per share Accounts Receivable – Trade Less:  Allowance for Doubtful Accounts Accounts Receivable, net Beginning Balance Additional deposits received Less: Deposits recognized as revenue [custom:AdvanceFromClient-0] Raw Materials Work In Process Finished Goods Total Inventory Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Less: accumulated depreciation Property and equipment, net Office equipment Machinery and equipment Leasehold improvements Accrued Interest Accrued Payroll Sales Tax Payable Other Accrued Expenses & Payables Accrued and other current liabilities [custom:StockPayableAmounts-1] Additional Expensed Incurred, Amount Shares Issued for Expensed Incurred, Amount Ending Stock Payable, Amount 2021 2022 Total Less: amount representing interest Present value of future minimum lease payments Less: current obligations under leases Long-term lease obligations 2021 2022 Total Warrants Stock Payable Total [custom:GrantedRestrictedShares] [custom:GrantedRestrictedValue] Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Revenues [Default Label] Cost of Revenue Gross Profit Operating Expenses [Default Label] Operating Income (Loss) Interest Expense DebtForgiveness Nonoperating Income (Expense) NetLoss Net Income (Loss) Available to Common Stockholders, Basic Gain (Loss) on Disposition of Assets for Financial Service Operations Increase (Decrease) in Time Deposits Increase (Decrease) in Inventories Increase (Decrease) in Accounts Payable AdvancesFromClients Net Cash Provided by (Used in) Operating Activities Property, Plant and Equipment, Disposals Increase (Decrease) in Intangible Assets, Current Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Shares, Issued Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture Inventory Disclosure [Text Block] Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] StockPayableTextBlock Deposit Contracts, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Receivables and Portions of Securitizations that can be Prepaid at Potential Loss, Policy [Policy Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Goodwill and Intangible Assets, Policy [Policy Text Block] ConsultingServicesPolicyTextBlock RelatedPartyTransactions Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Schedule of Inventory, Current [Table Text Block] Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Inventory, Gross Long-term Debt Accounts Receivable, Allowance for Credit Loss, Current Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accounts Payable and Other Accrued Liabilities StockPayableAmounts Capital Leases, Future Minimum Payments Due, Next Twelve Months Capital Leases, Future Minimum Payments Due in Two Years Capital Leases, Future Minimum Payments Due Convertible Notes Payable Total [Default Label] EX-101.PRE 9 ammj-20210630_pre.xml XBRL PRESENTATION FILE XML 10 f2sammj10q081221_htm.xml IDEA: XBRL DOCUMENT 0000945617 2021-01-01 2021-06-30 0000945617 2021-08-13 0000945617 2021-06-30 0000945617 2020-12-31 0000945617 2021-04-01 2021-06-30 0000945617 2020-04-01 2020-06-30 0000945617 2020-01-01 2020-06-30 0000945617 2019-12-31 0000945617 2020-06-30 0000945617 us-gaap:CommonStockMember 2020-03-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000945617 us-gaap:RetainedEarningsMember 2020-03-31 0000945617 2020-03-31 0000945617 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0000945617 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0000945617 us-gaap:CommonStockMember 2020-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000945617 us-gaap:RetainedEarningsMember 2020-06-30 0000945617 us-gaap:CommonStockMember 2021-03-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000945617 us-gaap:RetainedEarningsMember 2021-03-31 0000945617 2021-03-31 0000945617 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000945617 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000945617 us-gaap:CommonStockMember 2021-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000945617 us-gaap:RetainedEarningsMember 2021-06-30 0000945617 us-gaap:CommonStockMember 2019-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000945617 us-gaap:RetainedEarningsMember 2019-12-31 0000945617 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0000945617 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0000945617 us-gaap:CommonStockMember 2020-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000945617 us-gaap:RetainedEarningsMember 2020-12-31 0000945617 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0000945617 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0000945617 us-gaap:AcquisitionRelatedCostsMember 2021-06-30 0000945617 us-gaap:OfficeEquipmentMember 2021-06-30 0000945617 us-gaap:SoftwareDevelopmentMember 2020-12-31 0000945617 us-gaap:SoftwareDevelopmentMember 2021-06-30 0000945617 us-gaap:OfficeEquipmentMember 2020-12-31 0000945617 us-gaap:FurnitureAndFixturesMember 2021-06-30 0000945617 us-gaap:FurnitureAndFixturesMember 2020-12-31 0000945617 us-gaap:MachineryAndEquipmentMember 2021-06-30 0000945617 us-gaap:MachineryAndEquipmentMember 2020-12-31 0000945617 us-gaap:LeaseholdImprovementsMember 2021-06-30 0000945617 us-gaap:LeaseholdImprovementsMember 2020-12-31 0000945617 2019-01-01 2019-12-31 iso4217:USD shares iso4217:USD shares 0000945617 true --12-31 Q2 2021 This amendment is being filed to include the ixbrl in the html file. 10-Q/A true 2021-06-30 false 000-26108 AMERICAN CANNABIS COMPANY, INC. DE 90-1116625 2590 Walnut #6 Denver CO 80205 303 974-4770 Yes Yes Non-accelerated Filer true false false 80152938 1131833 1723132 23331 24955 2895 2895 331494 62402 24072 50302 1513625 1863686 468216 24655 1115182 1530316 163416 6001 2814915 4796756 1888341 264468 13153 63447 88843 136368 49244 28690 147131 1230186 109914 1870290 261154 16286 16286 1886576 261154 0.01 0.01 5000000 5000000 0 0 0 0 0.00001 0.00001 500000000 500000000 79902938 79902938 70727938 70727938 798 707 11408199 9634748 -8498817 -8008268 2910180 1627187 4796756 1888341 39501 131238 201393 355613 273401 418675 437489 634682 307077 307077 619979 549913 945958 990295 6006 22429 26706 114555 209148 287368 330257 423609 146074 146074 361228 309797 503037 538164 258751 240116 442921 452131 535641 240187 870569 560773 61006 92621 127743 163028 13027 19659 28690 24162 609674 352467 1027002 747963 -350923 -112351 -584081 -295832 18629 18810 -110543 900 10588 1799 16522 -17729 10588 93532 16522 -368654 -101763 -490549 -279310 -368652 -101763 -490549 -279310 -0 -0 -0 -0.01 76256839 54206866 76329457 53460270 490549 279310 500 8979 7095 28690 24162 -109914 1624 59435 1605 -119092 -45473 26230 346 -163416 25497 251314 163761 -25396 -60643 87124 10501 163416 -25947 -340990 -119471 360015 2269 2500 -1100000 4022 -1464037 231 130186 1083542 69503 1213728 69503 -591299 -49737 1723132 945181 1131833 895444 25472 690000 1100000 53456866 534 8398424 -7653402 745556 750000 7 94968 94975 -101763 -101763 54206866 541 8493392 -7755165 738768 76377938 763 10632985 -8130165 2503583 3000000 30 689970 690000 25000 500000 5 85244 85249 -368652 -368652 79902938 798 11408199 -8498817 2910180 52978605 529 8354920 -7475855 879594 478261 5 43504 43509 750000 7 94968 94975 -279310 -279310 54206866 541 8493392 -7755165 738768 70727938 707 9634748 -8008268 1627187 3000000 30 689970 690000 125000 1 -1 6050000 60 1083482 1083542 -490549 -490549 79902938 798 11408199 -8498817 2910180 <p id="xdx_807_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_z9My9SDdsdji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1. <span id="xdx_82B_zF8LWk7Lo9t1">Principles of Consolidation.</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The unaudited condensed consolidated financial statements for the three months ended June 30, 2021 and 2020 include the accounts of American Cannabis Company, Inc. and its wholly owned subsidiary, Hollister &amp; Blacksmith, Inc., doing business as American Cannabis Company, Inc. Intercompany accounts and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_805_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zbGLyi8KfHxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 2. <span id="xdx_825_ztV28Pz9N8u8">Description of Business.</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">American Cannabis Company, Inc. and its wholly owned subsidiary Company, Hollister &amp; Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and sell both exclusive and non-exclusive customer products commonly used in the industry.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Naturaleaf agreed to sell or assign to the Company the following assets:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in">1.</td><td style="text-align: justify">Three Medical Marijuana (MMC) Store Licenses;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in">2.</td><td style="text-align: justify">One Marijuana Infused Product Licenses (MIPS); and,</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in">3.</td><td style="text-align: justify">One Option Premises Cultivation License (OPC); and,</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in">4.</td><td style="text-align: justify">Related real property assets, goodwill, and related business assets.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result, the Company has expanded its business model to include the cultivation and retail sale of cannabis in the medicinal cannabis industry.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_z1STUrbgRqgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 3. <span id="xdx_82B_z3KoFwjKpaA8">Summary of Significant Accounting Policies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zLY5dJCEjm4j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_868_zO1cvyEo3Jig">Basis of Accounting</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_eus-gaap--UseOfEstimates_z52l03o5fQBf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_860_zh74F7e9sON6">Use of Estimates in Financial Reporting</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_844_ecustom--UnauditedInterimFinancialStatements_z1cYJHNGB9Bl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt; background-color: white"><i><span id="xdx_86E_zeng9cXzfJj5">Unaudited Interim Financial Statements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.5pt; text-align: justify; text-indent: -0.5pt; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: justify; text-indent: -0.5pt; background-color: white">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zIkYLdNpZGaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_862_zQtFYZyCh0Pg">Segment Information</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker, or decision-making group, in deciding how to allocate resources and assess performance. The Company reports results of operations in 3 distinct segments: Consulting Services, Soil Product and Equipment and Cannabis Products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Consulting Services segment provides services to the Cannabis industry as to the development and expansion of cultivation and retail facilities. These services include business plans, design advice and cultivation oversight. These services are offered throughout the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Soil Product and Equipment Segment handles the sale of our So-Hum Living Soils Product and the resale of Equipment in connection with our consulting services not only in the Cannabis industry but also to other agricultural industries. These products are offered for sale throughout the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Cannabis Product segment handles both the cultivation of and the retail sale of medicinal cannabis products in the State of Colorado.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zYvSDKyN1tGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86C_zexYlh6NzAV8">Cash and Cash Equivalents</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of June 30, 2021 and December 31, 2021, the Company had cash balances in excess of FDIC insured limits of $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_c20210630_zHp0rOs35zDb"><span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_c20201231_zqlcsOhwMvX7">250,000</span></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_845_eus-gaap--ReceivablesPolicyTextBlock_zDl0YgjQT9wa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_863_zkHCQUWZOrIh">Accounts Receivable</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of June 30, 2021, and December 31, 2020, the Company’s allowance for doubtful accounts was $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20210630_zn8Y6ILYwqd2" title="Allowance for doubtful accounts">60,354 </span>and $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20201231_zw8U9Gkhw4y8">57,512</span>, respectively. The Company recorded bad debt expense during the six months ended June 30, 2021 and 2020 of $<span id="xdx_906_eus-gaap--InterestAndDebtExpense_c20210101__20210630_zTj46PfO7R17" title="Bad debt expense">0</span> and $<span id="xdx_908_eus-gaap--InterestAndDebtExpense_c20200101__20200630_z89YIASHFo27">22,500</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_845_eus-gaap--DepositContractsPolicy_zpf2NiUZZyTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_865_zJwJQpuTibj3">Deposits</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deposits is comprised of advance payments made to third parties, for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zdnS9yCNetS8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_861_zRyJprkOdfBj">Inventory</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in first-out and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of June 30, 2021 and December 31, 2021, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third party vendors for retail sales at dispensaries is determined using the first in first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production related depreciation and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At June 30, 2021, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_840_eus-gaap--ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock_zgCp7K9m0Zek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_863_zDMpaxbe9A07">Prepaid Expenses and Other Current Assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z1hygVnBlE25" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_868_zkwdz8IGV5Vj">Significant Clients and Customers</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">During the six months ended June 30, 2021, three customers accounted for 42.5% of the Company’s total revenues for the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2020, three customers accounted for 35.4% of the Company’s total revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zBmb6a3kNVj6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86A_zz5UzUWRcZmg">Property and Equipment, net</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in progress construction are capitalized as incurred and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of June 30, 2021 and December 31, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zy00AHa2Rz1d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_864_zbIvuOr481Ea">Goodwill </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goodwill represents the excess of fair value over identifiable tangible and intangible net assets acquired in business combinations. Goodwill is not amortized, instead goodwill is reviewed for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_844_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zNK5erzVF4x5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86F_z5YoHPBaBm42">Accounting for the Impairment of Long-Lived Assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company evaluates long lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long lived assets as of June 30, 2021 and December 31, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z8WZhch1i41i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86F_zgMWv69KsS6j">Fair Value Measurements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level 1 – Quoted prices in active markets for identical assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_z6D9egAKL2Fj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_861_zvSdHS4CZxKa">Revenue Recognition</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “<i>Revenue from Contracts with Customers (Topic 606). </i>Due to the nature of our contracts with customers, adopting the new accounting principles did not have a significant impact on our prior period results of operations, cash flows or financial position.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our service and product revenues arise from contracts with customers.  Service revenue includes Operations Divisions consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, (c) Cannabis sales division.  The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may also enter into contracts with customers that identify a single, or few, distinct performance obligations, but that also have non-distinct, underlying performance obligations.  These contracts are typically fulfilled within one to six months.  Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods and, accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><i>(1)</i></td><td style="text-align: justify"><i>Identify the contract with the Customer. </i>Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><i>(2)</i></td><td style="text-align: justify"><i>Identify the performance obligations in the contract. </i>We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><i>(3)</i></td><td style="text-align: justify"><i>Determination of the transaction price. </i>Prices are typically fixed, and no price protections or variables are offered.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><i>(4)</i></td><td style="text-align: justify"><i>Allocation of the transaction price to the performance obligations in the contract</i>. Transaction prices are typically allocated to the performance obligations outlined in the contract.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><i>(5)</i></td><td style="text-align: justify"><i>Recognize Revenue when (or as) the entity satisfies a performance obligation. </i>We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Advances from Clients deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received.  Where possible, we obtain retainers to lessen our risk of non-payment by our customers.  Advances from Clients deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p id="xdx_842_ecustom--ProductAndEquipmentSalesPolicyTextBlock_z5sEnnJVxEW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86B_zuXLjNNAjtbc">Product and Equipment Sales</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, title has transferred, and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606. During the six months ended June 30, 2021 and 2020, sales returns were $0.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_846_ecustom--ConsultingServicesPolicyTextBlock_zZnOUdxJdWyd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86E_zNUs1Rbt37Ae">Consulting Services</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For hourly based fixed fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients” account, and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer based significant financing, that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the three months ended March 31, 2021 and 2020, we incurred no losses from fixed fee engagements that terminate prior to completion. We believe if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_ecustom--CannabisSalesPolicyTextBlock_zRCiPZK7bQb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_866_z85gkUns0hUk">Cannabis Sales</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the three months ended June 30, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_849_ecustom--LoyaltyRewardProgramPolicyTextBlock_zbnpYQcV4Ara" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86A_zAHVAJr2eQL8">Loyalty Reward Program</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based upon the total amount of a purchase, at the time of purchase. Management has determined that as there is no separate performance obligation to the reward program, i.e. the accumulation and redemption of points, and as such the Company recognizes the revenue at the time of purchase.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--CostOfSalesPolicyTextBlock_zpjN8ej9SoFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86B_zLbMGbjLdp42">Costs of Revenues</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_845_eus-gaap--AdvertisingCostsPolicyTextBlock_znx71mfQbnuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_863_zMPPha5fqTQa">Advertising and Promotion Costs</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Advertising and Promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the six months ended June 30, 2021 and 2020 these expenses were $<span id="xdx_90B_eus-gaap--OtherSellingAndMarketingExpense_c20210101__20210630_zfVvDizHU2ib" title="Selling and marketing expense">33,238</span> and $<span id="xdx_901_eus-gaap--OtherSellingAndMarketingExpense_c20200101__20200630_zpw37q3VbSzc">8,489</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84C_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zLnw81hKE0D1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_868_zl687PZ7OQb8">Shipping and Handling Costs</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zW2fMnYF25Ig" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_863_zjQfG6CbJdRk">Stock-Based Compensation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. During the six months ended June 30, 2021 and 2020, stock-based compensation expense for restricted shares for Company employees was $<span id="xdx_90E_eus-gaap--StockOptionPlanExpense_c20210101__20210630_zf9VPuMXYWg7" title="stock based compensation expense">28,690</span> and $<span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20200101__20200630_zgml7ulJGCch">4,503</span>, respectively and $13,027 and $19,659 for the three months ended June 30, 2021. Compensation expense for warrants are based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model and are expensed over the expected term of the awards. During the six months ended June 30, 2021, no warrants were issued as stock compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>         </i></b></p> <p id="xdx_84B_eus-gaap--ResearchAndDevelopmentExpensePolicy_zq2MnDvkCbv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86C_zpDXHFu7UYQ8">Research and Development</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a component of our equipment and supplies offerings, from time-to-time we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include, but are not limited to: The Satchel™, Cultivation Cube™, So-Hum Living Soils™ and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the six months ended June 30, 2021 and 2020, our research and development costs were de minimis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z2Mwxj9Fysec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_866_zwYdDpwien2">Income Taxes</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s corporate status changed from an S Corporation, which it had been since inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2010, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of June 30, 2021 and December 31, 2020, we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zZXgh4RK5Hl6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_867_zkKzrJWRYCtk">Net Loss Per Common Share</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities since that would have an anti-dilutive effect on earnings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“<b>IRC</b>”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p id="xdx_849_ecustom--RelatedPartyTransactions_zvZyR3jHMv82" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86C_zljbn922a0yd">Related Party Transactions</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company follows FASB ASC subtopic 850-10, <i>Related Party Disclosures,</i> for the identification of related parties and disclosure of related party transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_848_ecustom--ImpactOfCovid19Pandemic_zb2PC1PkMjqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86C_zXYrPUQCQco2">Impact of COVID-19 Pandemic</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 11, 2020<i>, </i>the World Health Organization declared the current coronavirus (“COVID-<i>19”</i>) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-<i>19</i> within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact upon many sectors of the economy, including retail commerce.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In response to state and local measures and for protection of both employees, the Company made required changes to operations, which did not have a material impact upon operations or the financial condition of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-<i>19</i> cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these unaudited condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zMhm4psZaA0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86A_zMyecVeRebcj">Recent Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In December 2019, the FASB issued ASU 2019-12<i>, “Simplifying the Accounting for Income Taxes</i>”.  The pronouncement simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740, “Income Taxes”.  The pronouncement also improves consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance.  This standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted.  The Company is still evaluating the impact this guidance will have on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In January 2020, the FASB issued ASU No. 2020-01, "<i>Investments — Equity Securities: Clarifying the Interactions between Topic 321, Topic 323, and Topic 815</i>" ("ASU No. 2020-01"). ASU No. 2020-01 clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with ASC 321, "<i>Investments — Equity Securities"</i> immediately before applying or upon discontinuing the equity method of accounting in ASC 323, "<i>Investments—Equity Method and Joint Ventures</i>." The provisions of ASU No. 2020-01 are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years with early adoption permitted, including early adoption in an interim period for public business entities for periods for which financial statements have not yet been issued. The Company is still evaluating the impact this guidance will have on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zLY5dJCEjm4j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_868_zO1cvyEo3Jig">Basis of Accounting</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_eus-gaap--UseOfEstimates_z52l03o5fQBf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_860_zh74F7e9sON6">Use of Estimates in Financial Reporting</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_844_ecustom--UnauditedInterimFinancialStatements_z1cYJHNGB9Bl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt; background-color: white"><i><span id="xdx_86E_zeng9cXzfJj5">Unaudited Interim Financial Statements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.5pt; text-align: justify; text-indent: -0.5pt; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; text-align: justify; text-indent: -0.5pt; background-color: white">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zIkYLdNpZGaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_862_zQtFYZyCh0Pg">Segment Information</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker, or decision-making group, in deciding how to allocate resources and assess performance. The Company reports results of operations in 3 distinct segments: Consulting Services, Soil Product and Equipment and Cannabis Products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Consulting Services segment provides services to the Cannabis industry as to the development and expansion of cultivation and retail facilities. These services include business plans, design advice and cultivation oversight. These services are offered throughout the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Soil Product and Equipment Segment handles the sale of our So-Hum Living Soils Product and the resale of Equipment in connection with our consulting services not only in the Cannabis industry but also to other agricultural industries. These products are offered for sale throughout the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Cannabis Product segment handles both the cultivation of and the retail sale of medicinal cannabis products in the State of Colorado.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zYvSDKyN1tGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86C_zexYlh6NzAV8">Cash and Cash Equivalents</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of June 30, 2021 and December 31, 2021, the Company had cash balances in excess of FDIC insured limits of $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_c20210630_zHp0rOs35zDb"><span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_c20201231_zqlcsOhwMvX7">250,000</span></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> 250000 250000 <p id="xdx_845_eus-gaap--ReceivablesPolicyTextBlock_zDl0YgjQT9wa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_863_zkHCQUWZOrIh">Accounts Receivable</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of June 30, 2021, and December 31, 2020, the Company’s allowance for doubtful accounts was $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20210630_zn8Y6ILYwqd2" title="Allowance for doubtful accounts">60,354 </span>and $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20201231_zw8U9Gkhw4y8">57,512</span>, respectively. The Company recorded bad debt expense during the six months ended June 30, 2021 and 2020 of $<span id="xdx_906_eus-gaap--InterestAndDebtExpense_c20210101__20210630_zTj46PfO7R17" title="Bad debt expense">0</span> and $<span id="xdx_908_eus-gaap--InterestAndDebtExpense_c20200101__20200630_z89YIASHFo27">22,500</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 60354 57512 0 22500 <p id="xdx_845_eus-gaap--DepositContractsPolicy_zpf2NiUZZyTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_865_zJwJQpuTibj3">Deposits</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deposits is comprised of advance payments made to third parties, for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zdnS9yCNetS8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_861_zRyJprkOdfBj">Inventory</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in first-out and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of June 30, 2021 and December 31, 2021, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third party vendors for retail sales at dispensaries is determined using the first in first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production related depreciation and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At June 30, 2021, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_840_eus-gaap--ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock_zgCp7K9m0Zek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_863_zDMpaxbe9A07">Prepaid Expenses and Other Current Assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z1hygVnBlE25" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_868_zkwdz8IGV5Vj">Significant Clients and Customers</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">During the six months ended June 30, 2021, three customers accounted for 42.5% of the Company’s total revenues for the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2020, three customers accounted for 35.4% of the Company’s total revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zBmb6a3kNVj6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86A_zz5UzUWRcZmg">Property and Equipment, net</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in progress construction are capitalized as incurred and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of June 30, 2021 and December 31, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zy00AHa2Rz1d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_864_zbIvuOr481Ea">Goodwill </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goodwill represents the excess of fair value over identifiable tangible and intangible net assets acquired in business combinations. Goodwill is not amortized, instead goodwill is reviewed for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_844_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zNK5erzVF4x5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86F_z5YoHPBaBm42">Accounting for the Impairment of Long-Lived Assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company evaluates long lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long lived assets as of June 30, 2021 and December 31, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z8WZhch1i41i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86F_zgMWv69KsS6j">Fair Value Measurements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level 1 – Quoted prices in active markets for identical assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_z6D9egAKL2Fj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_861_zvSdHS4CZxKa">Revenue Recognition</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “<i>Revenue from Contracts with Customers (Topic 606). </i>Due to the nature of our contracts with customers, adopting the new accounting principles did not have a significant impact on our prior period results of operations, cash flows or financial position.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our service and product revenues arise from contracts with customers.  Service revenue includes Operations Divisions consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, (c) Cannabis sales division.  The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may also enter into contracts with customers that identify a single, or few, distinct performance obligations, but that also have non-distinct, underlying performance obligations.  These contracts are typically fulfilled within one to six months.  Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods and, accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><i>(1)</i></td><td style="text-align: justify"><i>Identify the contract with the Customer. </i>Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><i>(2)</i></td><td style="text-align: justify"><i>Identify the performance obligations in the contract. </i>We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><i>(3)</i></td><td style="text-align: justify"><i>Determination of the transaction price. </i>Prices are typically fixed, and no price protections or variables are offered.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><i>(4)</i></td><td style="text-align: justify"><i>Allocation of the transaction price to the performance obligations in the contract</i>. Transaction prices are typically allocated to the performance obligations outlined in the contract.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><i>(5)</i></td><td style="text-align: justify"><i>Recognize Revenue when (or as) the entity satisfies a performance obligation. </i>We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Advances from Clients deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received.  Where possible, we obtain retainers to lessen our risk of non-payment by our customers.  Advances from Clients deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p id="xdx_842_ecustom--ProductAndEquipmentSalesPolicyTextBlock_z5sEnnJVxEW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86B_zuXLjNNAjtbc">Product and Equipment Sales</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, title has transferred, and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606. During the six months ended June 30, 2021 and 2020, sales returns were $0.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_846_ecustom--ConsultingServicesPolicyTextBlock_zZnOUdxJdWyd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86E_zNUs1Rbt37Ae">Consulting Services</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For hourly based fixed fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients” account, and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer based significant financing, that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the three months ended March 31, 2021 and 2020, we incurred no losses from fixed fee engagements that terminate prior to completion. We believe if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_ecustom--CannabisSalesPolicyTextBlock_zRCiPZK7bQb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_866_z85gkUns0hUk">Cannabis Sales</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the three months ended June 30, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_849_ecustom--LoyaltyRewardProgramPolicyTextBlock_zbnpYQcV4Ara" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86A_zAHVAJr2eQL8">Loyalty Reward Program</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based upon the total amount of a purchase, at the time of purchase. Management has determined that as there is no separate performance obligation to the reward program, i.e. the accumulation and redemption of points, and as such the Company recognizes the revenue at the time of purchase.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--CostOfSalesPolicyTextBlock_zpjN8ej9SoFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86B_zLbMGbjLdp42">Costs of Revenues</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_845_eus-gaap--AdvertisingCostsPolicyTextBlock_znx71mfQbnuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_863_zMPPha5fqTQa">Advertising and Promotion Costs</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Advertising and Promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the six months ended June 30, 2021 and 2020 these expenses were $<span id="xdx_90B_eus-gaap--OtherSellingAndMarketingExpense_c20210101__20210630_zfVvDizHU2ib" title="Selling and marketing expense">33,238</span> and $<span id="xdx_901_eus-gaap--OtherSellingAndMarketingExpense_c20200101__20200630_zpw37q3VbSzc">8,489</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> 33238 8489 <p id="xdx_84C_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zLnw81hKE0D1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_868_zl687PZ7OQb8">Shipping and Handling Costs</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zW2fMnYF25Ig" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_863_zjQfG6CbJdRk">Stock-Based Compensation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. During the six months ended June 30, 2021 and 2020, stock-based compensation expense for restricted shares for Company employees was $<span id="xdx_90E_eus-gaap--StockOptionPlanExpense_c20210101__20210630_zf9VPuMXYWg7" title="stock based compensation expense">28,690</span> and $<span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20200101__20200630_zgml7ulJGCch">4,503</span>, respectively and $13,027 and $19,659 for the three months ended June 30, 2021. Compensation expense for warrants are based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model and are expensed over the expected term of the awards. During the six months ended June 30, 2021, no warrants were issued as stock compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>         </i></b></p> 28690 4503 <p id="xdx_84B_eus-gaap--ResearchAndDevelopmentExpensePolicy_zq2MnDvkCbv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86C_zpDXHFu7UYQ8">Research and Development</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a component of our equipment and supplies offerings, from time-to-time we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include, but are not limited to: The Satchel™, Cultivation Cube™, So-Hum Living Soils™ and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the six months ended June 30, 2021 and 2020, our research and development costs were de minimis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z2Mwxj9Fysec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_866_zwYdDpwien2">Income Taxes</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s corporate status changed from an S Corporation, which it had been since inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2010, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of June 30, 2021 and December 31, 2020, we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zZXgh4RK5Hl6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_867_zkKzrJWRYCtk">Net Loss Per Common Share</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities since that would have an anti-dilutive effect on earnings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“<b>IRC</b>”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p id="xdx_849_ecustom--RelatedPartyTransactions_zvZyR3jHMv82" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86C_zljbn922a0yd">Related Party Transactions</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company follows FASB ASC subtopic 850-10, <i>Related Party Disclosures,</i> for the identification of related parties and disclosure of related party transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_848_ecustom--ImpactOfCovid19Pandemic_zb2PC1PkMjqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86C_zXYrPUQCQco2">Impact of COVID-19 Pandemic</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 11, 2020<i>, </i>the World Health Organization declared the current coronavirus (“COVID-<i>19”</i>) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-<i>19</i> within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact upon many sectors of the economy, including retail commerce.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In response to state and local measures and for protection of both employees, the Company made required changes to operations, which did not have a material impact upon operations or the financial condition of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-<i>19</i> cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these unaudited condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zMhm4psZaA0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86A_zMyecVeRebcj">Recent Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In December 2019, the FASB issued ASU 2019-12<i>, “Simplifying the Accounting for Income Taxes</i>”.  The pronouncement simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740, “Income Taxes”.  The pronouncement also improves consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance.  This standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted.  The Company is still evaluating the impact this guidance will have on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In January 2020, the FASB issued ASU No. 2020-01, "<i>Investments — Equity Securities: Clarifying the Interactions between Topic 321, Topic 323, and Topic 815</i>" ("ASU No. 2020-01"). ASU No. 2020-01 clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with ASC 321, "<i>Investments — Equity Securities"</i> immediately before applying or upon discontinuing the equity method of accounting in ASC 323, "<i>Investments—Equity Method and Joint Ventures</i>." The provisions of ASU No. 2020-01 are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years with early adoption permitted, including early adoption in an interim period for public business entities for periods for which financial statements have not yet been issued. The Company is still evaluating the impact this guidance will have on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_804_eus-gaap--AssetAcquisitionTextBlock_zYVMPSTeskml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 4. <span id="xdx_82C_zqelFdzMK4u4">Naturaleaf Asset Acquisition</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Naturaleaf agreed to sell or assign to the Company the following assets:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in">5.</td><td style="text-align: justify">Three Medical Marijuana (MMC) Store Licenses;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in">6.</td><td style="text-align: justify">One Marijuana Infused Product Licenses (MIPS); and,</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in">7.</td><td style="text-align: justify">One Option Premises Cultivation License (OPC); and,</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in">8.</td><td style="text-align: justify">Related real property assets, goodwill, and related business assets.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The aggregate consideration paid for the Assets was $2,890,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">The asset acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, <i>Business Combinations</i>. As the acquirer for accounting purposes, the Company has estimated the fair value of Medihemp LLC and Medical Cannabis Caregivers, Inc.’s (hereafter “Naturaleaf’s”) assets acquired and conformed the accounting policies of Naturaleaf to its own accounting policies. The Company expensed certain legal, auditing and licensing costs with the acquisition of $83,095.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As part of the acquisition, the owners of Naturaleaf retained the outstanding cash balance on the date of the acquisition and had agreed to the payment of all outstanding accounts payables and related party advances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The Company has performed a preliminary valuation analysis of the fair market value of Naturaleaf’s assets. The following table summarizes the allocation of the preliminary purchase price as of the acquisition date:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--NaturaleafAssetAcquisitionTableTextBlock_ztVh0w1d3tF5" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - Naturaleaf Asset Acquisition (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B4_z3DDATc6yyWk" style="display: none">Purchase price as of the acquisition</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20210630__us-gaap--NonrecurringAdjustmentAxis__us-gaap--AcquisitionRelatedCostsMember_zbkvbCuSICl6" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--Cash_iI_ztw9lD2enGvc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cash</td><td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0695">--</span></td><td> </td></tr> <tr id="xdx_403_eus-gaap--InventoryGross_iI_zWXbcDSUdPjl" style="vertical-align: bottom; background-color: White"> <td style="width: 37%">Inventory</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">150,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_zR5GCVFbfylh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property, plant and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">92,523</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iI_zCNcnsgzx9Ib" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Long Term Deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_zg6dBZPJs6Rl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Identifiable intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,111,161</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--Goodwill_iI_zNezl7czSBn5" style="vertical-align: bottom; background-color: White"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,530,316</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_zVWu30ceYhx4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accounts payable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0707">--</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--TotalConsiderationCost_iI_zfvwdX9BmjTi" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total consideration</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,890,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A2_z4xb6nG05ww6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Preliminary goodwill from the acquisition primarily relates to the future economic benefits arising from the assets acquired and is consistent with the Company's stated intentions and strategy. Other assets include inventory and fixed assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The preliminary fair value of Naturaleaf’s identifiable intangible assets was $1,111,161 million at April 30, 2021, consisting of $694,476 in licenses and $416,875 in brand names. Due to the indefinite life of the identifiable intangible assets at this time, the Company did not recognize an amortization expense during the six months ended June 30, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The estimated fair values assigned to identifiable assets acquired assumed are provisional and are based on the information that was available as of the acquisition date to estimate the fair value of assets acquired and liabilities assumed. The Company believes that information provides a reasonable basis for estimating the fair values of assets acquired and liabilities assumed, but the Company is waiting for additional information necessary to finalize those fair values. Therefore, the provisional measurements of fair value reflected are subject to change and such changes could be significant. The Company expects to finalize the valuation and complete the purchase price allocation as soon as practicable, but no later than one year from the acquisition date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The results of operations of Naturaleaf for the period from April 30, 2021 through June 30, 2021 are included in the Company's unaudited condensed consolidated financial statements as of June 30, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Unaudited Pro Forma Financial Information </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following unaudited pro forma information presents a summary of the Company’s combined operating results for the three and six months ended June 30, 2021 and 2020, as if the acquisition had occurred on January 1, 2020. The following pro forma financial information is not necessarily indicative of the Company’s operating results as they would have been had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including, but not limited to, differences between the assumptions used to prepare the pro forma information, basic shares outstanding and dilutive equivalents, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zXwivN4XtaCa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Naturaleaf Asset Acquisition (Details 1)"> <tr style="vertical-align: bottom"> <td style="display: none; font-size: 11pt"><span id="xdx_8B5_zv7SOsIMeoR">Pro Forma Financial Information</span> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_490_20210401__20210630_zVHBoXLQFtSa" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49E_20200401__20200630_zOvZqKpu8Lgi" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_496_20210101__20210630_zS4q65UM9VD6" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_497_20200101__20200630_zphPlC2vFVqb" style="font-size: 11pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended</td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2020</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2020</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaRevenue_zkUh4vs0PCGk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total Revenues</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">808,243</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">1,162,406</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">1,712,496</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">2,468,724</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaLossFromOperations_zLEwpiMBnHw6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Loss from Operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(351,728</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(8,908</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(383,864</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(88,189</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 11pt; padding-bottom: 1pt; padding-left: 5.4pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--BusinessAcquisitionsProFormaBasicAndDilutedLossPerShare_zuI11Uriy9yk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Basic and diluted loss per share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0730">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0731">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0732">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0733">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--NaturaleafAssetAcquisitionTableTextBlock_ztVh0w1d3tF5" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - Naturaleaf Asset Acquisition (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B4_z3DDATc6yyWk" style="display: none">Purchase price as of the acquisition</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20210630__us-gaap--NonrecurringAdjustmentAxis__us-gaap--AcquisitionRelatedCostsMember_zbkvbCuSICl6" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--Cash_iI_ztw9lD2enGvc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cash</td><td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0695">--</span></td><td> </td></tr> <tr id="xdx_403_eus-gaap--InventoryGross_iI_zWXbcDSUdPjl" style="vertical-align: bottom; background-color: White"> <td style="width: 37%">Inventory</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">150,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_zR5GCVFbfylh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property, plant and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">92,523</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iI_zCNcnsgzx9Ib" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Long Term Deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_zg6dBZPJs6Rl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Identifiable intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,111,161</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--Goodwill_iI_zNezl7czSBn5" style="vertical-align: bottom; background-color: White"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,530,316</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_zVWu30ceYhx4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accounts payable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0707">--</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--TotalConsiderationCost_iI_zfvwdX9BmjTi" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total consideration</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,890,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 150000 92523 6000 1111161 1530316 2890000 <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zXwivN4XtaCa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Naturaleaf Asset Acquisition (Details 1)"> <tr style="vertical-align: bottom"> <td style="display: none; font-size: 11pt"><span id="xdx_8B5_zv7SOsIMeoR">Pro Forma Financial Information</span> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_490_20210401__20210630_zVHBoXLQFtSa" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49E_20200401__20200630_zOvZqKpu8Lgi" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_496_20210101__20210630_zS4q65UM9VD6" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_497_20200101__20200630_zphPlC2vFVqb" style="font-size: 11pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended</td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2020</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2020</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 11pt"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaRevenue_zkUh4vs0PCGk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total Revenues</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">808,243</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">1,162,406</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">1,712,496</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">2,468,724</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaLossFromOperations_zLEwpiMBnHw6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Loss from Operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(351,728</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(8,908</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(383,864</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(88,189</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 11pt; padding-bottom: 1pt; padding-left: 5.4pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--BusinessAcquisitionsProFormaBasicAndDilutedLossPerShare_zuI11Uriy9yk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Basic and diluted loss per share</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0730">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0731">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0732">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0733">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 808243 1162406 1712496 2468724 -351728 -8908 -383864 -88189 <p id="xdx_804_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zg5ljwIuQG66" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 5. <span id="xdx_826_zrN80RRS5Xlb">Accounts Receivable and Advance from Clients</span>    </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">         </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accounts receivable was comprised of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_znRZgoE0SNQi" style="margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - Accounts Receivable and Advances from Clients - Accounts Receivable (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B2_zXWDNS9tIXqj" style="display: none">Accounts Receivable and Advance from Clients</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_499_20210630_zTFe8D8p7T3f" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49E_20201231_zL595P8sK4Q8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsReceivableGross_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left">Accounts Receivable – Trade</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">168,101</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">82,467</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di_zwGjeU71ER62" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less:  Allowance for Doubtful Accounts</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(144,770</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(57,512</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--AccountsAndNotesReceivableNet_iI_pp0p0_zO6vGOXOeGNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Accounts Receivable, net</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">23,331</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">24,955</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company had bad debt expense during the six months ended June 30, 2021 and 2020 of $0, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Advances from Clients had the following activity:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-left: -0.125in"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 35%; padding-left: 0in">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--AdvanceFromClients_iI_c20210630_zPXbXHUYTYAc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Beginning Balance">88,843</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0in">    Additional deposits received</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--AdditionalDepositsReceived_c20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additional deposits received">199,892</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0in">    Less:  Deposits recognized as revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_ecustom--LessDepositsRecognizedAsRevenue_c20210630_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Deposits recognized as revenue">(225,288</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 0in">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--AdvanceFromClient_iI_c20210630_z1XoVfmyGtSc" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">63,447</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_z3UhezrXPVb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_znRZgoE0SNQi" style="margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - Accounts Receivable and Advances from Clients - Accounts Receivable (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B2_zXWDNS9tIXqj" style="display: none">Accounts Receivable and Advance from Clients</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_499_20210630_zTFe8D8p7T3f" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49E_20201231_zL595P8sK4Q8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsReceivableGross_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left">Accounts Receivable – Trade</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">168,101</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">82,467</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di_zwGjeU71ER62" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less:  Allowance for Doubtful Accounts</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(144,770</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(57,512</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--AccountsAndNotesReceivableNet_iI_pp0p0_zO6vGOXOeGNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Accounts Receivable, net</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">23,331</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">24,955</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company had bad debt expense during the six months ended June 30, 2021 and 2020 of $0, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Advances from Clients had the following activity:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-left: -0.125in"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 35%; padding-left: 0in">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--AdvanceFromClients_iI_c20210630_zPXbXHUYTYAc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Beginning Balance">88,843</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0in">    Additional deposits received</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--AdditionalDepositsReceived_c20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additional deposits received">199,892</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0in">    Less:  Deposits recognized as revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_ecustom--LessDepositsRecognizedAsRevenue_c20210630_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: Deposits recognized as revenue">(225,288</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 0in">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--AdvanceFromClient_iI_c20210630_z1XoVfmyGtSc" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">63,447</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 168101 82467 144770 57512 23331 24955 88843 199892 -225288 63447 <p id="xdx_802_eus-gaap--InventoryDisclosureTextBlock_z9aePAxz682" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 6. <span id="xdx_824_zdaBuXKeoQij">Inventory</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventory consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zlXCTZP7LwGa" style="margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - Inventory (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8B8_z71hkM1GJQ5a" style="display: none">Inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_497_20210630" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_494_20201231" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryRawMaterials_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left; padding-left: 5.4pt">Raw Materials</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">92,132</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">39,746</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryWorkInProcess_iI_pp0p0_zJTShzJgbWnl" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">Work In Process</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">66,287</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0763">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Finished Goods</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">173,075</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">22,656</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryNet_iI_pp0p0_zhAk9oLHM8xh" style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total Inventory</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">331,494</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">62,402</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zw7csSh2aIU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>  </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zlXCTZP7LwGa" style="margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - Inventory (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8B8_z71hkM1GJQ5a" style="display: none">Inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_497_20210630" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_494_20201231" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryRawMaterials_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left; padding-left: 5.4pt">Raw Materials</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">92,132</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">39,746</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryWorkInProcess_iI_pp0p0_zJTShzJgbWnl" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">Work In Process</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">66,287</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0763">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Finished Goods</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">173,075</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">22,656</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryNet_iI_pp0p0_zhAk9oLHM8xh" style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total Inventory</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">331,494</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">62,402</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 92132 39746 66287 173075 22656 331494 62402 <p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zpvmeaYQLow4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 7. <span id="xdx_82B_z6JMJfEQlcaf">Property and Equipment, net</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Property and equipment, net, was comprised of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_zjKUDY9cZBm9" style="margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - Property and Equipment, net - Property and Equipment, Net (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0in"><span id="xdx_8B2_zZmw4IBWx091" style="display: none">Property and Equipment, Net</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-left: -0.125in"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left; padding-left: 0in">Office equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Property and equipment, gross">38,481</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Property and equipment, gross">34,071</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0in">Software</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">13,204</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">13,204</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0in">Furniture and Fixtures</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">2,328</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="-sec-ix-hidden: xdx2ixbrl0791">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0in">Machinery and Equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">329,992</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="-sec-ix-hidden: xdx2ixbrl0795">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0in">Leasehold Improvements</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">115,808</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="-sec-ix-hidden: xdx2ixbrl0799">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0in">Property and equipment, gross</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">499,813</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">47,275</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0in">Less: Accumulated Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210630_zE52imFhX0q1" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: accumulated depreciation">(31,597</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zH3O4Ljb9lM4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: accumulated depreciation">(22,621</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 0in">Property and equipment, net</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOtherNet_iI_pp0p0_c20210630_zRigcRMTVoBc" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">468,216</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOtherNet_iI_pp0p0_c20201231_zbEXGAPkgHOc" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">24,654</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zq4fFXiGqGkf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As part of the Naturaleaf Asset Acquistion, the Company acquired $92,535 in fixed assets consisting of machinery and equipment and leasehold improvements. During the six months ended June 30, 2021, the Company purchased office equipment in the amount of $<span id="xdx_90D_ecustom--OfficeEquipmentGross_iI_c20210630_zdpu2wmZyH3e" title="Office equipment">1,576</span> and has made purchases of machinery and equipment of $<span id="xdx_904_eus-gaap--MachineryAndEquipmentGross_iI_c20210630_zoIg9YEqikpj" title="Machinery and equipment">308,438</span> in order to upgrade operations at the new cultivation facilities and has spent $<span id="xdx_902_eus-gaap--LeaseholdImprovementsGross_iI_c20210630_zcp4Ftva8S38" title="Leasehold improvements">50,000 </span>in leasehold improvements at the cultivation facilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_zjKUDY9cZBm9" style="margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - Property and Equipment, net - Property and Equipment, Net (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0in"><span id="xdx_8B2_zZmw4IBWx091" style="display: none">Property and Equipment, Net</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-left: -0.125in"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left; padding-left: 0in">Office equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Property and equipment, gross">38,481</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Property and equipment, gross">34,071</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0in">Software</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">13,204</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">13,204</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0in">Furniture and Fixtures</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">2,328</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="-sec-ix-hidden: xdx2ixbrl0791">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0in">Machinery and Equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">329,992</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="-sec-ix-hidden: xdx2ixbrl0795">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0in">Leasehold Improvements</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">115,808</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="-sec-ix-hidden: xdx2ixbrl0799">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0in">Property and equipment, gross</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">499,813</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">47,275</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0in">Less: Accumulated Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210630_zE52imFhX0q1" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: accumulated depreciation">(31,597</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zH3O4Ljb9lM4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less: accumulated depreciation">(22,621</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 0in">Property and equipment, net</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOtherNet_iI_pp0p0_c20210630_zRigcRMTVoBc" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">468,216</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentOtherNet_iI_pp0p0_c20201231_zbEXGAPkgHOc" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">24,654</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 38481 34071 13204 13204 2328 329992 115808 499813 47275 31597 22621 468216 24654 1576 308438 50000 <p id="xdx_80D_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_z88RhzKVUQy3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 8. <span id="xdx_822_zmpPs8x9FYC5">Accrued and Other Current Liabilities</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accrued and other current liabilities consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zf9Uin7Lozgl" style="margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - Accrued and Other Current Liabilities - Accrued and Other Current Liabilities (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8B5_zL7tQvKzaDS2" style="display: none">Accrued and Other Current Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49C_20210630_zwFWAJxsX3kl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_492_20201231_zNzoUsRfmxOd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left; padding-left: 5.4pt">Accrued Interest</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">18,629</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">449</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">Accrued Payroll</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">33,112</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0827">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_zfwyRXLrnzTl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">Sales Tax Payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17,633</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsPayableOtherCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Other Accrued Expenses &amp; Payables</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">66,994</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">48,795</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0_zaX6HafyaCvj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Accrued and other current liabilities</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">136,368</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">49,244</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zfqszk7aabt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zf9Uin7Lozgl" style="margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - Accrued and Other Current Liabilities - Accrued and Other Current Liabilities (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8B5_zL7tQvKzaDS2" style="display: none">Accrued and Other Current Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49C_20210630_zwFWAJxsX3kl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_492_20201231_zNzoUsRfmxOd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left; padding-left: 5.4pt">Accrued Interest</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">18,629</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">449</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">Accrued Payroll</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">33,112</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0827">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_zfwyRXLrnzTl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">Sales Tax Payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17,633</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsPayableOtherCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Other Accrued Expenses &amp; Payables</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">66,994</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">48,795</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0_zaX6HafyaCvj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Accrued and other current liabilities</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">136,368</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">49,244</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 18629 449 33112 17633 66994 48795 136368 49244 <p id="xdx_80A_ecustom--StockPayableTextBlock_zYWtetECBhFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 9. <span id="xdx_82B_zTME0qQU1G8e">Stock Payable</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following summarizes the changes in common stock payable:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ScheduleOfStockPayable_zJnrY0i1nOo7" style="margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - Stock Payable (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0in"><span id="xdx_8B7_z29ZGwPzslN5" style="display: none">Schedule of stock payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-left: -0.125in"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: -0.125in">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--StockPayableAmounts_iS_pp0p0_d0_c20210101__20210630_zsjH2Nak0TC1" style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: left; padding-left: 0in">    Additional Expenses Incurred</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--AdditionalExpensedIncurredAmount_c20210101__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Additional Expensed Incurred, Amount">28,690</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0in">    Payments Upon Issuance of Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--SharesIssuedForExpensedIncurredAmount_pp0p0_d0_c20210101__20210630_zh9XiLHrenU3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Issued for Expensed Incurred, Amount">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 0in">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--StockPayableAmounts_iE_pp0p0_c20210101__20210630_zkbax6AAqVo3" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ending Stock Payable, Amount">28,690</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zIRPFLg571If" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ScheduleOfStockPayable_zJnrY0i1nOo7" style="margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - Stock Payable (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0in"><span id="xdx_8B7_z29ZGwPzslN5" style="display: none">Schedule of stock payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-left: -0.125in"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: -0.125in">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--StockPayableAmounts_iS_pp0p0_d0_c20210101__20210630_zsjH2Nak0TC1" style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: left; padding-left: 0in">    Additional Expenses Incurred</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--AdditionalExpensedIncurredAmount_c20210101__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Additional Expensed Incurred, Amount">28,690</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0in">    Payments Upon Issuance of Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--SharesIssuedForExpensedIncurredAmount_pp0p0_d0_c20210101__20210630_zh9XiLHrenU3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Issued for Expensed Incurred, Amount">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 0in">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--StockPayableAmounts_iE_pp0p0_c20210101__20210630_zkbax6AAqVo3" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ending Stock Payable, Amount">28,690</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> -0 28690 -0 28690 <p id="xdx_804_ecustom--OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock_zWJC0CuyKall" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 10. <span id="xdx_822_zqlHmDRwN6Df">Operating Lease Right-of-Use Asset/Operating Lease Liability</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company leases property under operating leases. Property leases include retail and cultivation space with fixed rent payments and lease terms ranging from one to two years. The Company is obligated to pay the lessor for maintenance, real estate taxes, insurance and other operating expenses on certain property leases. These expenses are variable and are not included in the measurement of the lease asset or lease liability. These expenses are recognized as variable rent expense when incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s lease portfolio consists of the following.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--LeasePortfolioTableTextBlock_z0cqJip6hLAe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="display: none; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span id="xdx_8B1_zOo97vQx5Akc">Schedule of lease</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Lease Name</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold">Asset Type</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Start Date</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration Date</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Monthly Rent</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Durango Lease</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="width: 18%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Real Property</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="width: 18%; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">5/1/2021</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="width: 17%; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">5/31/2022</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 15%; text-align: right">10,200</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Lehman Lease</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Real Property</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">5/1/2021</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">12/31/2022</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2,732</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Palmer Lease</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Real Property</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">5/1/2021</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">6/30/2022</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,069</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Greenspace Membership</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Real Property</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">4/15/2021</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">12/31/2021</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Tejon Lease</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Real Property</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">5/1/2021</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">4/30/2022</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,700</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On June 1, 2020, the Company entered into a new lease membership agreement for a one-year term for an amount of $2,895 per month, the lease expired on May 31, 2021. At that time the Company entered into an 8 ½ month lease for less space for an amount of $1,000 per month. We determined under ASC 842, due to the short-term nature of the lease that the lease membership agreement met the criteria of ASC 842-20-25-2 and as such it was not necessary to capitalize the lease and rent will be recognized on a monthly straight-line basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 1, 2020, as part of the Naturaleaf Acquisition, leases for grow facilities and dispensaries were assigned to the Company. These leases were determined to be operating leases under ASC 842 and such leases was capitalized. It was determined that the Tejon lease, due to the short-term nature of the lease met the criteria of ASC 842-20-25-2 and as such it was not necessary to capitalize the lease and rent would be recognized on a straight-line basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company records the lease asset and lease liability at the present value of lease payments over the lease term. The leases typically do not provide an implicit rate; therefore, the Company uses its estimated incremental borrowing rate at the time of lease commencement to discount the present value of lease payments. The Company’s discount rate for operating leases at June 30, 2021 was 12.5%. Leases often include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. Lease expense is recognized on a straight-line basis over the lease term to the extent that collection is considered probable. As a result, the Company been recognizing rents as they become payable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2021, the maturities of operating leases liabilities are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--OtherLiabilitiesTableTextBlock_zotfbUJORt5e" style="margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B1_zWjGnQwhoW3k" style="display: none">Operating leases liabilities</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_494_20210630_zmkiEtGNQnt2" style="border-bottom: black 1pt solid; text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt; padding-left: 10pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Operating</b></span><br/> <span style="font: 10pt Times New Roman, Times, Serif"><b>Lease</b>s</span></td> <td style="text-align: right"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_zjSwX7kkaYB7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td style="width: 10%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">84,474</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_z5Y8gDjT7vr2" style="vertical-align: bottom; background-color: White"> <td><span style="font: 10pt Times New Roman, Times, Serif">2022</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">91,158</span></td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_z8YSrHmoIMR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">175,632</span></td> <td> </td></tr> <tr id="xdx_407_ecustom--LessAmountRepresentingInterest_iI_zMjSAGUrcFfl" style="vertical-align: bottom; background-color: White"> <td><span style="font: 10pt Times New Roman, Times, Serif">Less: amount representing interest</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(12,216</span></td> <td><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_ecustom--PresentValueOfFutureMinimumLeasePayments_iI_zT3qPu5T6Gje" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font: 10pt Times New Roman, Times, Serif">Present value of future minimum lease payments</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">163,416</span></td> <td> </td></tr> <tr id="xdx_40B_ecustom--LessCurrentObligationsUnderLeases_iI_zdgtwNbmgHLb" style="vertical-align: bottom; background-color: White"> <td><span style="font: 10pt Times New Roman, Times, Serif">Less: current obligations under leases</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">147,131</span></td> <td> </td></tr> <tr id="xdx_40D_eus-gaap--CapitalLeaseObligations_iI_zjohRBgmPnD4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font: 10pt Times New Roman, Times, Serif">Long-term lease obligations</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">16,286</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2021, the aggregate remaining minimal annual lease payments under these operating leases, including those accounted for under practicable expedient were as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="margin-left: auto; border-collapse: collapse; width: 35%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: left">2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CapitalLeasesFutureMinimumPaymentsDueCurrent_iI_c20210630_zW4yygr3qHK4" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="2021">112,213</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--CapitalLeasesFutureMinimumPaymentsDueInTwoYears_iI_c20210630_zdHUcv4MCYUi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="2022">103,844</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--CapitalLeasesFutureMinimumPaymentsDue_iI_c20210630_z4Qw3kXkHDGg" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total">216,057</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_z4gTjeFGbvSd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--LeasePortfolioTableTextBlock_z0cqJip6hLAe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="display: none; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span id="xdx_8B1_zOo97vQx5Akc">Schedule of lease</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Lease Name</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold">Asset Type</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Start Date</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration Date</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Monthly Rent</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Durango Lease</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="width: 18%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Real Property</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="width: 18%; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">5/1/2021</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="width: 17%; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">5/31/2022</td><td style="width: 3%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 15%; text-align: right">10,200</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Lehman Lease</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Real Property</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">5/1/2021</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">12/31/2022</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2,732</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Palmer Lease</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Real Property</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">5/1/2021</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">6/30/2022</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,069</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Greenspace Membership</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Real Property</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">4/15/2021</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">12/31/2021</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Tejon Lease</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Real Property</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">5/1/2021</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">4/30/2022</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,700</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--OtherLiabilitiesTableTextBlock_zotfbUJORt5e" style="margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B1_zWjGnQwhoW3k" style="display: none">Operating leases liabilities</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_494_20210630_zmkiEtGNQnt2" style="border-bottom: black 1pt solid; text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt; padding-left: 10pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Operating</b></span><br/> <span style="font: 10pt Times New Roman, Times, Serif"><b>Lease</b>s</span></td> <td style="text-align: right"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_zjSwX7kkaYB7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td style="width: 10%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">84,474</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_z5Y8gDjT7vr2" style="vertical-align: bottom; background-color: White"> <td><span style="font: 10pt Times New Roman, Times, Serif">2022</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">91,158</span></td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_z8YSrHmoIMR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">175,632</span></td> <td> </td></tr> <tr id="xdx_407_ecustom--LessAmountRepresentingInterest_iI_zMjSAGUrcFfl" style="vertical-align: bottom; background-color: White"> <td><span style="font: 10pt Times New Roman, Times, Serif">Less: amount representing interest</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(12,216</span></td> <td><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_ecustom--PresentValueOfFutureMinimumLeasePayments_iI_zT3qPu5T6Gje" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font: 10pt Times New Roman, Times, Serif">Present value of future minimum lease payments</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">163,416</span></td> <td> </td></tr> <tr id="xdx_40B_ecustom--LessCurrentObligationsUnderLeases_iI_zdgtwNbmgHLb" style="vertical-align: bottom; background-color: White"> <td><span style="font: 10pt Times New Roman, Times, Serif">Less: current obligations under leases</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">147,131</span></td> <td> </td></tr> <tr id="xdx_40D_eus-gaap--CapitalLeaseObligations_iI_zjohRBgmPnD4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font: 10pt Times New Roman, Times, Serif">Long-term lease obligations</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">16,286</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2021, the aggregate remaining minimal annual lease payments under these operating leases, including those accounted for under practicable expedient were as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="margin-left: auto; border-collapse: collapse; width: 35%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: left">2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CapitalLeasesFutureMinimumPaymentsDueCurrent_iI_c20210630_zW4yygr3qHK4" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="2021">112,213</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--CapitalLeasesFutureMinimumPaymentsDueInTwoYears_iI_c20210630_zdHUcv4MCYUi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="2022">103,844</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--CapitalLeasesFutureMinimumPaymentsDue_iI_c20210630_z4Qw3kXkHDGg" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total">216,057</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 84474 91158 175632 -12216 163416 147131 16286 112213 103844 216057 <p id="xdx_809_eus-gaap--DebtDisclosureTextBlock_zpqTpTCzfBf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 11. <span id="xdx_825_zYs4JWGWWDK6">Loans Payable</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>PPP Loans</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 27, 2020, the CARES Act was enacted to provide financial aid to family and businesses impacted by the COVID-19 pandemic.  The Company participated in the CARES Act, and on August 6, 2020, the Company entered into a note payable with a bank under the Small Business Administration (“SBA”) Paycheck Protection Program (“PPP loan”) in the amount of $109,914. This loan payable matures on August 6, 2022 with a fixed interest rate of 1% per annum with interest deferred for six months. The PPP loan has an initial term of two years, is unsecured and guaranteed by the SBA. Under the terms of the PPP loan, the Company may apply for forgiveness of the amount due on the PPP loan. The Company used the proceeds from the PPP loan for qualifying expenses as defined in the PPP. The Company intends to apply for forgiveness of the PPP loan in accordance with the terms of the CARES Act. However, the Company cannot assure at this time that the PPP loan will be forgiven partially or in full. If the loan is not forgiven based on the PPP guidelines to be issued by the SBA, as defined, then, the monthly payment amount will be $6,186 beginning on March 6, 2021 through August 6, 2022. On March 3, 2021, the SBA forgave the principal of $109,914 and any accrued interest at that time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On April 23, 2021, the Company entered into a second note payable with a bank under the SBA PPP Loan in the amount of $130,186. The PPP Loan is subject to the same terms of forgiveness as above. The monthly payment amount will be $3,056 beginning on September 22, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Naturaleaf Seller Note</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As part of the Naturaleaf Acquisition, the Company issued a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”). The note has a term of 1 year with a due date of April 1, 2022 and does not require any payments prior to the due date. The note has an annual interest rate of 10%. At June 30, 2021, interest of $18,383 had been accrued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zBolXmyvl3Zh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 12. <span id="xdx_822_zNDY7RKShPQl">Related Party Transactions</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has a related party entity, Tabular Investments, LLC (“Tabular”) which was set to assign the Company’s interest in various equity partnership. The sole member of Tabular is Tad Mailander, the Company’s outside legal counsel and Director. The Company has valued all of its equity partnership investments at $0. Neither our direct equity ownership in, nor our assignments of equity to Tabular Investments, LLC are, or are reasonably likely to allow for, substantive terms, transactions, and arrangements, whether contractual or not contractual, that will have a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources. We have no direct or indirect majority influence or control over any entity in which we have a direct equity interest or equity interests assigned to Tabular. We do not have any direct or indirect interest in, and do not control Tabular. We have not absorbed losses from either our direct equity interests or assignments to Tabular, and we have provided no subordinated financial support to any project</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_807_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z4wGO7i1poz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 13. <span id="xdx_82F_zGlUw3W5EW6c">Stock Based Compensation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2021, the Company issued stock-based compensation for employees and service providers pursuant to its 2015 Equity Incentive Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Restricted Shares</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">From time to time, the Company grants certain employees restricted shares of its common stock to provide further compensation in-lieu of wages and to align the employee’s interests with the interests of its stockholders. Because vesting is based on continued employment, these equity-based incentives are also intended to attract, retain and motivate personnel upon whose judgment, initiative and effort the Company’s success is largely dependent.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2021, the Company granted <span id="xdx_906_ecustom--GrantedRestrictedShares_c20210101__20210630_zTfeciNwewF7">135,616 </span>restricted shares and recognized $<span id="xdx_90E_ecustom--GrantedRestrictedValue_c20210101__20210630_zzYpHyG7eYA5">28,690</span> in associated employee stock-based compensation expense , which is included as part of the outstanding stock payable June 30, 2021. The fair value of restricted stock unit is determined based on the quoted closing price of the Company’s common stock on the date grant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2020, the Company granted <span id="xdx_907_ecustom--GrantedRestrictedShares_c20200101__20200630_zMFRMwfwM3Qh">225,000 </span>restricted shares and recognized $<span id="xdx_90E_ecustom--GrantedRestrictedValue_c20200101__20200630_zbYmkrBhLEac">19,347</span> in associated employee stock-based compensation expense, which is included as part of the outstanding stock payable June 30, 2020, that was issued in December 2020. The fair value of the restricted stock is determined based on the quoted closing price of the Company’s common stock on the date of grant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2020, the Company issued <span id="xdx_907_ecustom--GrantedRestrictedShares_c20190101__20191231_zNXazyP8oQqi">478,261</span> shares of restricted shares granted during the fiscal year ended December 31, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Net Loss Per Share</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the reporting period. Diluted net loss per share is computed similarly to basic loss per share, except that it includes the potential dilution that could occur if dilutive securities are exercised.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Outstanding stock options and common stock warrants are considered anti-dilutive because we are in a net loss position.  Accordingly, the number of weighted average shares outstanding for basic and fully diluted net loss per share are the same.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following summarizes equity instruments that may, in the future, have a dilutive effect on earnings per share:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zoNfXN27AK6c" style="margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - Stock-based Compensation (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"><span id="xdx_8BC_zgcGqtxF2KAh" style="display: none">Schedule of stock based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_495_20210630_zdD65Tvv9xR8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49E_20201231_z0voPCf42kDd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstanding_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; padding-left: 5.4pt">Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">10,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">397,500</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Stock Payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">135,616</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--Total_iI_pp0p0_z9Y8l9QEsnYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 5.4pt">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">145,616</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">397,500</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zAGZuGPLTpg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2021, warrants with a cashless exercise provision were exercised for 125,000 restricted shares . Of which, a warrant for 100,000 shares was exercised by an officer/director of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2021, the Company did not issue or approve any warrants. Warrants exercisable for 287,500 shares expired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <b> </b></p> 135616 28690 225000 19347 478261 <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zoNfXN27AK6c" style="margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - Stock-based Compensation (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"><span id="xdx_8BC_zgcGqtxF2KAh" style="display: none">Schedule of stock based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_495_20210630_zdD65Tvv9xR8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49E_20201231_z0voPCf42kDd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstanding_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; padding-left: 5.4pt">Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">10,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">397,500</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Stock Payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">135,616</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--Total_iI_pp0p0_z9Y8l9QEsnYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 5.4pt">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">145,616</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">397,500</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 10000 397500 135616 145616 397500 <p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_znHUycaZu0N6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 14. <span id="xdx_824_zJLixVezU418">Shareholders’ Equity</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Preferred Stock</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $0.01 par value. No shares of preferred stock were issued and outstanding at June 30, 2021 and December 31, 2020, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Common Stock</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2021, the Company issued 6,050,000 registered shares of common stock in exchange for net proceeds of $1,083,541 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019 with White Lion Capital LLC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2021, the Company issued 3,000,000 shares of its restricted common stock to the sellers of Naturaleaf, as part of the acquisition of assets of Naturaleaf. The shares had a value of $690,000 based on a closing market price on April 23, 2021 of $0.23 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2021, warrants with a cashless exercise provision were exercised for 125,000 restricted shares . Of which, a warrant for 100,000 shares was exercised by an officer/director of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2020, the Company issued 478,261 shares of restricted shares granted during the fiscal year ended December 31, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_80E_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zRchlP3FUjz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 15.   <span id="xdx_827_zO6IgzKsPw0l">Commitments and Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Legal</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the ordinary course of its business, the Company becomes involved in various legal proceedings involving a variety of matters. The Company does not believe there are any pending legal proceedings that will have a material adverse effect on the Company’s business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. The Companies expenses legal fees in the period in which they are incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Turoff Matter</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">On November 15, 2019, Erin Turoff filed suit against the Company and Mr. Terry Buffalo, our chief executive officer and director, and Mr. Ellis Smith our chief development officer and director, in Denver County District Court. The complaint seeks a declaratory judgement and damages related to Ms. Turoff’s allegation that she was misclassified as an independent contractor while working for the Company. </span>Ms. Turoff alleges she is owed unpaid overtime, liquidated damages, wages, and other compensatory damages for her misclassification and alleged wrongful terminations. Ms. Turoff’s suit against Mr. Buffalo and Mr. Smith alleges that each are the alter ego of the Company and are therefore jointly and severally liable. All parties have appeared in the case and the case is currently in the discovery. At this time, there is no reasonable basis from which a determination or estimate may be made concerning any contingent liability related to this lawsuit. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zmnmEflN0013" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 16. <span id="xdx_826_zwZ1UrIbRLzg">Subsequent Events</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In accordance with ASC 855-10, the Company has analyzed its operations after Unaudited consolidated financial statements were available to be issued and has determined that there were no other significant subsequent events or transactions that would require recognition or disclosure in the unaudited condensed consolidated financial statements for the six months ended June 30, 2021, other than as follows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In August 2021, the Company issued 250,000 registered shares of common stock in exchange for net proceeds of $26,935 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019 with White Lion Capital LLC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> XML 11 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover - shares
 6 Months Ended
Jun. 30, 2021
Aug. 13, 2021
Cover [Abstract]    
Document Type 10-Q/A  
Amendment Flag true  
Amendment Description This amendment is being filed to include the ixbrl in the html file.  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2021  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2021  
Current Fiscal Year End Date --12-31  
Entity File Number 000-26108  
Entity Registrant Name AMERICAN CANNABIS COMPANY, INC.  
Entity Central Index Key 0000945617  
Entity Tax Identification Number 90-1116625  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 2590 Walnut #6  
Entity Address, City or Town Denver  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80205  
City Area Code 303  
Local Phone Number 974-4770  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   80,152,938
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and Equivalents $ 1,131,833 $ 1,723,132
Accounts Receivable, Net 23,331 24,955
Deposits 2,895 2,895
Inventory 331,494 62,402
Prepaid Expenses and Other Current Assets 24,072 50,302
Total Current Assets 1,513,625 1,863,686
Property and Equipment - Net 468,216 24,655
Other Assets    
Intangible Assets, net 1,115,182
Goodwill 1,530,316
Right of Use Assets - Operating Leases, net 163,416
Long Term Deposits 6,001
Total Other Assets 2,814,915
TOTAL ASSETS 4,796,756 1,888,341
Current Liabilities    
Accounts Payable 264,468 13,153
Advances from Clients 63,447 88,843
Accrued and Other Current Liabilities 136,368 49,244
Stock payable 28,690
Right of Use Liabilities, current 147,131
Note payables, current 1,230,186 109,914
Total Current Liabilities 1,870,290 261,154
Right of Use Liabilities 16,286
Total Long Term Liabilities 16,286
TOTAL LIABILITIES 1,886,576 261,154
Shareholders' Equity    
Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2021 and December 31, 2020
Common stock, $0.00001 par value; 500,000,000 shares authorized; 79,902,938 and 70,727,938 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively 798 707
Additional paid-in capital 11,408,199 9,634,748
Accumulated deficit (8,498,817) (8,008,268)
Total Shareholders' Equity 2,910,180 1,627,187
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 4,796,756 $ 1,888,341
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares
Jun. 30, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
Preferred stock Par Value $ 0.01 $ 0.01
Preferred Stock Shares Authorized 5,000,000 5,000,000
Preferred Stock Shares Issued 0 0
Preferred Stock Shares Outstanding 0 0
Common stock Par Value $ 0.00001 $ 0.00001
Common Stock Shares Authorized 500,000,000 500,000,000
Common Stock Shares Issued 79,902,938 70,727,938
Common Stock Shares Outstanding 79,902,938 70,727,938
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenues        
Consulting Services $ 39,501 $ 131,238 $ 201,393 $ 355,613
Product & Equipment 273,401 418,675 437,489 634,682
Cannabis Products 307,077 307,077
Total Revenues 619,979 549,913 945,958 990,295
Cost of Revenues        
Cost of Consulting Services 6,006 22,429 26,706 114,555
Cost of Products and Equipment 209,148 287,368 330,257 423,609
Cost of Cannabis Products 146,074 146,074
Total Cost of Revenues 361,228 309,797 503,037 538,164
Gross Profit 258,751 240,116 442,921 452,131
Operating Expenses        
General and Administrative 535,641 240,187 870,569 560,773
Selling and Marketing 61,006 92,621 127,743 163,028
Stock Based Compensation Expense 13,027 19,659 28,690 24,162
Total Operating Expenses 609,674 352,467 1,027,002 747,963
Loss from Operations (350,923) (112,351) (584,081) (295,832)
Other Income (Expense)        
Interest (expense) (18,629) (18,810)
Debt Forgiveness 110,543
Other income 900 10,588 1,799 16,522
Total Other (Expense) Income (17,729) 10,588 93,532 16,522
Net Loss (368,654) (101,763) (490,549) (279,310)
Income Tax Expense
NET LOSS $ (368,652) $ (101,763) $ (490,549) $ (279,310)
Basic net loss per common share $ (0) $ (0) $ (0) $ (0.01)
Basic weighted average common shares outstanding 76,256,839 54,206,866 76,329,457 53,460,270
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (490,549) $ (279,310)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on Sale of assets (500)
Depreciation 8,979 7,095
Stock-based compensation to employees 28,690 24,162
Debt Forgiveness (109,914)
Changes in operating assets and liabilities:    
Accounts receivable 1,624 59,435
Deposits 1,605
Inventory (119,092) (45,473)
Prepaid expenses and other current assets 26,230 346
Right to Use Lease Asset (163,416) 25,497
Accounts Payable 251,314 163,761
Advances from Clients (25,396) (60,643)
Accrued and other current liabilities 87,124 10,501
Operating Lease Liability 163,416 (25,947)
Net Cash used in Operating Activities (340,990) (119,471)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (360,015) (2,269)
Proceeds from sales of property and equipment 2,500
Acquisition of Assets (1,100,000)
Intangible assets (4,022)
Net Cash Provided by (Used in) Investing Activities (1,464,037) 231
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from PPP loan 130,186
Proceeds from sale of common stock 1,083,542 69,503
Net Cash Provided by Financing Activities 1,213,728 69,503
NET DECREASE IN CASH (591,299) (49,737)
CASH AT BEGINNING OF PERIOD 1,723,132 945,181
CASH AT END OF PERIOD 1,131,833 895,444
Cash paid for income taxes
Cash paid for interest
Stock issued for receivables 25,472
Stock issued for acquisition of assets 690,000
Note Payable issued for acquisition of assets $ 1,100,000
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance, December 31, 2021 at Dec. 31, 2019 $ 529 $ 8,354,920 $ (7,475,855) $ 879,594
Beginning Balance, Shares at Dec. 31, 2019 52,978,605      
Stock-based compensation to employees $ 5 43,504 43,509
Stock-based compensation to employees, Shares 478,261      
Stock issued for cash $ 7 94,968 94,975
Shares issued for cash, Shares 750,000      
Net Loss (279,310) (279,310)
Balance, June 30, 2021 at Jun. 30, 2020 $ 541 8,493,392 (7,755,165) 738,768
Ending Balance, Shares at Jun. 30, 2020 54,206,866      
Balance, December 31, 2021 at Mar. 31, 2020 $ 534 8,398,424 (7,653,402) 745,556
Beginning Balance, Shares at Mar. 31, 2020 53,456,866      
Stock-based compensation to employees
Stock issued for cash $ 7 94,968 94,975
Shares issued for cash, Shares 750,000      
Net Loss (101,763) (101,763)
Balance, June 30, 2021 at Jun. 30, 2020 $ 541 8,493,392 (7,755,165) 738,768
Ending Balance, Shares at Jun. 30, 2020 54,206,866      
Balance, December 31, 2021 at Dec. 31, 2020 $ 707 9,634,748 (8,008,268) 1,627,187
Beginning Balance, Shares at Dec. 31, 2020 70,727,938      
Stock issued for asset acquisition $ 30 689,970 $ 690,000
Stock issued for asset acquisition, Shares       3,000,000
Stock issued for cashless exercise of warrants $ 1 (1)
Stock issued for cashless exercise, Shares 125,000      
Stock issued for cash $ 60 1,083,482 1,083,542
Shares issued for cash, Shares 6,050,000      
Net Loss (490,549) (490,549)
Balance, June 30, 2021 at Jun. 30, 2021 $ 798 11,408,199 (8,498,817) 2,910,180
Ending Balance, Shares at Jun. 30, 2021 79,902,938      
Balance, December 31, 2021 at Mar. 31, 2021 $ 763 10,632,985 (8,130,165) 2,503,583
Beginning Balance, Shares at Mar. 31, 2021 76,377,938      
Stock issued for asset acquisition $ 30 689,970 $ 690,000
Stock issued for asset acquisition, Shares       3,000,000
Stock issued for cashless exercise of warrants
Stock issued for cashless exercise, Shares 25,000      
Stock issued for cash $ 5 85,244 85,249
Shares issued for cash, Shares 500,000      
Net Loss (368,652) (368,652)
Balance, June 30, 2021 at Jun. 30, 2021 $ 798 $ 11,408,199 $ (8,498,817) $ 2,910,180
Ending Balance, Shares at Jun. 30, 2021 79,902,938      
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Principles of Consolidation.
 6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Principles of Consolidation.

Note 1. Principles of Consolidation.

 

The unaudited condensed consolidated financial statements for the three months ended June 30, 2021 and 2020 include the accounts of American Cannabis Company, Inc. and its wholly owned subsidiary, Hollister & Blacksmith, Inc., doing business as American Cannabis Company, Inc. Intercompany accounts and transactions have been eliminated.

 
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Description of Business.
 6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Description of Business.

Note 2. Description of Business.

 

American Cannabis Company, Inc. and its wholly owned subsidiary Company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and sell both exclusive and non-exclusive customer products commonly used in the industry.

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

1.Three Medical Marijuana (MMC) Store Licenses;

 

2.One Marijuana Infused Product Licenses (MIPS); and,

 

3.One Option Premises Cultivation License (OPC); and,

 

4.Related real property assets, goodwill, and related business assets.

  

As a result, the Company has expanded its business model to include the cultivation and retail sale of cannabis in the medicinal cannabis industry.

 
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies
 6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 3. Summary of Significant Accounting Policies

 

Basis of Accounting

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.

 

Use of Estimates in Financial Reporting

 

The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.

 

Unaudited Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.

 

Segment Information

 

Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker, or decision-making group, in deciding how to allocate resources and assess performance. The Company reports results of operations in 3 distinct segments: Consulting Services, Soil Product and Equipment and Cannabis Products.

 

The Consulting Services segment provides services to the Cannabis industry as to the development and expansion of cultivation and retail facilities. These services include business plans, design advice and cultivation oversight. These services are offered throughout the United States.

 

The Soil Product and Equipment Segment handles the sale of our So-Hum Living Soils Product and the resale of Equipment in connection with our consulting services not only in the Cannabis industry but also to other agricultural industries. These products are offered for sale throughout the United States.

 

The Cannabis Product segment handles both the cultivation of and the retail sale of medicinal cannabis products in the State of Colorado.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of June 30, 2021 and December 31, 2021, the Company had cash balances in excess of FDIC insured limits of $250,000.

 

Accounts Receivable

 

Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of June 30, 2021, and December 31, 2020, the Company’s allowance for doubtful accounts was $60,354 and $57,512, respectively. The Company recorded bad debt expense during the six months ended June 30, 2021 and 2020 of $0 and $22,500, respectively.

 

Deposits

 

Deposits is comprised of advance payments made to third parties, for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale.

 

Inventory

 

Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in first-out and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of June 30, 2021 and December 31, 2021, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third party vendors for retail sales at dispensaries is determined using the first in first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production related depreciation and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At June 30, 2021, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary.

 

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

 

Significant Clients and Customers

 

During the six months ended June 30, 2021, three customers accounted for 42.5% of the Company’s total revenues for the period.

 

During the six months ended June 30, 2020, three customers accounted for 35.4% of the Company’s total revenues.

 

Property and Equipment, net

 

Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in progress construction are capitalized as incurred and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of June 30, 2021 and December 31, 2020.

 

Goodwill

 

Goodwill represents the excess of fair value over identifiable tangible and intangible net assets acquired in business combinations. Goodwill is not amortized, instead goodwill is reviewed for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value.

 

Accounting for the Impairment of Long-Lived Assets

 

The Company evaluates long lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long lived assets as of June 30, 2021 and December 31, 2020.

 

Fair Value Measurements

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.

 

Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.  

 

Revenue Recognition

 

We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “Revenue from Contracts with Customers (Topic 606). Due to the nature of our contracts with customers, adopting the new accounting principles did not have a significant impact on our prior period results of operations, cash flows or financial position.

 

Our service and product revenues arise from contracts with customers.  Service revenue includes Operations Divisions consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, (c) Cannabis sales division.  The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.

 

We may also enter into contracts with customers that identify a single, or few, distinct performance obligations, but that also have non-distinct, underlying performance obligations.  These contracts are typically fulfilled within one to six months.  Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods and, accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.

 

We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues:

 

(1)Identify the contract with the Customer. Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.

  

(2)Identify the performance obligations in the contract. We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.

  

(3)Determination of the transaction price. Prices are typically fixed, and no price protections or variables are offered.

  

(4)Allocation of the transaction price to the performance obligations in the contract. Transaction prices are typically allocated to the performance obligations outlined in the contract.

 

(5)Recognize Revenue when (or as) the entity satisfies a performance obligation. We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.

  

Advances from Clients deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received.  Where possible, we obtain retainers to lessen our risk of non-payment by our customers.  Advances from Clients deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.

 

Product and Equipment Sales

 

Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, title has transferred, and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606. During the six months ended June 30, 2021 and 2020, sales returns were $0.

 

Consulting Services

 

We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services.

 

For hourly based fixed fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients” account, and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer based significant financing, that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.

 

Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the three months ended March 31, 2021 and 2020, we incurred no losses from fixed fee engagements that terminate prior to completion. We believe if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.

 

We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.

 

Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price.

 

While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.

 

Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.

 

Cannabis Sales

 

Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the three months ended June 30, 2021.

 

Loyalty Reward Program

 

The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based upon the total amount of a purchase, at the time of purchase. Management has determined that as there is no separate performance obligation to the reward program, i.e. the accumulation and redemption of points, and as such the Company recognizes the revenue at the time of purchase.

 

Costs of Revenues

 

The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

 

Advertising and Promotion Costs

 

Advertising and Promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the six months ended June 30, 2021 and 2020 these expenses were $33,238 and $8,489, respectively.

 

Shipping and Handling Costs

 

For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.

 

Stock-Based Compensation

 

Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. During the six months ended June 30, 2021 and 2020, stock-based compensation expense for restricted shares for Company employees was $28,690 and $4,503, respectively and $13,027 and $19,659 for the three months ended June 30, 2021. Compensation expense for warrants are based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model and are expensed over the expected term of the awards. During the six months ended June 30, 2021, no warrants were issued as stock compensation.

         

Research and Development

 

As a component of our equipment and supplies offerings, from time-to-time we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include, but are not limited to: The Satchel™, Cultivation Cube™, So-Hum Living Soils™ and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the six months ended June 30, 2021 and 2020, our research and development costs were de minimis.

 

Income Taxes

 

The Company’s corporate status changed from an S Corporation, which it had been since inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2010, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of June 30, 2021 and December 31, 2020, we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.

 

Net Loss Per Common Share

 

The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities since that would have an anti-dilutive effect on earnings.

 

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

 

Related Party Transactions

 

The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

Impact of COVID-19 Pandemic

 

On March 11, 2020, the World Health Organization declared the current coronavirus (“COVID-19”) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact upon many sectors of the economy, including retail commerce.

 

In response to state and local measures and for protection of both employees, the Company made required changes to operations, which did not have a material impact upon operations or the financial condition of the Company.

 

While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-19 cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these unaudited condensed consolidated financial statements.

 

Recent Accounting Pronouncements

 

Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.

 

In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes”.  The pronouncement simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740, “Income Taxes”.  The pronouncement also improves consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance.  This standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted.  The Company is still evaluating the impact this guidance will have on its consolidated financial statements.

 

In January 2020, the FASB issued ASU No. 2020-01, "Investments — Equity Securities: Clarifying the Interactions between Topic 321, Topic 323, and Topic 815" ("ASU No. 2020-01"). ASU No. 2020-01 clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with ASC 321, "Investments — Equity Securities" immediately before applying or upon discontinuing the equity method of accounting in ASC 323, "Investments—Equity Method and Joint Ventures." The provisions of ASU No. 2020-01 are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years with early adoption permitted, including early adoption in an interim period for public business entities for periods for which financial statements have not yet been issued. The Company is still evaluating the impact this guidance will have on its consolidated financial statements.

 

 
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Naturaleaf Asset Acquisition
 6 Months Ended
Jun. 30, 2021
Business Combination and Asset Acquisition [Abstract]  
Naturaleaf Asset Acquisition

Note 4. Naturaleaf Asset Acquisition

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

5.Three Medical Marijuana (MMC) Store Licenses;

6.One Marijuana Infused Product Licenses (MIPS); and,

7.One Option Premises Cultivation License (OPC); and,

8.Related real property assets, goodwill, and related business assets.

  

The aggregate consideration paid for the Assets was $2,890,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000.

 

The asset acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations. As the acquirer for accounting purposes, the Company has estimated the fair value of Medihemp LLC and Medical Cannabis Caregivers, Inc.’s (hereafter “Naturaleaf’s”) assets acquired and conformed the accounting policies of Naturaleaf to its own accounting policies. The Company expensed certain legal, auditing and licensing costs with the acquisition of $83,095.

  

As part of the acquisition, the owners of Naturaleaf retained the outstanding cash balance on the date of the acquisition and had agreed to the payment of all outstanding accounts payables and related party advances.

 

The Company has performed a preliminary valuation analysis of the fair market value of Naturaleaf’s assets. The following table summarizes the allocation of the preliminary purchase price as of the acquisition date:

 

     
Cash  $ -- 
Inventory   150,000 
Property, plant and equipment   92,523 
Long Term Deposits   6,000 
Identifiable intangible assets   1,111,161 
Goodwill   1,530,316 
Accounts payable   -- 
Total consideration  $2,890,000 

 

Preliminary goodwill from the acquisition primarily relates to the future economic benefits arising from the assets acquired and is consistent with the Company's stated intentions and strategy. Other assets include inventory and fixed assets.

 

The preliminary fair value of Naturaleaf’s identifiable intangible assets was $1,111,161 million at April 30, 2021, consisting of $694,476 in licenses and $416,875 in brand names. Due to the indefinite life of the identifiable intangible assets at this time, the Company did not recognize an amortization expense during the six months ended June 30, 2021.

 

 

The estimated fair values assigned to identifiable assets acquired assumed are provisional and are based on the information that was available as of the acquisition date to estimate the fair value of assets acquired and liabilities assumed. The Company believes that information provides a reasonable basis for estimating the fair values of assets acquired and liabilities assumed, but the Company is waiting for additional information necessary to finalize those fair values. Therefore, the provisional measurements of fair value reflected are subject to change and such changes could be significant. The Company expects to finalize the valuation and complete the purchase price allocation as soon as practicable, but no later than one year from the acquisition date.

 

The results of operations of Naturaleaf for the period from April 30, 2021 through June 30, 2021 are included in the Company's unaudited condensed consolidated financial statements as of June 30, 2021.

 

Unaudited Pro Forma Financial Information

 

The following unaudited pro forma information presents a summary of the Company’s combined operating results for the three and six months ended June 30, 2021 and 2020, as if the acquisition had occurred on January 1, 2020. The following pro forma financial information is not necessarily indicative of the Company’s operating results as they would have been had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including, but not limited to, differences between the assumptions used to prepare the pro forma information, basic shares outstanding and dilutive equivalents, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses.

 

Pro Forma Financial Information             
   Three Months Ended  Six Months Ended
   June 30,  June 30,
   2021  2020  2021  2020
             
Total Revenues  $808,243   $1,162,406   $1,712,496   $2,468,724 
Loss from Operations  $(351,728)  $(8,908)  $(383,864)  $(88,189)
                     
Basic and diluted loss per share  $—     $—     $—     $—   

 

 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Accounts Receivable and Advance from Clients
 6 Months Ended
Jun. 30, 2021
Receivables [Abstract]  
Accounts Receivable and Advance from Clients

Note 5. Accounts Receivable and Advance from Clients    

         

Accounts receivable was comprised of the following:

 

          
   June 30, 2021   December 31, 2020 
Accounts Receivable – Trade  $168,101   $82,467 
Less:  Allowance for Doubtful Accounts   (144,770)   (57,512)
Accounts Receivable, net  $23,331   $24,955 

 

The Company had bad debt expense during the six months ended June 30, 2021 and 2020 of $0, respectively.

 

Our Advances from Clients had the following activity:

 

   Amount 
December 31, 2020  $88,843 
    Additional deposits received   199,892 
    Less:  Deposits recognized as revenue   (225,288)
June 30, 2021  $63,447 

 
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Inventory
 6 Months Ended
Jun. 30, 2021
Inventory Disclosure [Abstract]  
Inventory

Note 6. Inventory

 

Inventory consisted of the following:

 

          
   June 30, 2021   December 31, 2020 
Raw Materials  $92,132   $39,746 
Work In Process   66,287    - 
Finished Goods   173,075    22,656 
Total Inventory  $331,494   $62,402 

  

 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Property and Equipment, net
 6 Months Ended
Jun. 30, 2021
Property, Plant and Equipment [Abstract]  
Property and Equipment, net

Note 7. Property and Equipment, net

 

Property and equipment, net, was comprised of the following:

 

          
   June 30, 2021   December 31, 2020 
Office equipment  $38,481   $34,071 
Software   13,204    13,204 
Furniture and Fixtures   2,328    - 
Machinery and Equipment   329,992    - 
Leasehold Improvements   115,808    - 
Property and equipment, gross  $499,813   $47,275 
Less: Accumulated Depreciation   (31,597)   (22,621)
Property and equipment, net  $468,216   $24,654 

 

As part of the Naturaleaf Asset Acquistion, the Company acquired $92,535 in fixed assets consisting of machinery and equipment and leasehold improvements. During the six months ended June 30, 2021, the Company purchased office equipment in the amount of $1,576 and has made purchases of machinery and equipment of $308,438 in order to upgrade operations at the new cultivation facilities and has spent $50,000 in leasehold improvements at the cultivation facilities.

 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued and Other Current Liabilities
 6 Months Ended
Jun. 30, 2021
Payables and Accruals [Abstract]  
Accrued and Other Current Liabilities

Note 8. Accrued and Other Current Liabilities

 

Accrued and other current liabilities consisted of the following:

 

          
   June 30, 2021   December 31, 2020 
Accrued Interest  $18,629   $449 
Accrued Payroll   33,112    - 
Sales Tax Payable   17,633    - 
Other Accrued Expenses & Payables   66,994    48,795 
Accrued and other current liabilities  $136,368   $49,244 

 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Payable
 6 Months Ended
Jun. 30, 2021
Stock Payable  
Stock Payable

Note 9. Stock Payable

 

The following summarizes the changes in common stock payable:

 

     
   Amount 
December 31, 2020  $- 
    Additional Expenses Incurred   28,690 
    Payments Upon Issuance of Shares   - 
June 30, 2021  $28,690 

  

 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Operating Lease Right-of-Use Asset/Operating Lease Liability
 6 Months Ended
Jun. 30, 2021
Operating Lease Right-of-use Assetoperating Lease Liability  
Operating Lease Right-of-Use Asset/Operating Lease Liability

Note 10. Operating Lease Right-of-Use Asset/Operating Lease Liability

 

The Company leases property under operating leases. Property leases include retail and cultivation space with fixed rent payments and lease terms ranging from one to two years. The Company is obligated to pay the lessor for maintenance, real estate taxes, insurance and other operating expenses on certain property leases. These expenses are variable and are not included in the measurement of the lease asset or lease liability. These expenses are recognized as variable rent expense when incurred.

 

The Company’s lease portfolio consists of the following.

 

Schedule of lease              
Lease Name  Asset Type  Start Date  Expiration Date  Monthly Rent
Durango Lease  Real Property  5/1/2021  5/31/2022  $10,200 
Lehman Lease  Real Property  5/1/2021  12/31/2022  $2,732 
Palmer Lease  Real Property  5/1/2021  6/30/2022  $1,069 
Greenspace Membership  Real Property  4/15/2021  12/31/2021  $1,000 
Tejon Lease  Real Property  5/1/2021  4/30/2022  $3,700 

 

On June 1, 2020, the Company entered into a new lease membership agreement for a one-year term for an amount of $2,895 per month, the lease expired on May 31, 2021. At that time the Company entered into an 8 ½ month lease for less space for an amount of $1,000 per month. We determined under ASC 842, due to the short-term nature of the lease that the lease membership agreement met the criteria of ASC 842-20-25-2 and as such it was not necessary to capitalize the lease and rent will be recognized on a monthly straight-line basis.

 

On May 1, 2020, as part of the Naturaleaf Acquisition, leases for grow facilities and dispensaries were assigned to the Company. These leases were determined to be operating leases under ASC 842 and such leases was capitalized. It was determined that the Tejon lease, due to the short-term nature of the lease met the criteria of ASC 842-20-25-2 and as such it was not necessary to capitalize the lease and rent would be recognized on a straight-line basis.

 

The Company records the lease asset and lease liability at the present value of lease payments over the lease term. The leases typically do not provide an implicit rate; therefore, the Company uses its estimated incremental borrowing rate at the time of lease commencement to discount the present value of lease payments. The Company’s discount rate for operating leases at June 30, 2021 was 12.5%. Leases often include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. Lease expense is recognized on a straight-line basis over the lease term to the extent that collection is considered probable. As a result, the Company been recognizing rents as they become payable.

 

As of June 30, 2021, the maturities of operating leases liabilities are as follows:

 

       
    Operating
Leases		  
2021   $ 84,474  
2022     91,158  
Total     175,632  
Less: amount representing interest     (12,216 )
Present value of future minimum lease payments     163,416  
Less: current obligations under leases     147,131  
Long-term lease obligations   $ 16,286  

  

As of June 30, 2021, the aggregate remaining minimal annual lease payments under these operating leases, including those accounted for under practicable expedient were as follows: 

 

2021  $112,213 
2022   103,844 
Total  $216,057 

 

 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Loans Payable
 6 Months Ended
Jun. 30, 2021
Debt Disclosure [Abstract]  
Loans Payable

Note 11. Loans Payable

 

PPP Loans

 

On March 27, 2020, the CARES Act was enacted to provide financial aid to family and businesses impacted by the COVID-19 pandemic.  The Company participated in the CARES Act, and on August 6, 2020, the Company entered into a note payable with a bank under the Small Business Administration (“SBA”) Paycheck Protection Program (“PPP loan”) in the amount of $109,914. This loan payable matures on August 6, 2022 with a fixed interest rate of 1% per annum with interest deferred for six months. The PPP loan has an initial term of two years, is unsecured and guaranteed by the SBA. Under the terms of the PPP loan, the Company may apply for forgiveness of the amount due on the PPP loan. The Company used the proceeds from the PPP loan for qualifying expenses as defined in the PPP. The Company intends to apply for forgiveness of the PPP loan in accordance with the terms of the CARES Act. However, the Company cannot assure at this time that the PPP loan will be forgiven partially or in full. If the loan is not forgiven based on the PPP guidelines to be issued by the SBA, as defined, then, the monthly payment amount will be $6,186 beginning on March 6, 2021 through August 6, 2022. On March 3, 2021, the SBA forgave the principal of $109,914 and any accrued interest at that time.

 

On April 23, 2021, the Company entered into a second note payable with a bank under the SBA PPP Loan in the amount of $130,186. The PPP Loan is subject to the same terms of forgiveness as above. The monthly payment amount will be $3,056 beginning on September 22, 2022.

 

Naturaleaf Seller Note

 

As part of the Naturaleaf Acquisition, the Company issued a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”). The note has a term of 1 year with a due date of April 1, 2022 and does not require any payments prior to the due date. The note has an annual interest rate of 10%. At June 30, 2021, interest of $18,383 had been accrued.

 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions
 6 Months Ended
Jun. 30, 2021
Related Party Transactions [Abstract]  
Related Party Transactions

Note 12. Related Party Transactions

 

The Company has a related party entity, Tabular Investments, LLC (“Tabular”) which was set to assign the Company’s interest in various equity partnership. The sole member of Tabular is Tad Mailander, the Company’s outside legal counsel and Director. The Company has valued all of its equity partnership investments at $0. Neither our direct equity ownership in, nor our assignments of equity to Tabular Investments, LLC are, or are reasonably likely to allow for, substantive terms, transactions, and arrangements, whether contractual or not contractual, that will have a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources. We have no direct or indirect majority influence or control over any entity in which we have a direct equity interest or equity interests assigned to Tabular. We do not have any direct or indirect interest in, and do not control Tabular. We have not absorbed losses from either our direct equity interests or assignments to Tabular, and we have provided no subordinated financial support to any project

 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Based Compensation
 6 Months Ended
Jun. 30, 2021
Equity [Abstract]  
Stock Based Compensation

Note 13. Stock Based Compensation

 

During the six months ended June 30, 2021, the Company issued stock-based compensation for employees and service providers pursuant to its 2015 Equity Incentive Plan.

 

Restricted Shares

 

From time to time, the Company grants certain employees restricted shares of its common stock to provide further compensation in-lieu of wages and to align the employee’s interests with the interests of its stockholders. Because vesting is based on continued employment, these equity-based incentives are also intended to attract, retain and motivate personnel upon whose judgment, initiative and effort the Company’s success is largely dependent.

 

During the six months ended June 30, 2021, the Company granted 135,616 restricted shares and recognized $28,690 in associated employee stock-based compensation expense , which is included as part of the outstanding stock payable June 30, 2021. The fair value of restricted stock unit is determined based on the quoted closing price of the Company’s common stock on the date grant.

 

During the six months ended June 30, 2020, the Company granted 225,000 restricted shares and recognized $19,347 in associated employee stock-based compensation expense, which is included as part of the outstanding stock payable June 30, 2020, that was issued in December 2020. The fair value of the restricted stock is determined based on the quoted closing price of the Company’s common stock on the date of grant.

 

During the six months ended June 30, 2020, the Company issued 478,261 shares of restricted shares granted during the fiscal year ended December 31, 2019.

 

Net Loss Per Share

 

Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the reporting period. Diluted net loss per share is computed similarly to basic loss per share, except that it includes the potential dilution that could occur if dilutive securities are exercised.

 

Outstanding stock options and common stock warrants are considered anti-dilutive because we are in a net loss position.  Accordingly, the number of weighted average shares outstanding for basic and fully diluted net loss per share are the same.

 

The following summarizes equity instruments that may, in the future, have a dilutive effect on earnings per share:

 

          
   June 30, 2021   December 31, 2020 
Warrants   10,000    397,500 
Stock Payable   135,616    - 
Total   145,616    397,500 

 

Warrants

 

During the six months ended June 30, 2021, warrants with a cashless exercise provision were exercised for 125,000 restricted shares . Of which, a warrant for 100,000 shares was exercised by an officer/director of the Company.

 

During the six months ended June 30, 2021, the Company did not issue or approve any warrants. Warrants exercisable for 287,500 shares expired.

  
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders’ Equity
 6 Months Ended
Jun. 30, 2021
Equity [Abstract]  
Shareholders’ Equity

Note 14. Shareholders’ Equity

 

Preferred Stock

 

American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $0.01 par value. No shares of preferred stock were issued and outstanding at June 30, 2021 and December 31, 2020, respectively.

 

Common Stock

 

During the six months ended June 30, 2021, the Company issued 6,050,000 registered shares of common stock in exchange for net proceeds of $1,083,541 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019 with White Lion Capital LLC.

 

During the six months ended June 30, 2021, the Company issued 3,000,000 shares of its restricted common stock to the sellers of Naturaleaf, as part of the acquisition of assets of Naturaleaf. The shares had a value of $690,000 based on a closing market price on April 23, 2021 of $0.23 per share.

 

During the six months ended June 30, 2021, warrants with a cashless exercise provision were exercised for 125,000 restricted shares . Of which, a warrant for 100,000 shares was exercised by an officer/director of the Company.

 

During the six months ended June 30, 2020, the Company issued 478,261 shares of restricted shares granted during the fiscal year ended December 31, 2019.

 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 15.   Commitments and Contingencies

 

Legal

 

In the ordinary course of its business, the Company becomes involved in various legal proceedings involving a variety of matters. The Company does not believe there are any pending legal proceedings that will have a material adverse effect on the Company’s business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. The Companies expenses legal fees in the period in which they are incurred.

 

Turoff Matter

 

On November 15, 2019, Erin Turoff filed suit against the Company and Mr. Terry Buffalo, our chief executive officer and director, and Mr. Ellis Smith our chief development officer and director, in Denver County District Court. The complaint seeks a declaratory judgement and damages related to Ms. Turoff’s allegation that she was misclassified as an independent contractor while working for the Company. Ms. Turoff alleges she is owed unpaid overtime, liquidated damages, wages, and other compensatory damages for her misclassification and alleged wrongful terminations. Ms. Turoff’s suit against Mr. Buffalo and Mr. Smith alleges that each are the alter ego of the Company and are therefore jointly and severally liable. All parties have appeared in the case and the case is currently in the discovery. At this time, there is no reasonable basis from which a determination or estimate may be made concerning any contingent liability related to this lawsuit. 

 

 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events
 6 Months Ended
Jun. 30, 2021
Subsequent Events [Abstract]  
Subsequent Events

Note 16. Subsequent Events

 

In accordance with ASC 855-10, the Company has analyzed its operations after Unaudited consolidated financial statements were available to be issued and has determined that there were no other significant subsequent events or transactions that would require recognition or disclosure in the unaudited condensed consolidated financial statements for the six months ended June 30, 2021, other than as follows.

 

In August 2021, the Company issued 250,000 registered shares of common stock in exchange for net proceeds of $26,935 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019 with White Lion Capital LLC.

 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Policies)
 6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Basis of Accounting

Basis of Accounting

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.

 
Use of Estimates in Financial Reporting

Use of Estimates in Financial Reporting

 

The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.

 
Unaudited Interim Financial Statements

Unaudited Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.

 
Segment Information

Segment Information

 

Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker, or decision-making group, in deciding how to allocate resources and assess performance. The Company reports results of operations in 3 distinct segments: Consulting Services, Soil Product and Equipment and Cannabis Products.

 

The Consulting Services segment provides services to the Cannabis industry as to the development and expansion of cultivation and retail facilities. These services include business plans, design advice and cultivation oversight. These services are offered throughout the United States.

 

The Soil Product and Equipment Segment handles the sale of our So-Hum Living Soils Product and the resale of Equipment in connection with our consulting services not only in the Cannabis industry but also to other agricultural industries. These products are offered for sale throughout the United States.

 

The Cannabis Product segment handles both the cultivation of and the retail sale of medicinal cannabis products in the State of Colorado.

 
Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of June 30, 2021 and December 31, 2021, the Company had cash balances in excess of FDIC insured limits of $250,000.

 
Accounts Receivable

Accounts Receivable

 

Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of June 30, 2021, and December 31, 2020, the Company’s allowance for doubtful accounts was $60,354 and $57,512, respectively. The Company recorded bad debt expense during the six months ended June 30, 2021 and 2020 of $0 and $22,500, respectively.

 
Deposits

Deposits

 

Deposits is comprised of advance payments made to third parties, for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale.

 
Inventory

Inventory

 

Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in first-out and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of June 30, 2021 and December 31, 2021, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third party vendors for retail sales at dispensaries is determined using the first in first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production related depreciation and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At June 30, 2021, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary.

 
Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

 
Significant Clients and Customers

Significant Clients and Customers

 

During the six months ended June 30, 2021, three customers accounted for 42.5% of the Company’s total revenues for the period.

 

During the six months ended June 30, 2020, three customers accounted for 35.4% of the Company’s total revenues.

 
Property and Equipment, net

Property and Equipment, net

 

Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in progress construction are capitalized as incurred and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of June 30, 2021 and December 31, 2020.

 
Goodwill

Goodwill

 

Goodwill represents the excess of fair value over identifiable tangible and intangible net assets acquired in business combinations. Goodwill is not amortized, instead goodwill is reviewed for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value.

 
Accounting for the Impairment of Long-Lived Assets

Accounting for the Impairment of Long-Lived Assets

 

The Company evaluates long lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long lived assets as of June 30, 2021 and December 31, 2020.

 
Fair Value Measurements

Fair Value Measurements

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.

 

Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.  

 
Revenue Recognition

Revenue Recognition

 

We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “Revenue from Contracts with Customers (Topic 606). Due to the nature of our contracts with customers, adopting the new accounting principles did not have a significant impact on our prior period results of operations, cash flows or financial position.

 

Our service and product revenues arise from contracts with customers.  Service revenue includes Operations Divisions consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, (c) Cannabis sales division.  The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.

 

We may also enter into contracts with customers that identify a single, or few, distinct performance obligations, but that also have non-distinct, underlying performance obligations.  These contracts are typically fulfilled within one to six months.  Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods and, accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.

 

We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues:

 

(1)Identify the contract with the Customer. Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.

  

(2)Identify the performance obligations in the contract. We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.

  

(3)Determination of the transaction price. Prices are typically fixed, and no price protections or variables are offered.

  

(4)Allocation of the transaction price to the performance obligations in the contract. Transaction prices are typically allocated to the performance obligations outlined in the contract.

 

(5)Recognize Revenue when (or as) the entity satisfies a performance obligation. We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.

  

Advances from Clients deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received.  Where possible, we obtain retainers to lessen our risk of non-payment by our customers.  Advances from Clients deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.

 
Product and Equipment Sales

Product and Equipment Sales

 

Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, title has transferred, and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606. During the six months ended June 30, 2021 and 2020, sales returns were $0.

 
Consulting Services

Consulting Services

 

We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services.

 

For hourly based fixed fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients” account, and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer based significant financing, that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.

 

Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the three months ended March 31, 2021 and 2020, we incurred no losses from fixed fee engagements that terminate prior to completion. We believe if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.

 

We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.

 

Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price.

 

While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.

 

Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.

 
Cannabis Sales

Cannabis Sales

 

Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the three months ended June 30, 2021.

 
Loyalty Reward Program

Loyalty Reward Program

 

The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based upon the total amount of a purchase, at the time of purchase. Management has determined that as there is no separate performance obligation to the reward program, i.e. the accumulation and redemption of points, and as such the Company recognizes the revenue at the time of purchase.

 
Costs of Revenues

Costs of Revenues

 

The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

 
Advertising and Promotion Costs

Advertising and Promotion Costs

 

Advertising and Promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the six months ended June 30, 2021 and 2020 these expenses were $33,238 and $8,489, respectively.

 
Shipping and Handling Costs

Shipping and Handling Costs

 

For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.

 
Stock-Based Compensation

Stock-Based Compensation

 

Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. During the six months ended June 30, 2021 and 2020, stock-based compensation expense for restricted shares for Company employees was $28,690 and $4,503, respectively and $13,027 and $19,659 for the three months ended June 30, 2021. Compensation expense for warrants are based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model and are expensed over the expected term of the awards. During the six months ended June 30, 2021, no warrants were issued as stock compensation.

         
Research and Development

Research and Development

 

As a component of our equipment and supplies offerings, from time-to-time we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include, but are not limited to: The Satchel™, Cultivation Cube™, So-Hum Living Soils™ and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the six months ended June 30, 2021 and 2020, our research and development costs were de minimis.

 
Income Taxes

Income Taxes

 

The Company’s corporate status changed from an S Corporation, which it had been since inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2010, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of June 30, 2021 and December 31, 2020, we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.

 
Net Loss Per Common Share

Net Loss Per Common Share

 

The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities since that would have an anti-dilutive effect on earnings.

 

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

 
Related Party Transactions

Related Party Transactions

 

The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 
Impact of COVID-19 Pandemic

Impact of COVID-19 Pandemic

 

On March 11, 2020, the World Health Organization declared the current coronavirus (“COVID-19”) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact upon many sectors of the economy, including retail commerce.

 

In response to state and local measures and for protection of both employees, the Company made required changes to operations, which did not have a material impact upon operations or the financial condition of the Company.

 

While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-19 cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these unaudited condensed consolidated financial statements.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.

 

In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes”.  The pronouncement simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740, “Income Taxes”.  The pronouncement also improves consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance.  This standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted.  The Company is still evaluating the impact this guidance will have on its consolidated financial statements.

 

In January 2020, the FASB issued ASU No. 2020-01, "Investments — Equity Securities: Clarifying the Interactions between Topic 321, Topic 323, and Topic 815" ("ASU No. 2020-01"). ASU No. 2020-01 clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with ASC 321, "Investments — Equity Securities" immediately before applying or upon discontinuing the equity method of accounting in ASC 323, "Investments—Equity Method and Joint Ventures." The provisions of ASU No. 2020-01 are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years with early adoption permitted, including early adoption in an interim period for public business entities for periods for which financial statements have not yet been issued. The Company is still evaluating the impact this guidance will have on its consolidated financial statements.

 

 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Naturaleaf Asset Acquisition (Tables)
 6 Months Ended
Jun. 30, 2021
Business Combination and Asset Acquisition [Abstract]  
Purchase price as of the acquisition
     
Cash  $ -- 
Inventory   150,000 
Property, plant and equipment   92,523 
Long Term Deposits   6,000 
Identifiable intangible assets   1,111,161 
Goodwill   1,530,316 
Accounts payable   -- 
Total consideration  $2,890,000 
Pro Forma Financial Information
Pro Forma Financial Information             
   Three Months Ended  Six Months Ended
   June 30,  June 30,
   2021  2020  2021  2020
             
Total Revenues  $808,243   $1,162,406   $1,712,496   $2,468,724 
Loss from Operations  $(351,728)  $(8,908)  $(383,864)  $(88,189)
                     
Basic and diluted loss per share  $—     $—     $—     $—   

 

 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Accounts Receivable and Advance from Clients (Tables)
 6 Months Ended
Jun. 30, 2021
Receivables [Abstract]  
Accounts Receivable and Advance from Clients
          
   June 30, 2021   December 31, 2020 
Accounts Receivable – Trade  $168,101   $82,467 
Less:  Allowance for Doubtful Accounts   (144,770)   (57,512)
Accounts Receivable, net  $23,331   $24,955 

 

The Company had bad debt expense during the six months ended June 30, 2021 and 2020 of $0, respectively.

 

Our Advances from Clients had the following activity:

 

   Amount 
December 31, 2020  $88,843 
    Additional deposits received   199,892 
    Less:  Deposits recognized as revenue   (225,288)
June 30, 2021  $63,447 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Inventory (Tables)
 6 Months Ended
Jun. 30, 2021
Inventory Disclosure [Abstract]  
Inventory
          
   June 30, 2021   December 31, 2020 
Raw Materials  $92,132   $39,746 
Work In Process   66,287    - 
Finished Goods   173,075    22,656 
Total Inventory  $331,494   $62,402 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Property and Equipment, net (Tables)
 6 Months Ended
Jun. 30, 2021
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net
          
   June 30, 2021   December 31, 2020 
Office equipment  $38,481   $34,071 
Software   13,204    13,204 
Furniture and Fixtures   2,328    - 
Machinery and Equipment   329,992    - 
Leasehold Improvements   115,808    - 
Property and equipment, gross  $499,813   $47,275 
Less: Accumulated Depreciation   (31,597)   (22,621)
Property and equipment, net  $468,216   $24,654 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued and Other Current Liabilities (Tables)
 6 Months Ended
Jun. 30, 2021
Payables and Accruals [Abstract]  
Accrued and Other Current Liabilities
          
   June 30, 2021   December 31, 2020 
Accrued Interest  $18,629   $449 
Accrued Payroll   33,112    - 
Sales Tax Payable   17,633    - 
Other Accrued Expenses & Payables   66,994    48,795 
Accrued and other current liabilities  $136,368   $49,244 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Payable (Tables)
 6 Months Ended
Jun. 30, 2021
Stock Payable  
Schedule of stock payable
     
   Amount 
December 31, 2020  $- 
    Additional Expenses Incurred   28,690 
    Payments Upon Issuance of Shares   - 
June 30, 2021  $28,690 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables)
 6 Months Ended
Jun. 30, 2021
Operating Lease Right-of-use Assetoperating Lease Liability  
Schedule of lease
Schedule of lease              
Lease Name  Asset Type  Start Date  Expiration Date  Monthly Rent
Durango Lease  Real Property  5/1/2021  5/31/2022  $10,200 
Lehman Lease  Real Property  5/1/2021  12/31/2022  $2,732 
Palmer Lease  Real Property  5/1/2021  6/30/2022  $1,069 
Greenspace Membership  Real Property  4/15/2021  12/31/2021  $1,000 
Tejon Lease  Real Property  5/1/2021  4/30/2022  $3,700 
Operating leases liabilities
       
    Operating
Leases		  
2021   $ 84,474  
2022     91,158  
Total     175,632  
Less: amount representing interest     (12,216 )
Present value of future minimum lease payments     163,416  
Less: current obligations under leases     147,131  
Long-term lease obligations   $ 16,286  

  

As of June 30, 2021, the aggregate remaining minimal annual lease payments under these operating leases, including those accounted for under practicable expedient were as follows: 

 

2021  $112,213 
2022   103,844 
Total  $216,057 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2021
Equity [Abstract]  
Schedule of stock based compensation
          
   June 30, 2021   December 31, 2020 
Warrants   10,000    397,500 
Stock Payable   135,616    - 
Total   145,616    397,500 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Accounting Policies [Abstract]      
Cash, FDIC Insured Amount $ 250,000   $ 250,000
Allowance for doubtful accounts 60,354   $ 57,512
Bad debt expense 0 $ 22,500  
Selling and marketing expense 33,238 8,489  
stock based compensation expense $ 28,690 $ 4,503  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Naturaleaf Asset Acquisition (Details) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]    
Property, plant and equipment $ 499,813 $ 47,275
Goodwill 1,530,316
Acquisition-related Costs [Member]    
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]    
Cash  
Inventory 150,000  
Property, plant and equipment 92,523  
Long Term Deposits 6,000  
Identifiable intangible assets 1,111,161  
Goodwill 1,530,316  
Accounts payable  
Total consideration $ 2,890,000  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Naturaleaf Asset Acquisition (Details 1) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Business Combination and Asset Acquisition [Abstract]        
Total Revenues $ 808,243 $ 1,162,406 $ 1,712,496 $ 2,468,724
Loss from Operations $ (351,728) $ (8,908) $ (383,864) $ (88,189)
Basic and diluted loss per share
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Accounts Receivable and Advances from Clients - Accounts Receivable (Details) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Receivables [Abstract]    
Accounts Receivable – Trade $ 168,101 $ 82,467
Less:  Allowance for Doubtful Accounts (144,770) (57,512)
Accounts Receivable, net 23,331 $ 24,955
Beginning Balance 88,843  
Additional deposits received 199,892  
Less: Deposits recognized as revenue (225,288)  
[custom:AdvanceFromClient-0] $ 63,447  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Inventory (Details) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Inventory Disclosure [Abstract]    
Raw Materials $ 92,132 $ 39,746
Work In Process 66,287
Finished Goods 173,075 22,656
Total Inventory $ 331,494 $ 62,402
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Property and Equipment, net - Property and Equipment, Net (Details) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 499,813 $ 47,275
Less: accumulated depreciation (31,597) (22,621)
Property and equipment, net 468,216 24,654
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 38,481 13,204
Software Development [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 13,204 34,071
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 2,328
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 329,992
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 115,808
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Property and Equipment, net (Details Narrative)
Jun. 30, 2021
USD ($)
Property, Plant and Equipment [Abstract]  
Office equipment $ 1,576
Machinery and equipment 308,438
Leasehold improvements $ 50,000
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued and Other Current Liabilities - Accrued and Other Current Liabilities (Details) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Payables and Accruals [Abstract]    
Accrued Interest $ 18,629 $ 449
Accrued Payroll 33,112
Sales Tax Payable 17,633
Other Accrued Expenses & Payables 66,994 48,795
Accrued and other current liabilities $ 136,368 $ 49,244
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Payable (Details)
 6 Months Ended
Jun. 30, 2021
USD ($)
Stock Payable  
[custom:StockPayableAmounts-1] $ (0)
Additional Expensed Incurred, Amount 28,690
Shares Issued for Expensed Incurred, Amount (0)
Ending Stock Payable, Amount $ 28,690
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.21.2
Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)
Jun. 30, 2021
USD ($)
Operating Lease Right-of-use Assetoperating Lease Liability  
2021 $ 84,474
2022 91,158
Total 175,632
Less: amount representing interest (12,216)
Present value of future minimum lease payments 163,416
Less: current obligations under leases 147,131
Long-term lease obligations 16,286
2021 112,213
2022 103,844
Total $ 216,057
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-based Compensation (Details) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Equity [Abstract]    
Warrants $ 10,000 $ 397,500
Stock Payable 135,616
Total $ 145,616 $ 397,500
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Based Compensation (Details Narrative) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2019
Equity [Abstract]      
[custom:GrantedRestrictedShares] 135,616 225,000 478,261
[custom:GrantedRestrictedValue] $ 28,690 $ 19,347  
EXCEL 54 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 55 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 56 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 57 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 53 303 1 false 9 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://AmericanCannabisCompanyInc.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 5 false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) Sheet http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) Statements 6 false false R7.htm 00000007 - Disclosure - Principles of Consolidation. Sheet http://AmericanCannabisCompanyInc.com/role/PrinciplesOfConsolidation. Principles of Consolidation. Notes 7 false false R8.htm 00000008 - Disclosure - Description of Business. Sheet http://AmericanCannabisCompanyInc.com/role/DescriptionOfBusiness. Description of Business. Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Naturaleaf Asset Acquisition Sheet http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisition Naturaleaf Asset Acquisition Notes 10 false false R11.htm 00000011 - Disclosure - Accounts Receivable and Advance from Clients Sheet http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvanceFromClients Accounts Receivable and Advance from Clients Notes 11 false false R12.htm 00000012 - Disclosure - Inventory Sheet http://AmericanCannabisCompanyInc.com/role/Inventory Inventory Notes 12 false false R13.htm 00000013 - Disclosure - Property and Equipment, net Sheet http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet Property and Equipment, net Notes 13 false false R14.htm 00000014 - Disclosure - Accrued and Other Current Liabilities Sheet http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilities Accrued and Other Current Liabilities Notes 14 false false R15.htm 00000015 - Disclosure - Stock Payable Sheet http://AmericanCannabisCompanyInc.com/role/StockPayable Stock Payable Notes 15 false false R16.htm 00000016 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability Sheet http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability Operating Lease Right-of-Use Asset/Operating Lease Liability Notes 16 false false R17.htm 00000017 - Disclosure - Loans Payable Sheet http://AmericanCannabisCompanyInc.com/role/LoansPayable Loans Payable Notes 17 false false R18.htm 00000018 - Disclosure - Related Party Transactions Sheet http://AmericanCannabisCompanyInc.com/role/RelatedPartyTransactions Related Party Transactions Notes 18 false false R19.htm 00000019 - Disclosure - Stock Based Compensation Sheet http://AmericanCannabisCompanyInc.com/role/StockBasedCompensation Stock Based Compensation Notes 19 false false R20.htm 00000020 - Disclosure - Shareholders??? Equity Sheet http://AmericanCannabisCompanyInc.com/role/ShareholdersEquity Shareholders??? Equity Notes 20 false false R21.htm 00000021 - Disclosure - Commitments and Contingencies Sheet http://AmericanCannabisCompanyInc.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 00000022 - Disclosure - Subsequent Events Sheet http://AmericanCannabisCompanyInc.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - Naturaleaf Asset Acquisition (Tables) Sheet http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionTables Naturaleaf Asset Acquisition (Tables) Tables http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisition 24 false false R25.htm 00000025 - Disclosure - Accounts Receivable and Advance from Clients (Tables) Sheet http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvanceFromClientsTables Accounts Receivable and Advance from Clients (Tables) Tables http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvanceFromClients 25 false false R26.htm 00000026 - Disclosure - Inventory (Tables) Sheet http://AmericanCannabisCompanyInc.com/role/InventoryTables Inventory (Tables) Tables http://AmericanCannabisCompanyInc.com/role/Inventory 26 false false R27.htm 00000027 - Disclosure - Property and Equipment, net (Tables) Sheet http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNetTables Property and Equipment, net (Tables) Tables http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet 27 false false R28.htm 00000028 - Disclosure - Accrued and Other Current Liabilities (Tables) Sheet http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilitiesTables Accrued and Other Current Liabilities (Tables) Tables http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilities 28 false false R29.htm 00000029 - Disclosure - Stock Payable (Tables) Sheet http://AmericanCannabisCompanyInc.com/role/StockPayableTables Stock Payable (Tables) Tables http://AmericanCannabisCompanyInc.com/role/StockPayable 29 false false R30.htm 00000030 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables) Sheet http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables) Tables http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability 30 false false R31.htm 00000031 - Disclosure - Stock Based Compensation (Tables) Sheet http://AmericanCannabisCompanyInc.com/role/StockBasedCompensationTables Stock Based Compensation (Tables) Tables http://AmericanCannabisCompanyInc.com/role/StockBasedCompensation 31 false false R32.htm 00000032 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies 32 false false R33.htm 00000033 - Disclosure - Naturaleaf Asset Acquisition (Details) Sheet http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails Naturaleaf Asset Acquisition (Details) Details http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionTables 33 false false R34.htm 00000034 - Disclosure - Naturaleaf Asset Acquisition (Details 1) Sheet http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails1 Naturaleaf Asset Acquisition (Details 1) Details http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionTables 34 false false R35.htm 00000035 - Disclosure - Accounts Receivable and Advances from Clients - Accounts Receivable (Details) Sheet http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvancesFromClients-AccountsReceivableDetails Accounts Receivable and Advances from Clients - Accounts Receivable (Details) Details 35 false false R36.htm 00000036 - Disclosure - Inventory (Details) Sheet http://AmericanCannabisCompanyInc.com/role/InventoryDetails Inventory (Details) Details http://AmericanCannabisCompanyInc.com/role/InventoryTables 36 false false R37.htm 00000037 - Disclosure - Property and Equipment, net - Property and Equipment, Net (Details) Sheet http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails Property and Equipment, net - Property and Equipment, Net (Details) Details 37 false false R38.htm 00000038 - Disclosure - Property and Equipment, net (Details Narrative) Sheet http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNetDetailsNarrative Property and Equipment, net (Details Narrative) Details http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNetTables 38 false false R39.htm 00000039 - Disclosure - Accrued and Other Current Liabilities - Accrued and Other Current Liabilities (Details) Sheet http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilities-AccruedAndOtherCurrentLiabilitiesDetails Accrued and Other Current Liabilities - Accrued and Other Current Liabilities (Details) Details 39 false false R40.htm 00000040 - Disclosure - Stock Payable (Details) Sheet http://AmericanCannabisCompanyInc.com/role/StockPayableDetails Stock Payable (Details) Details http://AmericanCannabisCompanyInc.com/role/StockPayableTables 40 false false R41.htm 00000041 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1) Sheet http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1 Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1) Details http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables 41 false false R42.htm 00000042 - Disclosure - Stock-based Compensation (Details) Sheet http://AmericanCannabisCompanyInc.com/role/Stock-basedCompensationDetails Stock-based Compensation (Details) Details 42 false false R43.htm 00000043 - Disclosure - Stock Based Compensation (Details Narrative) Sheet http://AmericanCannabisCompanyInc.com/role/StockBasedCompensationDetailsNarrative Stock Based Compensation (Details Narrative) Details http://AmericanCannabisCompanyInc.com/role/StockBasedCompensationTables 43 false false All Reports Book All Reports f2sammj10q081221.htm ammj-20210630.xsd ammj-20210630_cal.xml ammj-20210630_def.xml ammj-20210630_lab.xml ammj-20210630_pre.xml f2sammj10q081221ex31_1.htm f2sammj10q081221ex32_1.htm img001.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 60 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f2sammj10q081221.htm": { "axisCustom": 0, "axisStandard": 3, "contextCount": 53, "dts": { "calculationLink": { "local": [ "ammj-20210630_cal.xml" ] }, "definitionLink": { "local": [ "ammj-20210630_def.xml" ] }, "inline": { "local": [ "f2sammj10q081221.htm" ] }, "labelLink": { "local": [ "ammj-20210630_lab.xml" ], "remote": [ "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml" ] }, "presentationLink": { "local": [ "ammj-20210630_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml" ] }, "schema": { "local": [ "ammj-20210630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd" ] } }, "elementCount": 321, "entityCount": 1, "hidden": { "http://AmericanCannabisCompanyInc.com/20210630": 30, "http://fasb.org/us-gaap/2021-01-31": 46, "http://xbrl.sec.gov/dei/2021": 6, "total": 82 }, "keyCustom": 57, "keyStandard": 246, "memberCustom": 0, "memberStandard": 9, "nsprefix": "AMMJ", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://AmericanCannabisCompanyInc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Naturaleaf Asset Acquisition", "role": "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisition", "shortName": "Naturaleaf Asset Acquisition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Accounts Receivable and Advance from Clients", "role": "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvanceFromClients", "shortName": "Accounts Receivable and Advance from Clients", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Inventory", "role": "http://AmericanCannabisCompanyInc.com/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Property and Equipment, net", "role": "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet", "shortName": "Property and Equipment, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Accrued and Other Current Liabilities", "role": "http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilities", "shortName": "Accrued and Other Current Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AMMJ:StockPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Stock Payable", "role": "http://AmericanCannabisCompanyInc.com/role/StockPayable", "shortName": "Stock Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AMMJ:StockPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AMMJ:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability", "role": "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability", "shortName": "Operating Lease Right-of-Use Asset/Operating Lease Liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AMMJ:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Loans Payable", "role": "http://AmericanCannabisCompanyInc.com/role/LoansPayable", "shortName": "Loans Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Related Party Transactions", "role": "http://AmericanCannabisCompanyInc.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Stock Based Compensation", "role": "http://AmericanCannabisCompanyInc.com/role/StockBasedCompensation", "shortName": "Stock Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "role": "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "lang": null, "name": "us-gaap:AccountsReceivableNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Shareholders\u2019 Equity", "role": "http://AmericanCannabisCompanyInc.com/role/ShareholdersEquity", "shortName": "Shareholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Commitments and Contingencies", "role": "http://AmericanCannabisCompanyInc.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Subsequent Events", "role": "http://AmericanCannabisCompanyInc.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AMMJ:NaturaleafAssetAcquisitionTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Naturaleaf Asset Acquisition (Tables)", "role": "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionTables", "shortName": "Naturaleaf Asset Acquisition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AMMJ:NaturaleafAssetAcquisitionTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Accounts Receivable and Advance from Clients (Tables)", "role": "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvanceFromClientsTables", "shortName": "Accounts Receivable and Advance from Clients (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Inventory (Tables)", "role": "http://AmericanCannabisCompanyInc.com/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Property and Equipment, net (Tables)", "role": "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNetTables", "shortName": "Property and Equipment, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Accrued and Other Current Liabilities (Tables)", "role": "http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilitiesTables", "shortName": "Accrued and Other Current Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "AMMJ:StockPayableTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AMMJ:ScheduleOfStockPayable", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Stock Payable (Tables)", "role": "http://AmericanCannabisCompanyInc.com/role/StockPayableTables", "shortName": "Stock Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "AMMJ:StockPayableTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AMMJ:ScheduleOfStockPayable", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockNoParValue", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "role": "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockNoParValue", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "AMMJ:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AMMJ:LeasePortfolioTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables)", "role": "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables", "shortName": "Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "AMMJ:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AMMJ:LeasePortfolioTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Stock Based Compensation (Tables)", "role": "http://AmericanCannabisCompanyInc.com/role/StockBasedCompensationTables", "shortName": "Stock Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "role": "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Naturaleaf Asset Acquisition (Details)", "role": "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails", "shortName": "Naturaleaf Asset Acquisition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "AMMJ:NaturaleafAssetAcquisitionTableTextBlock", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30_us-gaap_AcquisitionRelatedCostsMember", "decimals": "0", "lang": null, "name": "us-gaap:InventoryGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-04-012021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Naturaleaf Asset Acquisition (Details 1)", "role": "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails1", "shortName": "Naturaleaf Asset Acquisition (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-04-012021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Accounts Receivable and Advances from Clients - Accounts Receivable (Details)", "role": "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvancesFromClients-AccountsReceivableDetails", "shortName": "Accounts Receivable and Advances from Clients - Accounts Receivable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Inventory (Details)", "role": "http://AmericanCannabisCompanyInc.com/role/InventoryDetails", "shortName": "Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Property and Equipment, net - Property and Equipment, Net (Details)", "role": "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails", "shortName": "Property and Equipment, net - Property and Equipment, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "AMMJ:OfficeEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Property and Equipment, net (Details Narrative)", "role": "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNetDetailsNarrative", "shortName": "Property and Equipment, net (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "AMMJ:OfficeEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Accrued and Other Current Liabilities - Accrued and Other Current Liabilities (Details)", "role": "http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilities-AccruedAndOtherCurrentLiabilitiesDetails", "shortName": "Accrued and Other Current Liabilities - Accrued and Other Current Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-04-012021-06-30", "decimals": "0", "first": true, "lang": null, "name": "AMMJ:ConsultingAndAdvisoryRevenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "role": "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-04-012021-06-30", "decimals": "0", "first": true, "lang": null, "name": "AMMJ:ConsultingAndAdvisoryRevenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "AMMJ:ScheduleOfStockPayable", "AMMJ:StockPayableTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "AMMJ:StockPayableAmounts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Stock Payable (Details)", "role": "http://AmericanCannabisCompanyInc.com/role/StockPayableDetails", "shortName": "Stock Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "AMMJ:ScheduleOfStockPayable", "AMMJ:StockPayableTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "AMMJ:StockPayableAmounts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OtherLiabilitiesTableTextBlock", "AMMJ:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)", "role": "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1", "shortName": "Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OtherLiabilitiesTableTextBlock", "AMMJ:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Stock-based Compensation (Details)", "role": "http://AmericanCannabisCompanyInc.com/role/Stock-basedCompensationDetails", "shortName": "Stock-based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": "INF", "first": true, "lang": null, "name": "AMMJ:GrantedRestrictedShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Stock Based Compensation (Details Narrative)", "role": "http://AmericanCannabisCompanyInc.com/role/StockBasedCompensationDetailsNarrative", "shortName": "Stock Based Compensation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": "INF", "first": true, "lang": null, "name": "AMMJ:GrantedRestrictedShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "role": "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)", "role": "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Principles of Consolidation.", "role": "http://AmericanCannabisCompanyInc.com/role/PrinciplesOfConsolidation.", "shortName": "Principles of Consolidation.", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Description of Business.", "role": "http://AmericanCannabisCompanyInc.com/role/DescriptionOfBusiness.", "shortName": "Description of Business.", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Summary of Significant Accounting Policies", "role": "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "f2sammj10q081221.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 9, "tag": { "AMMJ_AdditionalDepositsReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additional deposits received" } } }, "localname": "AdditionalDepositsReceived", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvancesFromClients-AccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "AMMJ_AdditionalExpensedIncurredAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additional Expensed Incurred, Amount" } } }, "localname": "AdditionalExpensedIncurredAmount", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/StockPayableDetails" ], "xbrltype": "monetaryItemType" }, "AMMJ_AdvanceFromClient": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[custom:AdvanceFromClient-0]" } } }, "localname": "AdvanceFromClient", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvancesFromClients-AccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "AMMJ_AdvanceFromClients": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Beginning Balance" } } }, "localname": "AdvanceFromClients", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvancesFromClients-AccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "AMMJ_AdvancesFromClient": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Advances from Clients" } } }, "localname": "AdvancesFromClient", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "AMMJ_AdvancesFromClients": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "AdvancesFromClients", "verboseLabel": "Advances from Clients" } } }, "localname": "AdvancesFromClients", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AMMJ_BusinessAcquisitionsProFormaBasicAndDilutedLossPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted loss per share" } } }, "localname": "BusinessAcquisitionsProFormaBasicAndDilutedLossPerShare", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "perShareItemType" }, "AMMJ_BusinessAcquisitionsProFormaLossFromOperations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loss from Operations" } } }, "localname": "BusinessAcquisitionsProFormaLossFromOperations", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "AMMJ_CannabisProducts": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cannabis Products" } } }, "localname": "CannabisProducts", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "AMMJ_CannabisSalesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cannabis Sales" } } }, "localname": "CannabisSalesPolicyTextBlock", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AMMJ_ConsultingAndAdvisoryRevenues": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Consulting Services" } } }, "localname": "ConsultingAndAdvisoryRevenues", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "AMMJ_ConsultingServicesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConsultingServicesPolicyTextBlock", "verboseLabel": "Consulting Services" } } }, "localname": "ConsultingServicesPolicyTextBlock", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AMMJ_CostOfCannabisProduct": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_CostOfRevenue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost of Cannabis Products" } } }, "localname": "CostOfCannabisProduct", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "AMMJ_CostOfConsultingAndAdvisory": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_CostOfRevenue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost of Consulting Services" } } }, "localname": "CostOfConsultingAndAdvisory", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "AMMJ_CostOfEquipmentSupplies": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_CostOfRevenue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost of Products and Equipment" } } }, "localname": "CostOfEquipmentSupplies", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "AMMJ_DebtForgiveness": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "DebtForgiveness", "negatedLabel": "Debt Forgiveness" } } }, "localname": "DebtForgiveness", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "AMMJ_DebtForgiveness1": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt Forgiveness" } } }, "localname": "DebtForgiveness1", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AMMJ_Deposit": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deposits" } } }, "localname": "Deposit", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "AMMJ_DisclosureOperatingLeaseRightofuseAssetoperatingLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Right-of-use Assetoperating Lease Liability" } } }, "localname": "DisclosureOperatingLeaseRightofuseAssetoperatingLeaseLiabilityAbstract", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "xbrltype": "stringItemType" }, "AMMJ_DisclosureStockPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Payable" } } }, "localname": "DisclosureStockPayableAbstract", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "xbrltype": "stringItemType" }, "AMMJ_EquipmentSuppliesRevenues": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Product & Equipment" } } }, "localname": "EquipmentSuppliesRevenues", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "AMMJ_GrantedRestrictedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:GrantedRestrictedShares]" } } }, "localname": "GrantedRestrictedShares", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "AMMJ_GrantedRestrictedValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[custom:GrantedRestrictedValue]" } } }, "localname": "GrantedRestrictedValue", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AMMJ_ImpactOfCovid19Pandemic": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impact of COVID-19 Pandemic" } } }, "localname": "ImpactOfCovid19Pandemic", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AMMJ_LeasePortfolioTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of lease" } } }, "localname": "LeasePortfolioTableTextBlock", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "AMMJ_LessAmountRepresentingInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Less: amount representing interest" } } }, "localname": "LessAmountRepresentingInterest", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "AMMJ_LessCurrentObligationsUnderLeases": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Less: current obligations under leases" } } }, "localname": "LessCurrentObligationsUnderLeases", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "AMMJ_LessDepositsRecognizedAsRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Less: Deposits recognized as revenue" } } }, "localname": "LessDepositsRecognizedAsRevenue", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvancesFromClients-AccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "AMMJ_LongTermDeposits": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Long Term Deposits" } } }, "localname": "LongTermDeposits", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "AMMJ_LongTermLiabilities": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Long Term Liabilities" } } }, "localname": "LongTermLiabilities", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "AMMJ_LoyaltyRewardProgramPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loyalty Reward Program" } } }, "localname": "LoyaltyRewardProgramPolicyTextBlock", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AMMJ_NaturaleafAssetAcquisitionTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchase price as of the acquisition" } } }, "localname": "NaturaleafAssetAcquisitionTableTextBlock", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "AMMJ_NetLoss": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "NetLoss", "totalLabel": "Net Loss" } } }, "localname": "NetLoss", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "AMMJ_NotePayableIssuedForAcquisitionOfAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Note Payable issued for acquisition of assets" } } }, "localname": "NotePayableIssuedForAcquisitionOfAssets", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AMMJ_OfficeEquipmentGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Office equipment" } } }, "localname": "OfficeEquipmentGross", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AMMJ_OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Right-of-Use Asset/Operating Lease Liability" } } }, "localname": "OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability" ], "xbrltype": "textBlockItemType" }, "AMMJ_PresentValueOfFutureMinimumLeasePayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Present value of future minimum lease payments" } } }, "localname": "PresentValueOfFutureMinimumLeasePayments", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "AMMJ_ProceedsFromSaleOfOtherAssets": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Acquisition of Assets" } } }, "localname": "ProceedsFromSaleOfOtherAssets", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AMMJ_ProductAndEquipmentSalesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Product and Equipment Sales" } } }, "localname": "ProductAndEquipmentSalesPolicyTextBlock", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AMMJ_RelatedPartyTransactions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RelatedPartyTransactions", "verboseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactions", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AMMJ_RightToUseLeaseAsset1": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Right to Use Lease Asset" } } }, "localname": "RightToUseLeaseAsset1", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AMMJ_ScheduleOfStockPayable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of stock payable" } } }, "localname": "ScheduleOfStockPayable", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/StockPayableTables" ], "xbrltype": "textBlockItemType" }, "AMMJ_SharesIssuedForCashAndReceivablesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares issued for cash, Shares" } } }, "localname": "SharesIssuedForCashAndReceivablesShares", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "AMMJ_SharesIssuedForCashAndReceivablesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock issued for cash" } } }, "localname": "SharesIssuedForCashAndReceivablesValue", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "AMMJ_SharesIssuedForExpensedIncurredAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares Issued for Expensed Incurred, Amount" } } }, "localname": "SharesIssuedForExpensedIncurredAmount", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/StockPayableDetails" ], "xbrltype": "monetaryItemType" }, "AMMJ_StockBasedCompensationExpense": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock Based Compensation Expense" } } }, "localname": "StockBasedCompensationExpense", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "AMMJ_StockIssuedForAcquisitionOfAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock issued for acquisition of assets" } } }, "localname": "StockIssuedForAcquisitionOfAssets", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AMMJ_StockIssuedForAssetAcquisitionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock issued for asset acquisition, Shares" } } }, "localname": "StockIssuedForAssetAcquisitionShares", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "AMMJ_StockIssuedForAssetAcquisitionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock issued for asset acquisition" } } }, "localname": "StockIssuedForAssetAcquisitionValue", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "AMMJ_StockIssuedForCashlessExerciseShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock issued for cashless exercise, Shares" } } }, "localname": "StockIssuedForCashlessExerciseShares", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "AMMJ_StockIssuedForCashlessExerciseValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock issued for cashless exercise of warrants" } } }, "localname": "StockIssuedForCashlessExerciseValue", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "AMMJ_StockIssuedForReceivables": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock issued for receivables" } } }, "localname": "StockIssuedForReceivables", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AMMJ_StockPayable": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock payable" } } }, "localname": "StockPayable", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "AMMJ_StockPayableAmounts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "StockPayableAmounts", "periodEndLabel": "Ending Stock Payable, Amount", "periodStartLabel": "[custom:StockPayableAmounts-1]" } } }, "localname": "StockPayableAmounts", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/StockPayableDetails" ], "xbrltype": "monetaryItemType" }, "AMMJ_StockPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "StockPayableTextBlock", "verboseLabel": "Stock Payable" } } }, "localname": "StockPayableTextBlock", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/StockPayable" ], "xbrltype": "textBlockItemType" }, "AMMJ_StockbasedCompensationToEmployees1": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock-based compensation to employees" } } }, "localname": "StockbasedCompensationToEmployees1", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AMMJ_StockbasedCompensationToEmployeesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock-based compensation to employees, Shares" } } }, "localname": "StockbasedCompensationToEmployeesShares", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "AMMJ_SupplementalDisclosureOfCashFlowInformation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL CASH FLOW INFORMATION:" } } }, "localname": "SupplementalDisclosureOfCashFlowInformation", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "AMMJ_Total": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total [Default Label]", "verboseLabel": "Total" } } }, "localname": "Total", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Stock-basedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "AMMJ_TotalConsiderationCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total consideration" } } }, "localname": "TotalConsiderationCost", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "AMMJ_UnauditedInterimFinancialStatements": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unaudited Interim Financial Statements" } } }, "localname": "UnauditedInterimFinancialStatements", "nsuri": "http://AmericanCannabisCompanyInc.com/20210630", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r349", "r351", "r352" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndNotesReceivableNet": { "auth_ref": [ "r29", "r154", "r314" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of accounts and financing receivable. Includes, but is not limited to, notes and loan receivable.", "label": "Accounts Receivable, net" } } }, "localname": "AccountsAndNotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvancesFromClients-AccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "verboseLabel": "Accrued and Other Current Liabilities" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.", "label": "Accounts Payable and Other Accrued Liabilities", "verboseLabel": "Accrued and other current liabilities" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilities-AccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r43", "r296" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "auth_ref": [ "r305", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableOtherCurrent": { "auth_ref": [ "r9", "r43" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Other Accrued Expenses & Payables" } } }, "localname": "AccountsPayableOtherCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilities-AccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGross": { "auth_ref": [ "r154" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable \u2013 Trade" } } }, "localname": "AccountsReceivableGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvancesFromClients-AccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r29", "r314", "r335" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, Net" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Interest" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilities-AccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r8", "r9", "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Payroll" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilities-AccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r42", "r178" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquisitionRelatedCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information).", "label": "Acquisition-related Costs [Member]" } } }, "localname": "AcquisitionRelatedCostsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r30", "r238", "r296" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r93", "r94", "r95", "r235", "r236", "r237", "r269" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising and Promotion Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": { "auth_ref": [ "r157" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r35", "r157", "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "negatedLabel": "Less:\u00a0\u00a0Allowance for Doubtful Accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvancesFromClients-AccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionTextBlock": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for asset acquisition.", "label": "Naturaleaf Asset Acquisition" } } }, "localname": "AssetAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisition" ], "xbrltype": "textBlockItemType" }, "us-gaap_Assets": { "auth_ref": [ "r90", "r134", "r143", "r149", "r163", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r260", "r264", "r272", "r294", "r296", "r302", "r315" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r54", "r90", "r163", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r260", "r264", "r272", "r294", "r296" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r16", "r17", "r18", "r19", "r20", "r21", "r22", "r23", "r90", "r163", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r260", "r264", "r272", "r294" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total Other Assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]" } } }, "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Schedule of the nature and amount of any material, nonrecurring adjustments directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]" } } }, "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r253", "r254" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Pro Forma Financial Information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r253", "r254" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Total Revenues" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r256", "r257" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Identifiable intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r2", "r92", "r129" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Description of Business." } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/DescriptionOfBusiness." ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalLeaseObligations": { "auth_ref": [ "r25", "r286", "r317" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.", "label": "Long-term lease obligations" } } }, "localname": "CapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeaseObligationsCurrent": { "auth_ref": [ "r24", "r285", "r286" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer.", "label": "Right of Use Liabilities, current" } } }, "localname": "CapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r286" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum lease payments for capital leases.", "label": "Capital Leases, Future Minimum Payments Due", "verboseLabel": "Total" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r286" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Capital Leases, Future Minimum Payments Due, Next Twelve Months", "verboseLabel": "2021" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r286" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Capital Leases, Future Minimum Payments Due in Two Years", "verboseLabel": "2022" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r39", "r296", "r332", "r333" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r39", "r81" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Equivalents", "periodEndLabel": "CASH AT END OF PERIOD", "periodStartLabel": "CASH AT BEGINNING OF PERIOD" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets", "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r15", "r82" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r74", "r273" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "NET DECREASE IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r182", "r183", "r184", "r185", "r336" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r93", "r94", "r269" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockOtherSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.", "label": "Common Stock Shares Outstanding" } } }, "localname": "CommonStockOtherSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock Par Value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r28", "r296" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.00001 par value; 500,000,000 shares authorized; 79,902,938 and 70,727,938 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r123", "r312" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Significant Clients and Customers" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r25", "r303", "r316", "r334" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable", "verboseLabel": "Stock Payable" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Stock-basedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r66", "r90", "r163", "r186", "r187", "r188", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r272" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "totalLabel": "Total Cost of Revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Revenues" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Costs of Revenues" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r88", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r205", "r206", "r207", "r208", "r212" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Loans Payable" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/LoansPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DepositContractsPolicy": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the treatment of funds received from or paid to insureds, insurers and reinsurers on contracts for which the criteria for transferring or assuming insurance risk has not been satisfied by the insurer or reinsurer.", "label": "Deposit Contracts, Policy [Policy Text Block]", "verboseLabel": "Deposits" } } }, "localname": "DepositContractsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r79", "r176" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r64", "r98", "r99", "r100", "r101", "r102", "r107", "r109", "r112", "r113", "r114", "r117", "r118", "r270", "r271", "r307", "r323" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic net loss per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r115", "r116" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Loss Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r58", "r59", "r60", "r93", "r94", "r95", "r97", "r103", "r105", "r120", "r164", "r226", "r227", "r235", "r236", "r237", "r249", "r250", "r269", "r274", "r275", "r276", "r277", "r278", "r279", "r326", "r327", "r328", "r359" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnSalesOfAssets": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets utilized in financial service operations.", "label": "Gain (Loss) on Disposition of Assets for Financial Service Operations", "negatedLabel": "Gain on Sale of assets" } } }, "localname": "GainsLossesOnSalesOfAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r67" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r169", "r170", "r296", "r301" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets", "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r171", "r173" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r65", "r90", "r134", "r142", "r145", "r148", "r150", "r163", "r186", "r187", "r188", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r272" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r175", "r180" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Accounting for the Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r91", "r104", "r105", "r133", "r244", "r251", "r252", "r324" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r57", "r242", "r243", "r245", "r246", "r247", "r248" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r76", "r83" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r78" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts Payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r78" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent": { "auth_ref": [ "r78" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in intangible assets (for example patents and licenses).", "label": "Increase (Decrease) in Intangible Assets, Current", "negatedLabel": "Intangible assets" } } }, "localname": "IncreaseDecreaseInIntangibleAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r78" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "verboseLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingLiabilities": { "auth_ref": [ "r78" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.", "label": "Operating Lease Liability" } } }, "localname": "IncreaseDecreaseInOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r78" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Accrued and other current liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r78" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInTimeDeposits": { "auth_ref": [ "r309" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net cash inflow (outflow) of time deposits.", "label": "Increase (Decrease) in Time Deposits", "verboseLabel": "Deposits" } } }, "localname": "IncreaseDecreaseInTimeDeposits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r172", "r174" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpense": { "auth_ref": [ "r281" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.", "label": "Bad debt expense" } } }, "localname": "InterestAndDebtExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r61", "r132", "r280", "r282", "r308" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest (expense)" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r72", "r75", "r83" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r49" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished Goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "verboseLabel": "Inventory" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r52", "r296" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory", "verboseLabel": "Total Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets", "http://AmericanCannabisCompanyInc.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r11", "r53", "r85", "r119", "r166", "r167", "r168", "r299" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw Materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work In Process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsGross": { "auth_ref": [ "r7", "r177" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.", "label": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r44", "r90", "r144", "r163", "r186", "r187", "r188", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r261", "r264", "r265", "r272", "r294", "r295" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r34", "r90", "r163", "r272", "r296", "r304", "r319" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r46", "r90", "r163", "r186", "r187", "r188", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r261", "r264", "r265", "r272", "r294", "r295", "r296" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r12", "r13", "r14", "r25", "r26", "r90", "r163", "r186", "r187", "r188", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r261", "r264", "r265", "r272", "r294", "r295" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Long Term Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "Accounts Receivable and Advance from Clients" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvanceFromClients" ], "xbrltype": "textBlockItemType" }, "us-gaap_LoansPayable": { "auth_ref": [ "r25", "r303", "r313" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Note payables, current" } } }, "localname": "LoansPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r25", "r204", "r209", "r210", "r211", "r303", "r317" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "verboseLabel": "Long Term Deposits" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r7", "r177" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r74" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r74" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Provided by (Used in) Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r74", "r77", "r80" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash used in Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r55", "r56", "r60", "r63", "r80", "r90", "r96", "r98", "r99", "r100", "r101", "r104", "r105", "r110", "r134", "r142", "r145", "r148", "r150", "r163", "r186", "r187", "r188", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r271", "r272", "r306", "r322" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r98", "r99", "r100", "r101", "r107", "r108", "r111", "r114", "r134", "r142", "r145", "r148", "r150" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "negatedLabel": "Net Loss" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r68" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "AMMJ_NetLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other (Expense) Income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonrecurringAdjustmentAxis": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).", "label": "Nonrecurring Adjustment [Axis]" } } }, "localname": "NonrecurringAdjustmentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NonrecurringAdjustmentDomain": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information)." } } }, "localname": "NonrecurringAdjustmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses [Default Label]", "totalLabel": "Total Operating Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r134", "r142", "r145", "r148", "r150" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "AMMJ_NetLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r288" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Right of Use Liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r287" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of Use Assets - Operating Leases, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r283", "r284" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Total" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r283", "r284" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r283", "r284" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r92", "r106", "r129", "r268" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Principles of Consolidation." } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PrinciplesOfConsolidation." ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r8", "r9", "r10", "r45" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Accrued and Other Current Liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r325" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other liabilities.", "label": "Operating leases liabilities" } } }, "localname": "OtherLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income (Expense)" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OtherSellingAndMarketingExpense": { "auth_ref": [ "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of selling and marketing expense classified as other.", "label": "Selling and marketing expense" } } }, "localname": "OtherSellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PreferredStockNoParValue": { "auth_ref": [ "r27", "r213" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock Par Value" } } }, "localname": "PreferredStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r27", "r213" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r27", "r296" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2021 and December 31, 2020" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid Expenses and Other Current Assets" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r70" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r71" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from PPP loan" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r69" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from sales of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r55", "r56", "r60", "r73", "r90", "r96", "r104", "r105", "r134", "r142", "r145", "r148", "r150", "r163", "r186", "r187", "r188", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r259", "r262", "r263", "r266", "r267", "r271", "r272", "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "NET LOSS" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r42", "r179" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r181", "r337", "r338", "r339" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentDisposals": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Disposals", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentDisposals", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r41", "r177" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, plant and equipment", "verboseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/NaturaleafAssetAcquisitionDetails", "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r19", "r20", "r179", "r296", "r311", "r320" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and Equipment - Net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentOtherNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.", "label": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentOtherNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r40", "r179", "r337", "r338" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "verboseLabel": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r19", "r179" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r19", "r177" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for classification and method of accounting for interest-only strips, loans, other receivables, or retained interests in securitizations that can be contractually prepaid or otherwise settled in a way that the holder would not recover substantially all of its recorded investment.", "label": "Receivables and Portions of Securitizations that can be Prepaid at Potential Loss, Policy [Policy Text Block]", "verboseLabel": "Prepaid Expenses and Other Current Assets" } } }, "localname": "ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r156", "r160", "r161", "r162" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r289", "r290", "r291", "r292", "r293" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r31", "r227", "r238", "r296", "r318", "r329", "r330" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r93", "r94", "r95", "r97", "r103", "r105", "r164", "r235", "r236", "r237", "r249", "r250", "r269", "r326", "r328" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r86", "r87" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r62", "r90", "r130", "r131", "r141", "r146", "r147", "r151", "r152", "r153", "r163", "r186", "r187", "r188", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r272", "r310" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues [Default Label]", "totalLabel": "Total Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r9", "r43" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales Tax Payable" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilities-AccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "verboseLabel": "Accounts Receivable and Advance from Clients" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccountsReceivableAndAdvanceFromClientsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "verboseLabel": "Accrued and Other Current Liabilities" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/AccruedAndOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r11", "r36", "r37", "r38" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "verboseLabel": "Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r42", "r179" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r232", "r233", "r234" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of stock based compensation" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r135", "r136", "r137", "r138", "r139", "r140", "r152" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Information" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r230", "r231" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r228", "r239" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "Stock Based Compensation" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Ending Balance, Shares", "periodStartLabel": "Beginning Balance, Shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingCostPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.", "label": "Shipping and Handling Costs" } } }, "localname": "ShippingAndHandlingCostPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r84", "r92" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internally developed software for sale, licensing or long-term internal use.", "label": "Software Development [Member]" } } }, "localname": "SoftwareDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/PropertyAndEquipmentNet-PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r47", "r58", "r59", "r60", "r93", "r94", "r95", "r97", "r103", "r105", "r120", "r164", "r226", "r227", "r235", "r236", "r237", "r249", "r250", "r269", "r274", "r275", "r276", "r277", "r278", "r279", "r326", "r327", "r328", "r359" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r93", "r94", "r95", "r120", "r300" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture", "verboseLabel": "Stock-based compensation to employees" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionPlanExpense": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for option under share-based payment arrangement.", "label": "stock based compensation expense" } } }, "localname": "StockOptionPlanExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r28", "r32", "r33", "r90", "r158", "r163", "r272", "r296" ], "calculation": { "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance,\u00a0June 30, 2021", "periodStartLabel": "Balance,\u00a0December 31, 2021", "totalLabel": "Total Shareholders' Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets", "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders' Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r89", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r227", "r228" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r297", "r298" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r121", "r122", "r124", "r125", "r126", "r127", "r128" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates in Financial Reporting" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/Stock-basedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Basic weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://AmericanCannabisCompanyInc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r129": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r159": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r168": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r181": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r184": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r185": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r212": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r228": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r229": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "http://asc.fasb.org/topic&trid=2122478" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r239": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r268": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406127&loc=d3e45023-112735" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r293": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r298": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16)(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6487483&loc=d3e32239-158577" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123366838&loc=d3e3073-115593" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r341": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r342": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r343": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r344": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r345": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r346": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r347": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r348": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r349": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r351": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r352": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r353": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r354": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r355": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r356": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r357": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r358": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r92": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" } }, "version": "2.1" } ZIP 61 0001721868-21-000488-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001721868-21-000488-xbrl.zip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end